itraconazole has been researched along with voriconazole in 663 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 26 (3.92) | 18.2507 |
| 2000's | 224 (33.79) | 29.6817 |
| 2010's | 314 (47.36) | 24.3611 |
| 2020's | 99 (14.93) | 2.80 |
| Authors | Studies |
|---|---|
| Driscoll, MD; Lafite, P; Levy, C; Leys, D; Mast, N; McLean, KJ; Munro, AW; Pikuleva, IA; Rigby, SE | 1 |
| Hitchcock, CA; Martin, MV; Yates, J | 1 |
| Armstrong, D; Bernard, EM; Ishimaru, T; Murphy, M | 1 |
| Johnson, EM; Radford, SA; Warnock, DW | 1 |
| Jones, RN; Marco, F; Messer, S; Pfaller, MA | 1 |
| Nguyen, MH; Yu, CY | 2 |
| Kauffman, CA; Zarins, LT | 2 |
| McGinnis, MR; Pasarell, L | 1 |
| Denning, DW; Moore, CB; Oakley, KL | 1 |
| Cantu, RA; Fothergill, AW; Kirkpatrick, WR; Lopez-Ribot, JL; Mcatee, RK; McCarthy, DI; Patterson, TF; Revankar, SG; Rinaldi, MG; Sanche, SE | 1 |
| Cooper, CR; Fothergill, AW; McGinnis, MR; Pasarell, L; Rinaldi, MG; Sutton, DA | 1 |
| Denning, DW; Donnelly, JP; Meis, JF; Mensink, M; Rijs, AJ; Verweij, PE | 1 |
| Chandrasekar, PH; Cutright, JL; Manavathu, EK | 2 |
| Cuenca-Estrella, M; Martínez-Suárez, JV; Mellado, E; Monzón, A; Rodríguez-Tudela, JL | 1 |
| Brandt, ME; Ghannoum, MA; Hajjeh, RA; Jessup, CJ; Mbidde, EK; Messer, SA; Pfaller, MA; Tumberland, M; Zhang, J | 1 |
| Chandrasekar, PH; Cutright, J; Manavathu, EK | 1 |
| Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ | 1 |
| Abraham, OC; Chandrasekar, PH; Cutright, JL; Manavathu, EK | 1 |
| Johnson, EM; Szekely, A; Warnock, DW | 1 |
| Jones, RN; Marco, F; Messer, SA; Pfaller, MA | 1 |
| Amalfitano, G; Concia, E; Kwon-Chung, KJ; Luzzati, R; Mondon, P; Petter, R; Polacheck, I | 1 |
| Cuenca-Estrella, M; Díaz-Guerra, TM; Mellado, E; Monzón, A; Rodríguez-Tudela, JL | 1 |
| Arikan, S; Lozano-Chiu, M; Nangia, S; Paetznick, V; Rex, JH | 1 |
| Ciblak, MA; Li, RK; McGinnis, MR; Nordoff, N; Pasarell, L; Warnock, DW | 1 |
| Niki, Y | 1 |
| Chandrasekar, PH; Cutright, JL; Loebenberg, D; Manavathu, EK | 1 |
| Bretagne, S; Curfs, JH; Meis, JF; Verweij, PE; Weemaes, CM | 1 |
| Arikan, S; Kocagöz, S; Sancak, B; Unal, S; Uzun, O | 1 |
| Amariglio, N; Bielorai, B; Golan, H; Kaplinisky, C; Keller, N; Mandel, M; Neumann, Y; Paswell, J; Rechavi, G; Toren, A; Weintraub, M; Wolach, B | 1 |
| Dierich, MP; Lass-Flörl, C; Nagl, M; Speth, C; Ulmer, H; Würzner, R | 1 |
| Espinel-Ingroff, A | 1 |
| Leitner, I; Ryder, NS | 1 |
| Kämmerer, R; Klempien, I; Kujath, P; Muhl, E | 1 |
| Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ | 1 |
| Abraham, OC; Chandrasekar, PH; Manavathu, EK | 1 |
| Boyle, K; Espinel-Ingroff, A; Sheehan, DJ | 1 |
| Crego, AL; Gómez, J; Lavandera, JL; Marina, ML | 1 |
| Li, RK; McGinnis, MR; Nordoff, N; Pasarell, L; Warnock, DW | 1 |
| Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A | 1 |
| Cuenca-Estrella, M; Gómez-López, A; Monzón, A; Rodriguez-Tudela, JL | 1 |
| Denning, DW; Mosquera, J | 1 |
| De Roux, A; Grassot, A; Grysczyk, H; Lode, H; Mauch, H | 1 |
| Fothergill, AW; Gonzalez, G; Perea, S; Rinaldi, MG; Sutton, DA | 1 |
| Gil-Lamaignere, C; Maloukou, A; Mosquera, J; Roilides, E; Walsh, TJ | 1 |
| De Vries-Hospers, HG; Meis, JF; Rijs, AJ; Te Dorsthorst, DT; Verweij, PE | 1 |
| Bastide, JM; Dannaoui, E; Grillot, R; Mallie, M; Meletiadis, J; Piens, MA; Rigoni, AL; Tortorano, AM; Viviani, MA | 1 |
| Bacigalupo, A; Ferrua, MT; Gallamini, A; Ghirardo, D; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Viscoli, C | 1 |
| Kottom, TJ; Limper, AH; Morales, IJ; Puri, V; Thomas, CF; Vohra, PK | 1 |
| Bernal, S; Chávez M, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Ramirez, M; Serrano, Mdel C; Valverde-Conde, A | 1 |
| Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, JB; Pfaller, MA | 1 |
| Dierch, MP; Gunsilius, E; Kofler, G; Lass-Flörl, C; Speth, C; Würzner, R | 1 |
| Kamei, K | 1 |
| Lipp, HP | 2 |
| Hamza, SH; Mercado, PJ; Skelton, HG; Smith, KJ | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzón, A; Rodriguez-Tudela, JL | 3 |
| del Palacio, A; Garau, M; Pereiro, M | 1 |
| Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 2 |
| Chávez-Caballero, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Serrano-Martino, Mdel C; Valverde-Conde, A | 1 |
| Kontoyiannis, DP; Lewis, RE; Lionakis, MS; Liu, W; May, GS; Wiederhold, N | 1 |
| Chaturvedi, V; Gangwar, M; Ramani, R | 1 |
| Bonner, D; Fung-Tomc, J; Huczko, E; Minassian, B; Washo, T | 1 |
| Fujihara, N; Ichiyama, S; Iinuma, Y; Kudo, T; Saito, T; Takakura, S | 1 |
| Maertens, JA | 1 |
| Capilla, J; Guarro, J; Javier Pastor, F; Ortoneda, M; Pujol, I | 1 |
| Schwartz, S; Thiel, E | 1 |
| Nolard, N; Swinne, D; Van der Flaes, M; Watelle, M | 1 |
| Kuijper, EJ; Kullberg, BJ; van 't Wout, JW; Verweij, PE | 1 |
| Gavaldá, J; Lumbreras, C | 1 |
| Wark, P | 1 |
| Jones, AL; Pai, MP | 1 |
| Balajee, SA; Gribskov, JL; Imhof, A; Marr, KA | 1 |
| Cariani, L; Drago, M; Morace, G; Scaltrito, MM | 1 |
| Alexander, BD; Brennan, K; Forrest, G; Husain, S; Muñoz, P; Singh, N; Somani, J; Wagener, MM | 1 |
| Han, XY; Hassan, SA; Matsuda, SP; May, GS; Tarrand, JJ; Wilson, WK; Xiong, Q | 1 |
| García-Agudo, L; García-Martos, P; Gutiérrez-Calzada, J; Marín, P; Ruiz-Aragón, J; Saldarreaga, A | 1 |
| Klepser, ME; Lewis, RE; Wiederhold, NP | 1 |
| Alcazar-Fuoli, L; Buitrago, MJ; Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL | 1 |
| Bastide, JM; Blancard, A; Bonnin, A; Bretagne, S; Cambon, M; Chandenier, J; Chauveau, V; Couprie, B; Datry, A; Feuilhade, M; Grillot, R; Guiguen, C; Lavarde, V; Letscher, V; Linas, MD; Mallié, M; Michel, A; Morin, O; Paugam, A; Piens, MA; Raberin, H; Tissot, E; Toubas, D; Wade, A | 1 |
| Yasuda, MA | 1 |
| Nolard, N; Swinne, D; Watelle, M | 1 |
| Chaberny, IF; Fischer, S; Gastmeier, P; Gottlieb, J; Haubitz, B; Mattner, F; Mattner, L; Strueber, M; Weissbrodt, H | 1 |
| Eggink, CA; Klont, RR; Rijs, AJ; Verweij, PE; Wesseling, P | 1 |
| Böhme, A; Haas, A; Maschmeyer, G | 1 |
| Steinbach, WJ | 1 |
| Fruehwirth, F; Khoschsorur, G; Zelzer, S | 1 |
| Chen, E; Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, VL; Philip, A; Rex, JH; Rodriguez, J | 1 |
| Barchiesi, F; Cuenca-Estrella, M; Espinel-Ingroff, A; Pfaller, MA; Rinaldi, M; Rodriguez-Tudela, JL; Verweij, PE | 1 |
| Jagirdar, J; Scott, RS; Sutton, DA | 1 |
| Cetinkaya, Z; Kiraz, N | 1 |
| Jiménez-Cabello, T; Morera-López, Y; Torres-Rodríguez, JM | 1 |
| Cárdenes, CD; Carrillo-Muñoz, AJ; Carrillo-Orive, B; Casals, JB; Del Valle, O; Ezkurra, PA; Quindós, G; Rodríguez, V | 1 |
| Costa-de-Oliveira, S; Mårdh, PA; Pina-Vaz, C; Ricardo, E; Rodrigues, AG | 1 |
| Barchiesi, F; Cuenca-Estrella, M; Espinel-Ingroff, A; Fothergill, A; Pfaller, MA; Rinaldi, M; Rodriguez-Tudela, JL; Verweij, PE | 1 |
| Costa-de-Oliveira, S; Espinel-Ingroff, A; Pina-Vaz, C; Rodrigues, AG | 1 |
| Bagg, J; Brailsford, S; Davies, AN; Jackson, MS; Sweeney, MP | 1 |
| Alía-Aponte, C; Baró-Tomás, T; Jiménez-Cabello, T; Lázera, MS; Morera-López, Y; Torres-Rodríguez, JM | 1 |
| Bishara, J; Peled, N; Samra, Z; Yardeni, M | 1 |
| Niwa, T; Shiraga, T; Takagi, A | 1 |
| Espinel-Ingroff, A; Fothergill, A; Ghannoum, M; Manavathu, E; Ostrosky-Zeichner, L; Pfaller, M; Rinaldi, M; Schell, W; Walsh, T | 1 |
| Colombo, GL; Morlotti, L; Serra, G | 1 |
| Bennett, JE; Boucher, HW; Denning, DW; DePauw, B; Herbrecht, R; Lortholary, O; Patterson, TF; Ribaud, P; Rubin, RH; Schlamm, HT; Troke, P; Wingard, JR | 1 |
| Bagg, J; Coulter, WA; Kuriyama, T; Lewis, MA; Ready, D; Williams, DW | 1 |
| Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G | 1 |
| Cutler, JE; Hazen, KC; Wetter, TJ | 1 |
| Araujo, R; Pina-Vaz, C; Rodrigues, AG | 2 |
| Alcalá, L; Bouza, E; Guinea, J; Peláez, T | 3 |
| Gribskov, JL; Kirby, KA; Marr, KA; Panackal, AA; Rinaldi, M; Staab, JF | 1 |
| Black, TA; Hare, R; Loebenberg, D; Mann, PA; McNicholas, PM; Mendrick, CA; Norris, CC; Patel, R; Sabatelli, F | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL | 1 |
| Denning, DW; Dupont, B; Lode, H; Sambatakou, H | 1 |
| Arechavala, A; Bianchi, MH; López Daneri, G; Negroni, R; Robles, AM; Santiso, G | 1 |
| Chaturvedi, V; Cole, R; Gangwar, M; Ramani, R; Sheehan, DJ | 1 |
| Bailey, TA; Di Somma, A; Silvanose, CD | 1 |
| Cepero de García, MC; Espinel-Ingroff, A; Rincón, S | 1 |
| Bouges-Michel, C; Dannaoui, E; Garcia-Hermoso, D; Lortholary, O; Meneau, I; Naccache, JM; Sanglard, D; Valeyre, D | 1 |
| Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
| Denning, DW; Gardiner, RE; Howard, SJ; Moore, CB; Park, S; Perlin, DS; Webster, I | 1 |
| Denning, DW; Heep, M; Mosquera, J; Schmitt-Hoffmann, A; Sharp, A; Spickermann, J; Warn, PA | 1 |
| Canton, E; Espinel-Ingroff, A; Gibbs, D; Wang, A | 1 |
| Costa, CR; de Araujo, CR; de Fátima Lisboa Fernandes, O; do Rosário Rodrigues Silva, M; Miranda, KC; Passos, XS | 1 |
| Bandrés Gimeno, R; Muñoz Martínez, MJ | 1 |
| Maesaki, S | 2 |
| da Silva Barros, ME; de Assis Santos, D; Soares Hamdan, J | 1 |
| Araújo, CR; Costa, CR; e Souza, LK; Fernandes, Ode F; Nascimento, ES; Passos, XS; Sales, WS; Silva, Mdo R | 1 |
| Avci, B; Cetinkaya, Z; Ermis, SS; Inan, UU; Kusbeci, T; Ozturk, F; Yavas, G | 1 |
| Sellart-Altisent, M; Torres-Rodríguez, JM | 1 |
| James, C; Moore, MH; Murphy, D | 1 |
| Arthington-Skaggs, B; Ellis, D; Espinel-Ingroff, A; Fothergill, A; Gibbs, DL; Iqbal, N; Messer, S; Pfaller, MA; Rinaldi, M; Wang, A | 1 |
| Alvarado-Ramírez, E; Torres-Rodríguez, JM | 1 |
| Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA | 1 |
| Aller, AI; Castro, C; Claro, R; Colom, MF; Martín-Mazuelos, E; Serrano, C | 1 |
| Hay, RJ | 1 |
| Gupta, A; Mao, Q; Unadkat, JD | 1 |
| Germaud, P; Pipet, A | 1 |
| Acharya, NR; Chidambaram, JD; Fothergill, AW; Hong, KC; Lalitha, P; Lietman, TM; Maxey, KJ; McLeod, SD; Prajna, NV; Ruiz, J; Shapiro, BL; Srinivasan, M | 1 |
| Chen, SC; Sorrell, TC | 1 |
| Cetinkaya, Z; Ermis, SS; Inan, UU; Kiraz, N; Küsbeci, T; Oztürk, F; Yavas, GF | 1 |
| Kaya, AD; Kiraz, N | 1 |
| Chang, CL; Kim, MN; Kim, SH; Lee, HS; Lee, JS; Lee, K; Lee, WG; Ryang, DW; Shin, BM; Shin, JH; Shin, MG; Suh, SP; Uh, Y | 1 |
| Espinel-Ingroff, A; Goldani, LZ; Goodrich, JM; Queiroz-Telles, F; Schlamm, HT; Shikanai-Yasuda, MA | 1 |
| Abrantes, R; Córdoba, S; Davel, G; Rodero, L; Vitale, RG; Vivot, W | 1 |
| Alves, SH; Argenta, JS; Cavalheiro, AS; Ferreiro, L; Pereira, DI; Santurio, JM; Spanamberg, A | 1 |
| Auler, ME; Dias, AL; Gandra, RF; Gonçalves da Silva, E; Matsumoto, FE; Melhem, MS; Paula, CR; Ruiz, LS; Szeszs, MW | 1 |
| Conti, S; Drago, M; Fanti, F; Morace, G; Polonelli, L; Scaltrito, MM | 1 |
| Carrillo-Muñoz, AJ; Casals, JB; del Valle, O; Estivill, MD; Ezkurra, PA; Giusiano, G; Quindós, G; Santos, P | 1 |
| Andrew, S; Fitzgerald, D; Singh, MN | 1 |
| Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA | 1 |
| Espinel-Ingroff, A; Hockey, H; Johnson, E; Troke, P | 1 |
| Almeida, C; Martín-Mazuelos, E; Méndez, CC; Pemán, J; Serrano, MC; Valverde, A | 1 |
| Ali, S; Whittle, AM | 1 |
| Ergon, C; Metin, DY; Ozkutuk, A; Polat, SH; Yucesoy, M | 1 |
| Andes, D; Smith, J | 1 |
| Aragane, N; Fukuno, Y; Fukuoka, M; Hayashi, S; Kawaura, F; Kobayashi, H; Matsuishi, E; Sano, A; Tanaka, M | 1 |
| Alastruey-Izquierdo, A; Alcazar-Fuoli, L; Cuenca-Estrella, M; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
| Ooi, WW; Srinivasan, J | 1 |
| Ayala, J; Elizondo, M; González, GM | 1 |
| Dolande, M; Panizo, MM; Reviákina, V; Selgrad, S | 1 |
| Altas, K; Boekhout, T; Kantarcioğlu, AS; Yücel, A | 1 |
| Hollenbach, E | 1 |
| Gafter-Gvili, A; Goldberg, E; Leibovici, L; Paul, M; Vidal, L | 1 |
| Espinel-Ingroff, A; Hockey, H; Johnson, E; Szekely, A; Troke, P | 1 |
| Anderson, R; Steel, HC; Tintinger, GR | 1 |
| Brown, TA; Grooters, AM; Hosgood, GL | 1 |
| Donders, AR; Kuijpers, J; Melchers, WJ; Mellado, E; Rijs, AJ; Samson, RA; Snelders, E; van der Lee, HA; Varga, J; Verweij, PE | 1 |
| Bertilsson, L; Hynninen, VV; Korhonen, T; Kurkinen, KJ; Laine, K; Neuvonen, PJ; Olkkola, KT | 1 |
| Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Touw, DJ; Verweij, PE | 1 |
| Bearman, G; Pakyz, A | 1 |
| Maesaki, S; Tarumoto, N | 1 |
| Fujii, Y; Inase, N; Yoshizawa, Y | 1 |
| dos Santos Lazéra, M; Guarro, J; Pastor, FJ; Pujol, I | 1 |
| Fothergill, AW; Rinaldi, MG; Sutton, DA | 1 |
| de Mol, P; Meis, JF | 1 |
| Fatuzzo, F; Iacobello, C; La Rosa, R; Larocca, L; Montineri, A; Nigro, L | 1 |
| Alp, S; Arikan, S; Hascelik, G; McNicholas, P; Sancak, B | 1 |
| Beernaert, LA; Dorrestein, GM; Haesebrouck, F; Martel, A; Pasmans, F; Van Waeyenberghe, L; Vercammen, F; Verstappen, F | 1 |
| Amrein, C; Benammar, M; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Lefeuvre, S | 1 |
| Ben-Ami, R; Chamilos, G; Kontoyiannis, DP; Lamaris, GA; Lewis, RE; Samonis, G | 1 |
| Danzi, M; Marino, A; Mungiguerra, M; Pisano, L; Ricciardi, AM; Ricciardi, R | 1 |
| Hasegawa, A; Imaji, M; Kano, R; Maruyama, H; Murakami, Y; Okabayashi, K; Osumi, T; Watanabe, T | 1 |
| Bulut, Y; Günday, E; Güven, M; Yenişehirli, G | 1 |
| Ambudkar, SV; Manoharlal, R; Prasad, R; Prasad, T; Puri, N; Sharma, M; Shukla, S | 1 |
| Brilhante, RS; Cordeiro, Rde A; de Camargo, ZP; de Lima, RA; Medrano, DJ; Monteiro, AJ; Rocha, MF; Sidrim, JJ; Tavares, JL | 1 |
| Li, R; Liu, W; Wan, Z; Wang, X; Yang, J | 1 |
| Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S | 1 |
| Accoceberry, I; Bernadou, JM; Breilh, D; Gordien, JB; Pigneux, A; Rouault, A; Saux, MC; Tabrizi, R; Vigouroux, S | 1 |
| Alp, S; Arikan, S; Hasçelik, G; Sancak, B | 1 |
| Albarrag, A; Anderson, MJ; Arendrup, MC; Cerar, D; Denning, DW; Fisher, MC; Howard, SJ; Laverdiere, M; Pasqualotto, AC; Perlin, DS | 1 |
| Angel, LF; Brady, R; Cadena, J; Levine, DJ; Levine, SM; Maxwell, PR; Michalek, JE; Restrepo, MI; Sanchez, JF | 1 |
| Balajee, SA; Brandt, ME; Gade, L; McCloskey, CB | 1 |
| Denning, DW; Howard, SJ; Pasqualotto, AC | 1 |
| Anasetti, C; Field, T; Gergis, U; Greene, J; Huang, Y; Kharfan-Dabaja, M; Markey, K; Perkins, J; Schell, MJ; Wetzstein, G | 1 |
| Cao, Y; Che, X; Ji, H; Miao, Z; Sheng, C; Wang, W; Yao, J; Zhang, W | 1 |
| Bonnal, C; Bouges-Michel, C; Bretagne, S; Chochillon, C; Dannaoui, E; Datry, A; Develoux, M; Dromer, F; Matheron, J; Paugam, A | 1 |
| Bueno, JG; Gallego, M; Martinez, C; Mesa, AC; Sanclemente, G; Zapata, B | 1 |
| Al-Abdely, HM; Al-Tawfiq, JA | 1 |
| Alvarado, G; Blamble, D; Cortes, J; Faderl, S; Hernandez, M; Kantarjian, H; Koller, C; Mattiuzzi, GN; Pierce, S; Verstovsek, S; Xiao, L | 1 |
| Bakker-Woudenberg, IA; Tavakol, M; van de Sande, WW; van Vianen, W | 1 |
| Bellete, B; Flori, P; Hafid, J; Manhsung, RT; Morel, J; Raberin, H | 1 |
| Badali, H; De Hoog, GS; Illnait-Zaragozi, MT; Meis, JF; Najafzadeh, MJ | 1 |
| Dag, I; Kasifoglu, N; Kiraz, N; Kiremitci, A; Oz, Y; Yamac, M | 1 |
| Besse, B; Hennequin, C; Le Pape, P; Loge, C; Morio, F | 1 |
| Vera-Cabrera, L; Welsh, E; Welsh, O | 1 |
| Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA | 1 |
| Baietto, L; D'Avolio, A; De Rosa, FG; Di Perri, G; Sciandra, M; Siccardi, M; Simiele, M; Ventimiglia, G | 1 |
| Kondori, N; Mattsby-Baltzer, I; Svensson, E | 1 |
| Murayama, N; Nakamoto, M; Niwa, T; Shimizu, M; Yamazaki, H | 1 |
| Canton, E; Diekema, DJ; Espinel-Ingroff, A; Fothergill, A; Johnson, E; Pelaez, T; Pfaller, MA; Rinaldi, MG; Turnidge, J | 1 |
| Kelly, DE; Kelly, SL; Lamb, DC; Martel, CM; Melo, N; Nes, WD; Parker, JE; Warrilow, AG | 1 |
| Heeres, J; Lewi, P; Meerpoel, L | 1 |
| Kelly, DE; Kelly, SL; Martel, CM; Melo, N; Nes, WD; Parker, JE; Warrilow, AG | 1 |
| Belda, S; Cremades, R; Lopez, P; Rodriguez, JC; Royo, G; Ruiz-Garcia, M; Soler, L | 1 |
| Cleveland, KO; Mazumder, SA; Norwood, J | 1 |
| Bowyer, P; Bueid, A; Denning, DW; Harrison, E; Howard, SJ; Moore, CB; Richardson, MD | 1 |
| Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, N; Warrilow, AG; Weig, M | 1 |
| Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, NJ; Warrilow, AG | 1 |
| Cutlan, JE; Geddes, ER; Hymes, SR; Polder, K; Torres-Cabala, CA | 1 |
| Guarro, J; Mayayo, E; Pastor, FJ; Pujol, I; Ruíz-Cendoya, M; Sutton, DA | 1 |
| Arendrup, MC; Johansen, HK; Lass-Flörl, C; Mellado, E; Mortensen, KL; Rodriguez-Tudela, JL | 1 |
| Chen, J; Chen, RZ; Huang, HQ; Lai, W; Xi, LY; Xue, RZ; Zhang, J; Zhang, XH | 1 |
| Bille, J; Calandra, T; Decosterd, LA; Marchetti, O; Mercier, T; Pesse, B; Rochat, B; Tissot, F; Widmer, N; Zanolari, B | 1 |
| Chen, DM; Guo, LN; Liu, Y; Lü, HX; Shi, JY; Shi, Y; Wang, H; Xi, LY; Xu, YC; Zhao, WS; Zhou, X | 1 |
| Fujiya, M; Hosoki, T; Ikuta, K; Kohgo, Y; Okamura, N; Sato, K; Torimoto, Y; Yamamoto, M | 1 |
| Alanio, A; Botterel, F; Bretagne, S; Cordonnier, C; Costa, JM; Farrugia, C; Foulet, F; Hicheri, Y; Liance, M; Sitterlé, E | 1 |
| Ko, KS; Lee, JY; Peck, KR; Song, JH | 1 |
| Boyken, L; Diekema, D; Hollis, R; Kroeger, J; Messer, S; Pfaller, M; Tendolkar, S | 1 |
| Bouza, E; Escribano, P; Guinea, J; Peláez, T; Recio, S | 1 |
| Pena, TA; Samavati, L; Soubani, AO | 1 |
| Ahmad, S; Chandra, J; Chowdhary, A; Kathuria, S; Khan, ZU; Khanna, G; Randhawa, HS; Roy, P; Singh, V | 1 |
| Karthaus, M | 1 |
| Barnes, A; Barr, FJ; Hotston-Moore, A; Malik, R; Murphy, KF; Pearson, GR | 1 |
| Nweze, EI; Ogbonnaya, UL | 1 |
| Arendrup, MC; Fuursted, K; Gahrn-Hansen, B; Howard, SJ; Jensen, RH; Johansen, HK; Knudsen, JD; Mortensen, KL | 1 |
| Calvo, E; Guarro, J; Hernández, P; Mayayo, E; Pastor, FJ | 1 |
| Ilkit, M; Kiraz, N; Oz, Y; Ozdemir, HG | 1 |
| Alves, SH; Azevedo, MI; Botton, SA; Dutra, V; Jesus, FP; Lautert, C; Machado, ML; Mahl, DL; Santurio, JM; Zanette, RA | 1 |
| Bajaj, MS; Kashyap, S; Meel, R; Pushker, N; Sen, S | 1 |
| George, J; Reboli, AC | 1 |
| Baxter, CG; Denning, DW; Felton, TW; Marshall, A; Roberts, M | 1 |
| Brilhante, RS; Caetano, EP; Castelo-Branco, Dde S; Cordeiro, Rde A; de Lima, RA; Fechine, MA; Marques, FJ; Mesquita, JR; Monteiro, AJ; Mourão, CI; Ribeiro, JF; Rocha de Castro E Silva, K; Rocha, FA; Rocha, MF; Sidrim, JJ | 1 |
| Biancalana, FS; Lyra, L; Schreiber, AZ | 1 |
| Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY | 1 |
| Abe, S; Asada, M; Hata, K; Horii, T; Inoue, S; Matsukura, M; Miyazaki, M; Murai, N; Nakamoto, K; Shirotori, S; Tanaka, K; Watanabe, NA; Yoshimatsu, K | 1 |
| Berbel, RF; Casella, AM; de Freitas, D; Höfling-Lima, AL | 1 |
| Alves, SH; Azevedo, MI; Rossato, L; Santurio, JM; Spader, TB; Tronco-Alves, GR; Venturini, TP; Weiler, CB | 1 |
| Castanheira, M; Duncanson, F; Jones, RN; Messer, SA; Moet, GJ; Pfaller, MA | 1 |
| Cook, G; Glasmacher, A; Heussel, CP; Kantecki, M; Kibbler, CC; Marks, DI; Miller, PJ; Pagliuca, A; Ribaud, P; Schlamm, HT; Solano, C | 1 |
| Beguin, H; Detandt, M; Hendrickx, M | 1 |
| Bassetti, M; Molinari, MP; Mussap, M; Nicco, E; Taramasso, L; Viscoli, C | 1 |
| Cafarchia, C; Figueredo, LA; Iatta, R; Montagna, MT; Otranto, D | 1 |
| Bouza, E; Escribano, P; González-Rivera, M; Guinea, J; Peláez, T; Recio, S | 1 |
| Hirano, K; Hosogaya, N; Ide, S; Imamura, Y; Iwanaga, N; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Mihara, T; Minematsu, A; Miyazaki, T; Morinaga, Y; Nakamura, S; Nishino, T; Takazono, T; Tashiro, M; Tashiro, T; Tsukamoto, M; Yamamoto, Y; Yanagihara, K; Yasuoka, A | 1 |
| Chu, J; Meehan, S; Patel, R; Patel, U | 1 |
| Granata, JD; Lustenberger, DP; Scharschmidt, TJ | 1 |
| Labbé, AC; Laverdière, M; Levallois, J; Nadeau-Fredette, AC; Ouimet, D; Vallée, M | 1 |
| Ananda-Rajah, MR; Bajel, A; Cheng, A; Downey, MT; Grigg, A; Slavin, MA; Spelman, T; Thursky, KT; Vincent, J | 1 |
| Castanheira, M; Diekema, DJ; Duncanson, FP; Guarro, J; Jones, RN; Pfaller, MA | 1 |
| Lass-Flörl, C | 1 |
| Chang, YC; Dolan, MA; Garraffo, HM; Ghannoum, MA; Kwon-Chung, KJ; Sionov, E | 1 |
| Briegel, J; Chouker, A; Frey, L; Kaufmann, I; Mayr, D; Spiekermann, K; Thiel, M; van der Heide, V | 1 |
| Kontoyiannis, DP; Lewis, RE; Lortholary, O; Roilides, E; Spellberg, B; Walsh, TJ | 1 |
| Hu, Y; Li, X; Liang, Y; Lu, C; Xi, L; Yang, Y; Zhang, J | 1 |
| Mavridou, E; Melchers, WJ; Meletiadis, J; Mouton, JW; Verweij, PE | 1 |
| Deering, KM; Dunn, JL; Field, CL; Frasca, S; Gilbert-Marcheterre, K; Meegan, J; Nyaoke, A; Risatti, G; Romano, TA; Sidor, IF; Spoon, T; Tuttle, AD | 1 |
| Bedin, M; D'Angelo, M; Gion, M; Grandesso, S; Mazzuccato, S; Sapino, B; Solinas, M | 1 |
| Egerer, G | 1 |
| Chakrabarti, A; Jatana, M; Rudramurthy, SM; Singh, R | 1 |
| Chakrabarty, A; Gupta, A; Gupta, N; Parchand, S; Ram, J | 1 |
| Aubin, GG; Bretagne, S; Danner-Boucher, I; Garcia-Hermoso, D; Haloun, A; Le Pape, P; Miegeville, M; Morio, F; Sacchetto, E | 1 |
| Bai, C; Chen, B; Huang, HD; Huang, Y; Li, Q; Wang, Q; Wu, N; Yao, XP | 1 |
| Chen, TC; Chen, YC; Chen, YH; Lu, PL | 1 |
| Bartolesi, AM; Fanci, R; Pecile, P; Pini, G | 1 |
| Brilhante, RS; Caetano, ÉP; Camargo, ZP; Castelo-Branco, DS; Cordeiro, RA; Fechine, MA; Lima, RA; Mesquita, JR; Monteiro, AJ; Pereira, JF; Rocha, MF; Sidrim, JJ | 1 |
| Alanio, A; Bretagne, S; Brisse, S; Cabaret, O; Cordonnier, C; Costa, JM; Sitterlé, E | 1 |
| Kema, GH; Melchers, WJ; van de Sande-Bruisma, N; Verweij, PE | 1 |
| Das, S; Gupta, N; Jain, S; Malik, JN | 1 |
| Bicmen, C; Doluca, M; Gulat, S; Gunduz, AT; Tuksavul, F | 1 |
| Adachi, Y; Araki, K; Ikeda, T; Ishikawa, S; Kadowaki, T; Kimura, M; Kobayashi, K; Nagaoka, S; Wakabayashi, K; Yano, S | 1 |
| Clark, LP; Folio, L; Henderson, CM; Holland, SM; Kwon-Chung, KJ; Nardone, G; Peterson, SW; Riedlinger, G; Shea, Y; Sugui, JA; Zelazny, AM; Zerbe, CS | 1 |
| Fasler, D; Gerber, B; Guggenberger, R; Manz, MG; Nair, G; Schanz, U; Stussi, G | 1 |
| Baez, AA; Bonfietti, LX; Castro e Silva, DM; Martins, MA; Melhem, MS; Pukinskas, SR; Purisco, SU; Szeszs, MW | 1 |
| Ahmed, S; de Hoog, GS; Feng, P; Klaassen, CH; Lai, W; Lu, C; Meis, JF; Najafzadeh, MJ; Sun, J; Xi, L | 1 |
| Aller, AI; Canton, E; Castañón-Olivares, LR; Chowdhary, A; Cordoba, S; Cuenca-Estrella, M; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Govender, N; Hagen, F; Illnait-Zaragozi, MT; Johnson, E; Kidd, S; Lass-Flörl, C; Lockhart, SR; Martins, MA; Meis, JF; Melhem, MS; Ostrosky-Zeichner, L; Pelaez, T; Pfaller, MA; Schell, WA; St-Germain, G; Trilles, L; Turnidge, J | 1 |
| Aomori, T; Araki, T; Fujita, Y; Hiromura, K; Nakamura, T; Nojima, Y; Okada, Y; Shimizu, R; Tomizawa, T; Yamamoto, K | 1 |
| Hashimoto, N; Hattori, Y; Kato, J; Koda, Y; Mori, T; Okamoto, S; Sadahira, K; Shimizu, T; Tsukada, Y; Yamane, A; Yokoyama, K | 1 |
| Duan, J; Xiong, X; Zhai, S | 1 |
| Balfour-Lynn, IM; Bentley, S; Gupta, A | 1 |
| Barclay, ML; Begg, EJ; Moore, GA; Zhang, M | 1 |
| Fan, YM; Huang, WM; Li, W; Yang, YP; Zhou, Y | 1 |
| Kelly, DE; Kelly, SL; Parker, JE; Warrilow, AG | 1 |
| Yoshida, M | 1 |
| Gärtner, P; Knoth, H; Petry, T | 1 |
| Albarrag, AM; Anderson, MJ; Bowyer, P; Denning, DW; Gregson, L; Harrison, E; Howard, SJ; Leatherbarrow, H; Pasqualotto, AC | 1 |
| Shi, Y; Sun, HM; Xu, XY; Zhao, BL | 1 |
| Furuya, N; Mano, Y; Morishige, H; Oguri, T | 1 |
| Datta, S; Goel, N; Oberoi, JK; Prasad, K; Raveendran, R; Wattal, C | 1 |
| Agarwal, K; Chowdhary, A; Gaur, SN; Kathuria, S; Meis, JF; Randhawa, HS; Roy, P; Singh, PK | 1 |
| Chowdhary, A; Kathuria, S; Khan, N; Kumar, DA; Meis, JF; Muralidhar, S; Prakash, A; Randhawa, HS; Sharma, C; Singh, PK; Wankhede, S | 1 |
| Cano, J; Crous, PW; da Cunha, KC; Fothergill, AW; Gené, J; Guarro, J; Hoog, Sd; Madrid, H; Sutton, DA | 1 |
| Bader, O; Buchheidt, D; Christner, M; Groß, U; Held, J; Kuhns, M; Lugert, R; Peter, S; Reichard, U; Schumacher, U; Tintelnot, K; Weig, M | 1 |
| Gao, X; Ji, X; Marks, DI; Schlamm, HT; Stephens, JM; Tarallo, M | 1 |
| Arikan-Akdagli, S; Canton, E; Hazirolan, G; Sahin, S | 1 |
| Monod, M; Pot, SA; Spiess, BM; Unger, L; Voelter-Ratson, K | 1 |
| Blitz, A; Burger, P; Gallia, G; Ishii, M; Leyngold, I; Olivi, A; Subramanian, PS | 1 |
| Amat, P; Benet, I; Bravo, D; Clari, MÁ; Costa, E; Giménez, E; Muñoz-Cobo, B; Navarro, D; Nieto, J; Remigia, MJ; Solano, C | 1 |
| Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Johnson, A; McEntee, L; Moore, CB; Richardson, M | 1 |
| Han, A; Hu, G; Kan, X; Lin, G; Qiu, X; Wang, C; Wang, Z; Xu, T | 1 |
| Chen, SC; Meyer, W; Middleton, PG | 1 |
| Curfs-Breuker, I; de Hoog, GS; Feng, P; Meis, JF; Najafzadeh, MJ; Rezaei-Matehkolaei, A; Saradeghi Keisari, M; Shamsian, SA; Vicente, VA | 1 |
| Dupont, L; Lagrou, K; Maertens, J; Meersseman, P; Saegeman, V; Vermeulen, E | 1 |
| Chen, H; Chen, M; Liao, W; Pan, W; Zhou, J | 1 |
| Chen, J; Huang, J; Li, L; Yang, Q | 1 |
| Dorsey, SA; Fothergill, AW; Furmaga, W; Lewis, JS; Patterson, TF; Pennick, GJ; Sutton, DA; Wiederhold, NP | 1 |
| Cuenca-Estrella, M; Escribano, P; Guinea, J; Martín-Mazuelos, E; Pemán, J; Sánchez-Reus, F; Zaragoza, Ó | 1 |
| Mitra, AK; Pal, D; Patel, M; Paturi, DK; Vadlapatla, RK | 1 |
| Beckman, EN; Garces, JC; Garcia-Diaz, JB; Keller, RA; Loss, GE; Pankey, GA; Schieffelin, JS; Staffeld-Coit, C | 1 |
| Horiuchi, C; Ikeda, T; Iwanaga, N; Kamiya, C; Katsuragi, S; Kobayashi, Y; Miyoshi, T; Neki, R; Sata, M; Tanaka, H; Yamanaka, K; Yamashita, Y; Yoshimatsu, J | 1 |
| Aguiar, A; Faria, M; Fernandes, C; Lago, M; Natário, A; Pinto, E | 1 |
| Enderby, CY; Heckman, MG; Keller, CA; Thomas, CS | 1 |
| Chowdhary, A; Hagen, F; Meis, JF; Sharma, C | 1 |
| Brown, EV; Davoodi, P; Perry, JR; Wright, SA | 1 |
| Aquino, VR; Bergamasco, MD; Castro, PT; Colombo, AL; Gonçalves, SS; Negri, CE; Xafranski, H | 1 |
| Akshita, K; Datry, A; Fekkar, A; Lescar, J; Mazier, D; Meyer, I; Palous, M; Srinivasaraghavan, K; Verma, C | 1 |
| Chishimba, L; Denning, DW; Langridge, P; Niven, RM; Powell, G | 1 |
| Kikuchi, T; Kikuchi, Y; Miki, H; Nishimaki, K; Saito, W; Sasamori, K; Shishikura, Y | 1 |
| Dolton, MJ; McLachlan, AJ | 1 |
| Han, X; Huang, G; Li, W; Liu, Q; Meng, M; Ni, X; Wang, J; Wei, Z; Yang, X; Ye, X; Zheng, A | 1 |
| Huang, X; Li, D; Mylonakis, E; Xi, L | 1 |
| Hamblin, MR; Hu, Y; Huang, X; Lu, S; Mylonakis, E; Xi, L; Zhang, J | 1 |
| Colón, B; Flowers, SA; Rogers, PD; Schuler, MA; Whaley, SG | 1 |
| Cheung, BP; Samaranayake, LP; Samaranayake, YH; Yau, JY; Yeung, KW | 1 |
| Fukatsu, S; Habu, Y; Kimura, Y; Matsubara, K; Ozaki, J; Sato, E; Shida, A; Yamamoto, H; Yano, I | 1 |
| Li, J; Liu, B; Pan, A; Zhang, L; Zhou, S | 1 |
| Kawakami, J; Mino, Y; Naito, T; Yamada, T | 1 |
| Aguirre-Garza, M; Carolina Rojas, O; González, GM; León-Cachón, RB; Moreno-Treviño, MG; Pérez-Maya, AA | 1 |
| Kamei, K; Kikuchi, K; Ochiai, E; Tamiya, H; Toyotome, T; Watanabe, A; Yaguchi, T; Yahiro, M | 1 |
| Badali, H; de Hoog, GS; Mashedi, O; Meis, JF; Mohammadi, R | 1 |
| He, C; Kang, M; Lei, Y; Xiao, YL; Xie, Y; Zhang, CY | 1 |
| Goeman, E; Kidd, SE; Meis, JF; Slavin, MA; Verweij, PE | 1 |
| Fong, PH; Lee, VH; Seneviratne, CJ; Wong, SS | 1 |
| Amorim, A; Araujo, R; Oliveira, M; Sampaio-Maia, B | 1 |
| Chang, YC; Eckhaus, MA; Fedorova, N; Figat, A; Joardar, V; Kwon-Chung, KJ; Losada, L; Mounaud, S; Nierman, WC; Pakala, S; Pakala, SB; Sugui, JA; Venepally, P | 1 |
| Dominique, S; Favennec, L; Gargala, G; Lavergne, RA; Le Pape, P; Meis, JF; Morio, F; Verweij, PE | 1 |
| Kelly, DE; Kelly, SL; Lamb, DC; Nes, WD; Parker, JE; Rolley, NJ; Smith, SN; Warrilow, AG | 1 |
| Ebenezer, J; Maheswaran, S; Mathews, SS; Rupa, V | 1 |
| Ağca, H; Ak, S; Akalın, H; Cilo, BD; Ener, B; Özmerdiven, GE; Tunca, B | 1 |
| Chen, X; Hu, Y; Wang, B; Yang, L; Yu, L | 1 |
| Dabó, H; Gomes, I; Marinho, A | 1 |
| Bulanda, M; Jagielski, T; Skóra, M | 1 |
| Chowdhary, A; Curfs-Breuker, I; de Hoog, GS; Hagen, F; Madrid, H; Meis, JF | 1 |
| Dong, HY; Guo, H; Li, SX; Li, YM; Ma, ZL; Shi, JP; Song, YJ; Zhang, H; Zhang, LL | 1 |
| Badali, H; Chowdhary, A; de Hoog, GS; Fakhim, H; Khodavaisy, S; Meis, JF | 1 |
| Barrs, VR; Beatty, JA; Kidd, SE; Martin, P; Talbot, JJ | 1 |
| Albert, ND; Bellanger, AP; Kontoyiannis, DP; Lewis, RE; Walsh, TJ | 1 |
| Block, C; Moses, AE; Or, R; Shapira, MY; Strahilevitz, J; Tzadok, R | 1 |
| Coste, AT; Sanglard, D | 1 |
| Abbas, MA; Ahmed, SA; Al-Hatmi, AM; de Hoog, GS; Jouvion, G; Kolecka, A; Mahgoub, el S | 1 |
| Chai, LY; Khoo, AL; Lim, BP; Ong, B; Tan, BH; Tan, G; Tee, C; Teng, M; Zhao, YJ | 1 |
| Dehghan, P; Hashemi, SJ; Melchers, WJ; Mohammadi, F; Rafati, H; Rezaie, S; Seyedmousavi, S; Tamadon, Y; Tolooe, A; van der Lee, HA; Verweij, PE; Zoll, J | 1 |
| Arendrup, MC; Cuenca-Estrella, M; Jensen, RH | 1 |
| Cogliati, M; De Lorenzis, G; Esposto, MC; Lazzarini, C; Prigitano, A; Tortorano, AM | 1 |
| Fosso, MY; Garneau-Tsodikova, S; Shrestha, SK | 1 |
| Gökbolat, E; Ilkit, M; Kiraz, N; Öz, Y; Özdemir, HG; Seyedmousavi, S | 1 |
| Badali, H; Dolatabadi, S; Fakhim, H; Mirhendi, H; Nabili, M; Poorzad, N; Vaezi, A; Zarei, F | 1 |
| Yaguchi, T | 1 |
| Alencar, LP; Bandeira, TJPG; Brilhante, RSN; Cordeiro, RA; Evangelista, AJJ; Franco, JDS; Marques, FJF; Melo, CVS; Oliveira, JS; Rocha, MFG; Serpa, R; Sidrim, JJC | 1 |
| Baek, JO; Jeong, JH; Kim, JH; Lee, JR; Roh, JY; Ryu, HR; Seo, YH; Yun, CH | 1 |
| Al-Hatmi, AM; Bonifaz, A; Curfs-Breuker, I; De Hoog, GS; Meis, JF; Meletiadis, J | 1 |
| Adjapong, G; Bartlett, M; Garrill, A; Hale, M | 1 |
| Diogo, HP; Ramos, JJ | 1 |
| Kachuei, R; Khodavaisy, S; Rezaie, S; Sharifynia, S | 1 |
| Alencar, LP; Bandeira, SP; Bandeira, TJ; Brandine, GS; Brilhante, RS; Castelo-Branco, DS; Cordeiro, RA; Guedes, GM; Melo, LM; Moreira, JL; Paiva, MA; Pereira-Neto, WA; Ponte, YB; Rocha, MF; Sales, JA; Sidrim, JJ | 1 |
| Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W | 1 |
| Feng, B; Shen, JL; Tang, XF; Xu, HQ; Xu, SX | 1 |
| Aala, F; Amirizad, K; Aslani, N; Badali, H; Hashemi, SJ; Khodavaisy, S; Nazeri, M; Nouripour-Sisakht, S; Rezaie, S; Sorkherizi, MS | 1 |
| Ding, X; Gao, L; Liu, Z; Sun, Y; Wu, Q; Zeng, T | 1 |
| Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Koenderink, JB; Lempers, VJ; Russel, FG; van den Heuvel, JJ | 1 |
| Andes, D; Azie, N; Franks, B; Harrington, R; Kelley, C; Khandelwal, N; Kristy, R; Lee, E; Spalding, J; Tan, RD; Wu, EQ; Yang, H | 1 |
| Aliyali, M; Badali, H; Badiee, P; Hagen, F; Khodavaisy, S; Moazeni, M; Nabili, M; Shokohi, T; Zarrinfar, H | 1 |
| Fujiwara, T; Kida, H; Komatsu, R; Matsumoto, M; Toyotome, T; Wada, T | 1 |
| Alem, N; Karabıçak, N | 1 |
| Busso-Lopes, AF; Kamei, K; Lyra, L; Mikami, Y; Moretti, ML; Peron, IH; Reichert-Lima, F; Schreiber, AZ; Taguchi, H | 1 |
| Chakrabarti, A; Ghosh, A; Honnavar, P; Pamidi, U; Rastogi, V; Rudramurthy, SM | 1 |
| Garvey, EP; Hoekstra, WJ; Kelly, DE; Kelly, SL; Nes, WD; Parker, JE; Price, CL; Schotzinger, RJ; Warrilow, AG | 1 |
| Augustynowicz-Kopeć, E; Garczewska, B; Jarzynka, S; Kuś, J; Skorupa, W | 1 |
| Holman, TR; Hughes, DD; Kelly, DE; Kelly, SL; Nes, WD; Parker, JE; Price, CL; Rolley, NJ; Smyrniotis, CJ; Thoss, V; Warrilow, AG | 1 |
| Garneau-Tsodikova, S; Ngo, HX; Shrestha, SK | 1 |
| Benjamin Lash, D; Heidari, A; Jolliff, J; Munoz, A | 1 |
| Barrueta, JA; Bow, EJ; Charbonneau, C; Cordonnier, C; Cornely, OA; Cragin, L; De Salas-Cansado, M; Garcia-Vidal, C; Jarque, I; Marks, DI; Pagliuca, A; Peral, C; Shaul, AJ; Slavin, M; Solano, C; Sorensen, S; Vanness, DJ | 1 |
| Izumikawa, K; Tashiro, M | 1 |
| Bader, O; Buname, G; Groß, U; Mshana, SE; Mushi, MF | 1 |
| Alegre, LR; Carrillo-Muñoz, AJ; Cattana, ME; Córdoba, SB; de Los Ángeles Sosa, M; Fernández, MS; Giusiano, GE; Rojas, FD; Zalazar, LC | 1 |
| Amirrajab, N; Badali, H; Gohar, AA; Moazeni, M; Nabili, M; Shokohi, T | 1 |
| Hsueh, PR; Wang, H; Xu, YC | 1 |
| Bouza, E; Escribano, P; Guinea, J; Montilla, P; Muñoz, P; Padilla, B | 1 |
| Akashi, K; Ikesue, H; Masuda, S; Matsukawa, K; Miyamoto, T; Shiratsuchi, M; Suetsugu, K; Tsuchiya, Y; Uchida, M; Watanabe, H; Yamamoto-Taguchi, N | 1 |
| Basu, SS; Jarolim, P; Mason, DS; Petrides, A | 1 |
| Hasegawa, A; Kamata, H; Kano, R; Kimura, S; Lim, SY; Ooya, K; Yanai, T | 1 |
| Ahmed, SA; Behrens-Baumann, W; de Hoog, GS; Harak, H; Hofmüller, W; Seibold, M; Tammer, I; van Diepeningen, AD | 1 |
| Cen, W; Feng, W; Lv, Y; Ma, Y; Qiao, Z; Wang, Y; Xi, Z; Yang, J | 1 |
| Long, N; Lu, L; Sang, H; Xu, X; Zeng, Q | 1 |
| Guo, H; Jiang, L; Li, DM; Li, SX; Song, YJ; Zhang, H; Zhao, YJ; Zhu, KJ | 1 |
| Behr, J; Ceelen, F; Ihle, F; Kneidinger, N; Matthes, S; Neurohr, C; Schramm, R; Stelzer, D; Vogeser, M; Weber, A; Winter, H; Zimmermann, G; Zoller, M | 1 |
| Chen, F; Feng, CL; He, Q; Shi, Y; Su, X; Zhang, M | 1 |
| Gao, J; Gao, N; Li, C; Wu, Y; Ying, C | 1 |
| Hope, WW; Stott, KE | 1 |
| D'Inzeo, T; De Carolis, E; Mello, E; Posteraro, B; Sanguinetti, M; Torelli, R; Vella, A; Verweij, PE | 1 |
| Garvey, EP; Hoekstra, WJ; Kelly, DE; Kelly, SL; Nes, WD; Parker, JE; Price, CL; Schotzinger, RJ; Warrilow, AGS; Wiederhold, NP | 1 |
| Birch, M; Buil, JB; Law, D; Meis, JF; Melchers, WJG; Rijs, AJMM; Verweij, PE | 1 |
| Cox, SK; Redig, P; Souza, MJ | 1 |
| Corrêa, C; Fuentefria, AM; Goldani, LZ; Heidrich, D; Rosa, PD; Scroferneker, ML; Vettorato, G | 1 |
| Ashu, EE; Korfanty, GA; Xu, J | 1 |
| Blaich, C; Gehlen, D; Liss, B; Müller, C; Prozeller, D; Streichert, T; Wiesen, MHJ | 1 |
| Albrecht-Eckardt, D; Amarsaikhan, N; Braus, GH; Kniemeyer, O; Ogel, ZB; Sasse, C | 1 |
| Gao, L; Lu, Q; Sun, Y; Tian, D; Xiang, S | 1 |
| Aydin, F; Cebeci Güler, N; Tosun, I | 1 |
| Aquino, VR; Bergamasco, MD; Castro, PTO; Colombo, AL; Gonçalves, SS; Hagen, F; Martino, MDV; Meis, JF; Negri, CE; Queiroz-Telles, F; Sousa, ACP | 1 |
| Anract, P; Archambeau, D; Epelboin, L; Eyrolle, L; Gaume, M; Gauzit, R; Larousserie, F; Lavielle, M; Leclerc, P; Lortholary, O; Marie-Hardy, L; Paugam, A; Roux, C; Salmon, D | 1 |
| Allender, MC; Archer, G; Baitchman, E; Chu, CT; Cox, S; Driskell, EA; Hsiao, SH; Kane, L; Lindemann, DM; Rzadkowska, M; Singh, K; Sykes, JM | 1 |
| Gao, L; He, C; Li, M; Sun, Y; Zeng, T | 1 |
| Byun, SA; Choi, MJ; Jung, JS; Kim, SH; Park, YJ; Shin, JH; Shin, MG; Suh, SP; Won, EJ | 1 |
| Brüggemann, RJM; Buil, JB; Meis, JF; Melchers, WJG; Mouton, JW; Verweij, PE; Wasmann, RE; Zoll, J | 1 |
| Benamu, E; Fernandez-Pol, S; Ho, DY; Liu, AY; Xie, L; Yu, AT | 1 |
| Al-Hatmi, AMS; Alves, SH; Azevedo, MI; Keller, JT; Rossato, L; Santurio, JM; Venturini, TP; Weiblen, C | 1 |
| Basak, GW; Brillowska-Dąbrowska, A; Kurzyk, E; Mroczyńska, M; Nawrot, U; Sulik-Tyszka, B; Wróblewska, M; Włodarczyk, K | 1 |
| Almaguer, M; Fernández, CM; Illnait, MT; Martínez, GF; Perurena, MR; San Juan, JL; Velar, RE | 1 |
| Chandra, A; Gupta, MK; Prakash, P; Tilak, R | 1 |
| Bader, O; Becker, K; Groß, U; Idelevich, EA | 1 |
| Brilhante, RSN; Castelo-Branco, DSCM; Chaves, LJQ; Cordeiro, RA; Correia, EEM; de Oliveira, JS; Guedes, GMM; Pereira Neto, WA; Pinheiro, AQ; Rocha, MFG; Sidrim, JJC | 1 |
| Kooshki, P; Mahmoudabadi, AZ; Rezaei-Matehkolaei, A | 1 |
| Chakrabarti, A; Dogra, S; Mushtaq, K; Narang, T; Paul, RA; Rudramurthy, SM; Shankarnarayan, SA; Shaw, D | 1 |
| Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A | 1 |
| Brilhante, RSN; Castelo-Branco, DSCM; Cordeiro, RA; Guedes, GMM; Rocha, MFG; Sidrim, JJC; Silva, MLQD | 1 |
| Bartoszewicz, M; Król, J; Nawrot, U | 1 |
| Chi, YM; Di, QG; Du, JF; Jiang, MM; Li, M; Lv, J; Mai, ZT; Shi, J; Song, Z; Sun, BH | 1 |
| Bongomin, F; Denning, DW; Harris, C; Hayes, G; Kosmidis, C | 1 |
| Qiao, M; Qiu, HY; Sun, AN; Tang, L; Tang, XW; Wu, DP; Yang, XF; Zhang, L | 1 |
| Carey, B; Hodgson, T; Lambourne, J; Porter, S | 1 |
| Andes, D; Desai, A; Kitt, T; Kovanda, L; Walsh, TJ; Zhao, M | 1 |
| Alcazar-Fuoli, L; Bernal-Martínez, L; Gomez-Lopez, A | 1 |
| Bénet, T; Bienvenu, AL; Cassier, P; Dananché, C; Dupont, D; Gustin, MP; Hénaff, L; Loeffert, ST; Vanhems, P; Wallon, M | 1 |
| Fujita, H; Fukushima, S; Kobayashi, T; Matsumoto, T; Miyazaki, Y; Nakamura, I; Shimoinaba, M; Watanabe, Y | 1 |
| Almeida-Paes, R; Brito-Santos, F; Coelho, RA; do Valle, ACF; Figueiredo-Carvalho, MHG; Freitas, DFS; Gutierrez-Galhardo, MC; Meyer, W; Silva, JVDS; Trilles, L; Zancopé-Oliveira, RM | 1 |
| Keniya, MV; Monk, BC; Ruma, YN; Tyndall, JDA | 1 |
| Abutaleb, NS; Eldesouky, HE; Li, X; Mohammad, H; Seleem, MN | 1 |
| Alcántara-Castro, M; Castelan-Ramírez, I; Flores-Alvarado, V; González-Robles, A; Hernández-Martínez, D; Hernández-Olmos, P; Lorenzo-Morales, J; Omaña-Molina, M; Ramírez-Flores, E; Reyes-Batlle, M; Salazar-Villatoro, L; Servín-Flores, C; Vanzzini-Zago, V | 1 |
| Milanezi, ACM; VAN DER Sand, ST; Witusk, JPD | 1 |
| Chen, L; Li, M; Li, N; Qi, F; Wang, N; Zhu, L | 1 |
| Bao, SS; Chen, MC; Chen, RJ; Cui, X; Dong, YY; Hu, GX; Lou, D; Pan, WH; Sun, W; Wang, Z | 1 |
| Castelan-Ramírez, I; Hernández-Martínez, D; Hernández-Olmos, P; Lorenzo-Morales, J; Omaña-Molina, M; Piñero, JE; Ramírez-Flores, E; Reyes-Batlle, M; Sifaoui, I; Vanzzini-Zago, V | 1 |
| Bongomin, F; Hassanzad, M; Hedayati, MT; Hedayati, N; Maleki, M; Mortezaee, V; Poorabdollah, M; Sharifynia, S; Velayati, AA | 1 |
| Flowers, SA; Kelly, DE; Kelly, SL; Nishimoto, AT; Parker, JE; Price, CL; Rogers, PD; Warrilow, AG | 1 |
| Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E | 1 |
| Daly, RC; Kennedy, CC; Pennington, KM; Peters, S; Razonable, RR; Scott, JP; Wylam, M | 1 |
| Faria-Ramos, I; Lisboa, C; Miranda, I; Pedrosa, AF; Ricardo, E; Rodrigues, AG; Silva, R; Teixeira-Santos, R | 1 |
| Ando, T; Fujiuchi, S; Hayashi, Y; Ichihara, K; Imamura, Y; Izumikawa, K; Kakeya, H; Kishi, K; Kohno, S; Miyazaki, T; Miyazaki, Y; Mukae, H; Ogawa, K; Saijo, T; Takazono, T; Tashiro, M; Tokimatsu, I; Yamamoto, K; Yanagihara, K | 1 |
| Gong, N; Jiang, J; Yang, L; Zhou, H | 1 |
| Chen, M; Chen, R; Chen, Y; Hu, G; Huang, C; Sun, W; Wang, Z; Zhang, X | 1 |
| Altintop, YA; Atalay, MA; Ergul, AB; Koc, AN | 1 |
| Andes, DR; Bayless, M; Lepak, AJ; McCreary, EK; Schulz, LT; Van, AP; Wiebe, DA | 1 |
| Aquino, V; Borges, R; Meneghello Fuentefria, A; Ramirez-Castrillon, M; Rosa, PDD; Zubaran Goldani, L | 1 |
| Baharani, A; Reddy P, RR; Reddy, AK | 1 |
| Cao, CW; Fu, YJ; Guo, J; Huang, CY; Li, BK; Li, TM; Pan, KS; Wei, FL; Zheng, YQ | 1 |
| Fang, Y; Gao, L; Jia, L; Kosgey, JC; Xiong, J; Yang, J; Yu, P; Zhang, F | 1 |
| Braga, SS | 1 |
| Li, R; Sun, L; Wan, Z; Yu, J | 1 |
| Assiri, AM; Assiri, R; Bukhari, IA; Saeed, A | 1 |
| Afsarian, MH; Ahmadi, B; Ansari, S; Ansari, Z; Lotfali, E; Norouzi, M; Rezaei-Matehkolaei, A | 1 |
| Akune, Y; Inoshima, Y; Kano, R; Ohno, Y | 1 |
| Chen, X; Hu, Y; Liu, K; Lu, Y; Mao, Z; Qi, X; Sun, H; Wu, Z; Yang, Y; Zhou, X | 1 |
| Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K | 1 |
| Bigot, J; Botterel, F; Bougnoux, ME; Dannaoui, E; Dellière, S; Fekkar, A; Guitard, J; Hennequin, C; Senghor, Y; Verdurme, L | 1 |
| Ding, XL; Liu, LN; Miao, LY; Tian, JX; Xue, L; Yan, HH; Zhang, JJ; Zhang, WJ; Zhang, WW | 1 |
| Aneke, CI; Cafarchia, C; Otranto, D; Rhimi, W | 1 |
| AlFouzan, W; Anastasiadis, E; Dhar, R; El Chaar, M; Ghaddar, A; Ghaddar, N; Halimeh, R; Yusef, H | 1 |
| Brilhante, RSN; Caetano, ÉP; Castelo-Branco, DSCM; Cordeiro, RA; Guedes, GMM; Paiva, MAN; Rocha, MFG; Sidrim, JJC; Teixeira, CEC | 1 |
| Kauffman, CA; Schwartz, IS | 1 |
| Borman, AM; Fraser, M; Johnson, EM; Muller, J; Palmer, MD; Patterson, Z; Szekely, A; Walsh-Quantick, J | 1 |
| Li, H; Tu, B; Yin, G | 1 |
| Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M | 1 |
| Agarwal, R; Dhooria, S; Muthu, V; Prasad, KT; Sehgal, IS | 1 |
| Gao, L; Li, M; Sun, Y; Yuan, M; Zeng, T | 1 |
| Bongomin, F; Denning, DW; Garcez, T | 1 |
| Kraft, L; Ribeiro, VST; Telles, JP; Tuon, FF | 1 |
| Arron, ST; Brownell, I; Cahoon, EK; Cowen, EW; D'Arcy, ME; Engels, EA; Hess, GP; Israni, AK; Pfeiffer, RM; Rivera, DR; Triplette, MA; Yanik, EL | 1 |
| Lin, G; Xie, S; Xu, RA; Ye, L; Ye, X | 1 |
| Arendrup, MC; Friberg, N; Guinea, J; Kahlmeter, G; Mares, M; Meletiadis, J | 1 |
| El-Hawary, EE; Fawzy, MM; Nofal, A | 1 |
| Dongke, C; Heping, X; Linqiang, D; Longhua, H; Xia, Z; Xiaomei, G; Yiguo, C | 1 |
| Cortés, JA; Nocua-Báez, LC; Robles, R; Tarazona-Guaranga, L; Uribe-Jerez, P | 1 |
| Epps, KL; Epps, QJ; Young, DC; Zobell, JT | 1 |
| Brito Devoto, T; Carmona, M; Cuestas, ML; Formento, N; Gordó, M; Hermida-Alava, K; Luque, A; Sautua, F; Scandiani, M | 1 |
| Baluku, JB; Bongomin, F; Kazibwe, A; Olum, R; Russell, L | 1 |
| Bautista-de Lucio, VM; Calvillo-Medina, RP; Campos Guillén, J; Escudero-Leyva, E; Müller-Morales, CA; Ponce-Angulo, DG; Raymundo, T | 1 |
| Franklin, AD; Hendrix, MJ; Larson, L; Powderly, WG; Rauseo, AM; Rutjanawech, S; Spec, A | 1 |
| Cheng, G; Huang, L; Li, T; Luo, X; Xue, X; Zhang, Y | 1 |
| Gharaghani, M; Taghipour, S; Zarei Mahmoudabadi, A | 1 |
| Alastruey-Izquierdo, A; Bonuomo, V; Buil, J; Campos-Herrero, MI; Candoni, A; Cattaneo, C; Colombo, AL; Delia, M; Dos Santos, MC; Farina, F; Forghieri, F; Fortun, J; Fracchiolla, N; Garcia-Vidal, C; Gudiol, C; Hoenigl, M; Jenks, J; Lass-Flörl, C; López-Soria, L; Nadali, G; Nucci, M; Pagano, L; Pérez Nadales, E; Rabagliati, R; Rico, JC; Roiz, MP; Sastre, E; Thompson, GR | 1 |
| Lam, JKW; Liao, Q | 1 |
| Agarwal, R; Chakrabarti, A; Choudhary, H; Ghosh, A; Kaur, H; Rudramurthy, SM; Singh, R; Singh, S | 1 |
| Abboud, C; Achcar, ME; Bidon, B; Bouchara, JP; Dabboussi, F; Dannaoui, E; Hamze, B; Hamze, M; Mallat, H; Osman, M; Papon, N; Zakaria, A | 1 |
| Denk, D; Guthrie, A; Macgregor, SK; Reed, K; Stidworthy, MF | 1 |
| Chen, RJ; Cheng, C; Cui, X; Huang, CK; Sun, W; Wang, J; Wang, Y; Wang, Z | 1 |
| Castanheira, M; Collingsworth, TD; Davis, AP; Deshpande, LM; Pfaller, MA | 1 |
| An, N; Fan, Y; Feng, J; Wang, D; Yang, X; Yang, Y | 1 |
| Hsueh, PR; Jing, R; Li, XW; Li, Y; Wang, CY; Xiao, M; Xu, YC; Yang, WH; Zou, GL | 1 |
| Mammen, MD; Rupa, V; Sahni, RD; Varghese, GM | 1 |
| Brüggemann, RJ; Bury, D; Muilwijk, EW; Tissing, WJE; Wolfs, TFW | 1 |
| Agarwal, R; Aggarwal, AN; Chakrabarti, A; Dhooria, S; Muthu, V; Prasad, KT; Sehgal, IS | 1 |
| Fatahinia, M; Kiasat, N; Mahmoudabadi, AZ; Moslem, M | 1 |
| Bajalan, Z; Hemmat, N; Javadi, A; Mohammadi, F | 1 |
| Brandi, SL; Eldrup, E; Feltoft, CL; Serup, J | 1 |
| Eadie, K; Fahal, AH; Nyuykonge, B; van Amelsvoort, L; van de Sande, W; Verbon, A | 1 |
| Bafghi, MH; Darroudi, M; Nazari, R; Zargar, M; Zarrinfar, H | 1 |
| Govender, NP; Hoffmann, D; Mitton, B; Rule, R; Said, M | 1 |
| Couraud, S; Dannaoui, E; Déméautis, T; Devouassoux, G; Dupont, D; Durieu, I; Garnier, H; Kramer, R; Lina, B; Menotti, J; Persat, F; Rabodonirina, M; Reix, P; Sénéchal, A; Simon, L; Wallon, M | 1 |
| Huo, BN; Ji, HH; Jia, YT; Liu, Y; Song, L; Tang, XW; Zhang, N | 1 |
| Wolf, J | 1 |
| Deng, S; Hu, Q; Li, Y; Sun, S; Tang, M | 1 |
| Fukami, T; Kamei, K; Kawashima, M; Matsui, H; Nagai, H; Narumoto, O; Sano, T; Sasaki, Y; Sekiguchi, R; Suzuki, J; Takeda, K; Tamura, A; Watanabe, A; Watanabe, M | 1 |
| Geng, XN; Gou, KF; Qiu, XJ; Su, YD; Wang, HJ; Zhou, CY | 1 |
| Gupta, AK; Talukder, M; Venkataraman, M | 1 |
| Billaud, EM; Dannaoui, E; Derobertmasure, A; Kably, B; Launay, M; Lefeuvre, S | 1 |
| Chen, L; Chen, W; Li, L | 1 |
| Gao, L; Sun, Y; Tan, L; Yang, J; Yao, Z; Zeng, T | 1 |
| Ito, H; Ogawa, R | 1 |
| Fukushima, S; Hiruma, M; Kano, R; Kashiwada-Nakamura, K; Kimura, U; Kubo, M; Matsumoto, T; Noguchi, H; Yaguchi, T | 1 |
| Deng, Z; Li, Z; Wang, C; Wu, C | 1 |
| Paaopanchon, C; Pesee, S; Phantumvanit, P; Roytrakul, S; Samaranayake, L | 1 |
| Gawęda, M; Knapik, P; Latos, M; Ochman, M; Pandel, A; Pióro, A; Przybyłowski, P; Stącel, T; Urlik, M | 1 |
| Do, TBT; Ha, TNT; Le, CC; Ngo, TMC; Nguyen, PV; Santona, A; Ton Nu, PA; Tran Thi, G; Vo, MT | 1 |
| Kano, R; Shirakata, C; Sugawara, S | 1 |
| Abastabar, M; Aghili, SR; Badali, H; Haghani, I; Hedayati, MT; Javidnia, J; Khojasteh, S; Meis, JF; Moazeni, M; Nargesi, S; Nosratabadi, M; Shabanzadeh, S; Shokohi, T; Zaedi, A | 1 |
| Lu, F; Wang, B; Wang, Y; Xu, Y; Zhang, L; Zhang, M | 1 |
| Alegre, L; Giusiano, G; Latorre, W; Mussin, J; Rojas, FD; Sosa, MLÁ | 1 |
| Agarwal, A; Agrawal, D; Chowdhary, A; Khurana, A; Sardana, K; Singh, A | 1 |
| Bonfietti, L; de Camargo, ZP; de Carvalho, JA; de Souza Carvalho Melhem, M; de Souza Lima, BJF; Guevara, A; Hagen, F; Hahn, RC; Nery, AF; Rodrigues, AM; Vicente, VA | 1 |
| Abd-Elbaset, A; Elkholy, BM; Fawzy, M; Khattab, F; Taha, M | 1 |
| Babaei, M; Daie Ghazvini, R; Erami, M; Fattahi, M; Getso, MI; Hashemi, SJ; Khodavaisy, S; Mehri, N; Momen-Heravi, M; Parviz, S; Raiesi, O | 1 |
| Im, SA; Kang, HM; Kim, K; Lee, JW; Park, YJ; Yoo, IY | 1 |
| Cui, F; Kan, S; Li, X; Liu, W; Pang, Q | 1 |
| Alexander, AB; Gai, JJ; Highland, MA; Horgan, MD; Innis, C; Liguori, BL; Norton, TM; Ossiboff, RJ; Pesavento, PA; Stacy, BA; Wellehan, JFX | 1 |
| Duan, Z; Li, M; Liu, Y; Tong, J; Zeng, R; Zheng, N | 1 |
| Escribano, P; Gómez, A; Guinea, J; Muñoz, P; Reigadas, E; Serrano-Lobo, J | 1 |
| An, R; Chen, Y; Cui, F; Cui, M; Fan, S; Kan, S; Li, D; Li, P; Li, X; Liang, X; Liao, Q; Liu, W; Lv, G; Mei, H; Pang, Q; Qiao, Q; Song, N; Xiong, Z; Zhang, M; Zheng, H | 1 |
| Ahmed, NH; Gupta, N; Naik, R; Sidhu, N; Tandon, R; Vanathi, M | 1 |
| Gómez-López, A; Martín-Gómez, MT; Salavert Lletí, M | 1 |
| Abastabar, M; Aghili, SR; Akhtari, J; Al Hatmi, AMS; Al-Harrasi, A; Badali, H; Haghani, I; Hajheydari, Z; Hedayati, MT; Javidnia, J; Kermani, F; Khojasteh, S; Moazeni, M; Shokohi, T; Yahyazadeh, Z | 1 |
| Beraquet, CAG; Giordano, ALPL; Lyra, L; Pontes, L; Schreiber, AZ | 1 |
| Bao, Y; Li, X; Wang, W; Wu, Y; Yang, Q; Zheng, Y | 1 |
| Chen, P; Chen, Y; Feng, Z; Gao, F; Jin, Y; Lin, W; Lu, C; Shang, Z; Wang, F; Yang, J | 1 |
| Charkhchian, M; Mirzadeh, M; Mohammadi, F | 1 |
| Fatahinia, M; Halvaeezadeh, M; Jalaee, GA; Mahmoudabadi, AZ | 1 |
| Agrawal, S; Bafna, S; Bhatt, S; Chatterjee, P; Chithambaram, NS; Das, RR; Gupta, H; Gupta, S; Jat, KR; Kalyan, P; Kapoor, R; Kaur, H; Kaur, J; Kaur, S; Kulkarni, SP; Kumar, A; Kumar, K; Mathew, JL; Rawat, SS; Saxena, V; Singh, A; Sivabalan, S; Srivastava, S; Tayal, A | 1 |
| Carvalhaes, CG; Castanheira, M; Pfaller, MA | 1 |
| Carballo Gonzalez, C; Gomez-Lopez, A; Ortega Madueño, S; Sanchez Galiano, S | 1 |
| Brito Devoto, T; Cuestas, ML; Finquelievich, JL; García-Effrón, G; Hermida-Alva, K; Posse, G | 1 |
| Bamba, S; Denis, O; Lagrou, K; Montesinos, I; Nakanabo Diallo, S; Resendiz-Sharpe, A; Rodriguez-Villalobos, H; Rouamba, T; Yerbanga, IW | 1 |
| Cha, JH; Cho, Y; Choi, H; Kim, J; Kim, KJ; Lee, CK; Nam, M; Nam, MH; Yim, J; Yun, SG | 1 |
| Celis-Ramírez, AM; Contreras, A; Ehemann, K | 1 |
| Bazydlo, L; Girton, M; Tomsig, J | 1 |
| Algueró, M; Bartroli, J; Boncompte, E; Conte, L; Forn, J; García-Rafanell, J; Merlos, M; Ramis, J; Turmo, E; Vericat, ML | 2 |
| Liu, L; Marichal, P; Odds, F; Saha, AK | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Abonía, R; Delgado, P; Enriz, RD; Garibotto, FM; Insuasty, B; Juárez, S; Nogueras, M; Quiroga, J; Rodero, L; Sortino, M; Zacchino, SA | 1 |
| Alastruey-Izquierdo, A; Cuenca-Estrella, M; Monzón, A; Rodriguez-Tudela, JL | 1 |
| Bergès, T; Bouchara, JP; Chabasse, D; Hennequin, C; Tronchin, G; Vandeputte, P | 1 |
| Bouza, E; Guinea, J; Martínez-Alarcón, J; Peláez, T; Torres-Narbona, M | 1 |
| Colombo, AL; Costa, SF; da Matta, VL; de Souza Carvalho Melhem, M; dos Anjos Martins, M; Duboc de Almeida, GM; Levin, AS; Moretti, ML; Nucci, M; Rodero, L; Souza Dias, MB | 1 |
| Aurbach, U; Cornely, O; Seifert, H; Stefanik, D | 1 |
| Cheng, S; Clancy, CJ; Clapp, W; Nguyen, KT; Nguyen, MH | 1 |
| Cao, YB; Jiang, YY; Sun, QY; Wu, QY; Xu, JM; Zhang, DZ; Zhang, J; Zhang, WN; Zhao, HQ | 1 |
| Alcázar-Fuoli, L; Cuenca-Estrella, M; Garcia-Effron, G; Melchers, WJ; Mellado, E; Rodríguez-Tudela, JL; Verweij, PE | 1 |
| Herrmann, JV; Miltenberger, R; Müller, FM; Salvenmoser, S; Staudigel, A; Tredup, A | 1 |
| Deising, HB; Serfling, A; Wohlrab, J | 1 |
| Casadevall, A; Gácser, A; Martinez, LR; Nosanchuk, JD; Ntiamoah, P | 1 |
| Enriz, RD; Freile, M; Gupta, MP; Kouznetsov, VV; Sortino, M; Vargas Méndez, LY; Vásquez, Y; Zacchino, SA | 1 |
| Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C | 1 |
| Guo, Q; Li, Y; Ma, L; Shi, C; Sun, S; Yu, J | 1 |
| Fritsche, TR; Jones, RN; Rhomberg, PR; Sader, HS | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Gutierrez, MO; Rodriguez-Tudela, JL | 1 |
| Alastruey-Izquierdo, A; Alcazar-Fuoli, L; Cuenca-Estrella, M; Mellado, E; Rodriguez-Tudela, JL | 2 |
| Boekhout, T; Curfs-Breuker, I; Fernández, CM; Illnait-Zaragozi, MT; Martínez, GF; Meis, JF | 1 |
| Aguirrebengoa, K; Arteaga, C; Chen, SC; Ellis, D; Heath, CH; Lutsar, I; Nguyen, Q; Rovira, M; Slavin, M; Troke, P | 1 |
| Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL | 1 |
| Azor, M; Cano, J; Fothergill, AW; Gené, J; Guarro, J; Rinaldi, MG; Sutton, DA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Dho, G; Esposto, MC; Gianni, C; Grancini, A; Ossi, C; Prigitano, A; Tortorano, AM; Viviani, MA | 1 |
| Chu, CC; Hsueh, PR; Ruan, SY | 1 |
| Jiang, Y; Jin, Y; Li, P; Liu, P; Sun, P; Sun, Q; Wu, Q; Xie, W; Yang, X; Zhang, D; Zhang, Y; Zhu, S | 1 |
| Alastruey-Izquierdo, A; Castelli, MV; Cuenca-Estrella, M; Cuesta, I; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
| Artico, M; Botta, M; Caporuscio, F; Cirilli, R; D'Auria, FD; De Melo, NR; Kelly, SL; La Regina, G; La Torre, F; Lamb, DC; Nencioni, L; Olla, S; Palamara, AT; Piscitelli, F; Silvestri, R; Tafi, A | 1 |
| Coleman, DC; Dudley, E; Kelly, DE; Kelly, SL; Lamb, DC; Melo, NR; Moran, GP; Smith, SN; Sullivan, DJ; Warrilow, AG | 1 |
| Fille, M; Hausdorfer, J; Hinterberger, G; Lass-Flörl, C; Mayr, A; Perkhofer, S; Speth, C | 1 |
| Kelly, DE; Kelly, SL; Manning, NJ; Merkamm, M; Parker, JE; Pompon, D | 1 |
| Müller, FM; Salvenmoser, S; Seidler, MJ | 1 |
| Garcia-Effron, G; Kontoyiannis, DP; Lewis, RE; Perlin, DS | 1 |
| Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD | 1 |
| Alastruey-Izquierdo, A; Cuenca-Estrella, M; Lass-Flörl, C; Perkhofer, S; Rodriguez-Tudela, JL | 1 |
| Jackson, CJ; Kelly, DE; Kelly, SL; Lamb, DC; Marczylo, TH; Parker, JE; Warrilow, AG | 1 |
| Chai, X; Dan, Z; Hu, H; Jiang, Y; Sun, Q; Wu, Q; Yu, S; Zhang, J | 1 |
| Arendrup, MC; Bruun, B; Buzina, W; Garcia-Effron, G; Jensen, HE; Lass-Flörl, C; Lundin, C; Mortensen, KL; Perlin, DS; Reiter, N | 1 |
| Dimopoulos, G; Falagas, ME; Velegraki, A | 1 |
| Alastruey-Izquierdo, A; Castelli, MV; Cuenca-Estrella, M; Cuesta, I; Monzon, A; Rodriguez-Tudela, JL | 1 |
| Chai, X; Dan, Z; Hu, H; Wu, Q; Yu, S; Zhang, D; Zhang, J; Zhao, Q; Zou, Y | 1 |
| Cao, Y; Che, X; Dong, G; Ji, H; Miao, Z; Sheng, C; Wang, W; Xu, Y; Yao, J; Zhang, W | 1 |
| Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE | 1 |
| Calvo, E; Guarro, J; Pastor, FJ; Rodríguez, MM; Salas, V; Sutton, DA | 1 |
| Gao, C; Pang, G; Sun, S; Wang, B; Xu, Y; Zhao, D; Zhou, L | 1 |
| Brüggemann, RJ; Mavridou, E; Melchers, WJ; Mouton, JW; Verweij, PE | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Coste, A; Ischer, F; Jacobsen, MD; MacCallum, DM; Odds, FC; Sanglard, D | 1 |
| Inamine, T; Izumikawa, K; Kakeya, H; Kohno, S; Miyazaki, T; Miyazaki, Y; Nagayoshi, Y; Saijo, T; Seki, M; Yamamoto, Y; Yamauchi, S; Yanagihara, K | 1 |
| Cao, Y; Che, X; Dong, G; Ji, H; Miao, Z; Sheng, C; Wang, S; Wang, W; Xu, Y; Yao, J; Zhang, W | 1 |
| Karawajczyk, A; Melchers, WJ; Schaftenaar, G; Snelders, E; Verweij, PE | 1 |
| Alastruey-Izquierdo, A; Cuenca-Estrella, M; Cuesta, I; Rodriguez-Tudela, JL; Walther, G | 1 |
| Bauer, T; Cornely, OA; Farowski, F; Hartmann, P; Müller, C; Rüping, MJ; Steinbach, A; Vehreschild, JJ | 1 |
| Bartley, R; Biswas, C; Chen, SC; Djordjevic, JT; Ellis, DH; Jolliffe, KA; Obando, D; Pantarat, N; Sorrell, TC; Widmer, F | 1 |
| Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Warrilow, AG; Weig, M | 1 |
| Chai, X; Guan, Z; Hu, H; Sun, Q; Wu, Q; Yan, Y; Yu, S; Zou, Y | 1 |
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Zhang, D; Zhang, J; Zou, Y | 3 |
| Cao, Y; Chai, X; Hu, H; Jiang, Y; Sun, Q; Wu, Q; Zhang, D; Zhang, J; Zhao, Q; Zou, Y | 1 |
| Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Xu, J; Yu, S; Zhang, D; Zhang, J; Zou, Y | 1 |
| Chai, X; Hu, H; Liao, J; Wu, Q; Xu, M; Yu, S; Zhao, Q; Zou, Y | 1 |
| Hu, Y; Shen, F; Wang, K; Wang, L; Yang, W; Zhu, J | 1 |
| Akalin, G; Bertout, S; Demirci, F; Fulcrand, P; Maillard, LT; Martinez, J; Masurier, N; Quinonéro, O; Turan-Zitouni, G | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chai, X; Ding, H; Li, L; Wang, B; Wu, Q; Yu, S; Zou, Y | 1 |
| Cai, T; Cao, X; Cao, Y; Chu, W; Hu, W; Sun, Z; Wang, R; Yang, Y | 1 |
| Gerwick, WH; Kurtán, T; Liu, B; Mándi, A; Sun, P; Tang, H; Wang, ZW; Xu, DX; Zhang, W | 1 |
| Besson, T; Chosson, E; Duflos, M; Guillon, R; Hédou, D; Le Pape, P; Logé, C; Pagniez, F; Picot, C; Tonnerre, A | 1 |
| Garvey, EP; Hoekstra, WJ; Moore, WR; Rafferty, SW; Schotzinger, RJ; Yates, CM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chandrika, NT; Garneau-Tsodikova, S; Ngo, HX; Shrestha, SK | 1 |
| Garneau-Tsodikova, S; Garzan, A; Shrestha, SK | 1 |
| Emami, S; Keighobadi, M; Tavangar, P | 1 |
| Cheng, M; Hao, C; Jiang, X; Su, X; Wei, P; Wu, M; Zhang, X; Zhao, D; Zhao, L; Zhao, S | 1 |
| Wang, SQ; Wang, YF; Xu, Z | 1 |
| Chen, Y; Cheng, M; Su, X; Sun, N; Sun, Y; Tian, L; Wang, X; Zhao, D; Zhao, L; Zhao, S | 1 |
| Benhamou, RI; Dorot, O; Elias, R; Fridman, M; Jaber, QZ; Oved, K; Pichinuk, E; Zada, SL | 1 |
| Gazzola, S; Guillon, R; Le Pape, P; Logé, C; Montoir, D; Ourliac-Garnier, I; Pagniez, F; Picot, C; Planchat, A; Soklou, KE; Tonnerre, A | 1 |
| Han, G; Li, C; Li, Z; Liu, N; Sheng, C; Tu, J | 1 |
| Chen, X; Li, C; Liu, N; Sheng, C; Tu, J; Xu, D; Zhu, T | 1 |
| Hashimoto, K; Kato, I; Kawai, M; Kimura, C; Kondo, N; Maki, H; Mizusawa, E; Naito, A; Nozu, K; Ukai, Y | 1 |
| Cheng, M; Cui, H; Jiang, H; Li, S; Liu, L; Su, X; Sun, Y; Wu, T; Yin, W; Zhang, Y; Zhao, D; Zhao, L; Zheng, Y | 1 |
| Guengerich, FP; Hargrove, TY; Lepesheva, GI; Nes, WD; Rachakonda, G; Villalta, F; Wawrzak, Z | 1 |
65 review(s) available for itraconazole and voriconazole
| Article | Year |
|---|---|
In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.
Topics: Amphotericin B; Antifungal Agents; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Triazoles; Voriconazole | 2001 |
[Present status and future prospects of azole antifungal agents in Japan].
Topics: Antifungal Agents; Azoles; Cyclodextrins; Drug Design; Fluconazole; Forecasting; Itraconazole; Japan; Miconazole; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
[Clinical development of antimycotics. Medical challenges].
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Excipients; Fungi; Humans; Itraconazole; Lipopeptides; Liposomes; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Voriconazole | 2003 |
History of the development of azole derivatives.
Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Pyrimidines; Triazoles; Voriconazole | 2004 |
CNS-aspergillosis: are there new treatment options?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blood-Brain Barrier; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Male; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
[New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole | 2004 |
[Invasive aspergillosis: clinical manifestations and treatment].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Caspofungin; Dermatomycoses; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Immunologic Factors; Itraconazole; Lipopeptides; Neuroaspergillosis; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Respiratory Tract Infections; Triazoles; Voriconazole | 2003 |
Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment.
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Azoles; Evidence-Based Medicine; Forecasting; Humans; Itraconazole; Ketoconazole; Pyrimidines; Triazoles; Voriconazole | 2004 |
Pharmacological management of paracoccidioidomycosis.
Topics: Amphotericin B; Central Nervous System Fungal Infections; Drug Resistance; Fluconazole; Follow-Up Studies; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Paracoccidioidomycosis; Pyrimidines; Sulfonamides; Triazoles; Voriconazole | 2005 |
[Update on therapy of invasive mycoses in hematology and oncology].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Drug Combinations; Echinocandins; Hematologic Neoplasms; Humans; Itraconazole; Lipopeptides; Liposomes; Mycoses; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Risk Factors; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis | 2005 |
Antifungal agents in children.
Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole | 2005 |
[Drug-drug interaction of antifungal drugs].
Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microsomes, Liver; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
[The future of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole | 2007 |
Fusarium infections of the skin.
Topics: Antifungal Agents; Dermatomycoses; Fusarium; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2007 |
Antifungal agents.
Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Half-Life; Humans; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2007 |
[New development in the treatment of deep-seated mycoses].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.
Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
Antifungal agents--clinical pharmacokinetics and drug interactions.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Echinocandins; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
Invasive candidiasis in the ICU: evidence based and on the edge of evidence.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Intensive Care Units; Itraconazole; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2008 |
Treatment of invasive candidal infections: systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Confidence Intervals; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Odds Ratio; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
[Oral antifungal agents].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Diabetes Complications; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Clinical efficacies of antifungal injections].
Topics: Amphotericin B; Antifungal Agents; Drug Delivery Systems; Echinocandins; Fluconazole; Humans; Infusions, Intravenous; Injections; Itraconazole; Lipopeptides; Liposomes; Micafungin; Mycoses; Organophosphates; Pyrimidines; Triazoles; Voriconazole | 2008 |
Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.
Topics: Amino Acid Substitution; Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Pyrimidines; Sequence Analysis, DNA; Sterol 14-Demethylase; Triazoles; Voriconazole | 2010 |
Onychomycosis.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2010 |
Traditional and emerging antifungal therapies.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole | 2010 |
Conazoles.
Topics: Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Miconazole; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole | 2010 |
Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature.
Topics: Adult; Aged; Antifungal Agents; Female; Humans; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Risk Factors; Sarcoidosis, Pulmonary; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Therapy, Combination; Echinocandins; Evidence-Based Medicine; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2011 |
Anidulafungin: when and how? The clinician's view.
Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Mycoses; North America; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole | 2012 |
Triazole antifungal agents in invasive fungal infections: a comparative review.
Topics: Antifungal Agents; Fluconazole; Fungi; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
[Azole resistance in Aspergillus fumigatus in the Netherlands--increase due to environmental fungicides?].
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Environmental Microbiology; Fungicides, Industrial; Humans; Itraconazole; Microbial Sensitivity Tests; Netherlands; Pyrimidines; Triazoles; Voriconazole | 2012 |
Diagnosis of airway-invasive pulmonary aspergillosis by tree-in-bud sign in an immunocompetent patient: case report and literature review.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Biopsy; Bronchiolitis; Bronchoscopy; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Humans; Immunocompetence; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Lung; Male; Pyrimidines; Sputum; Tomography, X-Ray Computed; Triazoles; Tuberculosis, Pulmonary; Voriconazole; Young Adult | 2013 |
Fungal infections and treatment in cystic fibrosis.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Candida; Candidiasis; Cystic Fibrosis; DNA, Fungal; Female; Humans; Itraconazole; Male; Pyrimidines; Scedosporium; Sputum; Triazoles; Vital Capacity; Voriconazole | 2013 |
Rhodotorula minuta as onychomycosis agent in a Chinese patient: first report and literature review.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Asian People; China; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Onychomycosis; Pyrimidines; Rhodotorula; Triazoles; Voriconazole | 2014 |
Clinically relevant drug-drug interactions between antiretrovirals and antifungals.
Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Carbamates; Cyclopropanes; Drug Interactions; Drug Monitoring; Echinocandins; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Itraconazole; Mycoses; Organophosphates; Pyrimidines; Ritonavir; Sulfonamides; Triazoles; Voriconazole | 2014 |
Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cholesterol; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole | 2014 |
Optimizing azole antifungal therapy in the prophylaxis and treatment of fungal infections.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Itraconazole; Mycoses; Population Surveillance; Precision Medicine; Triazoles; Voriconazole | 2014 |
Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification.
Topics: Antifungal Agents; Azoles; Communicable Diseases, Emerging; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Voriconazole | 2015 |
Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis.
Topics: Adult; Antifungal Agents; Aspergillus; Candida; Cost-Benefit Analysis; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Economic; Mycoses; Singapore; Survival Analysis; Triazoles; Voriconazole | 2016 |
Newer antifungal agents micafungin and voriconazole for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis.
Topics: Antifungal Agents; Echinocandins; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Itraconazole; Lipopeptides; Micafungin; Mycoses; Randomized Controlled Trials as Topic; Voriconazole | 2016 |
The Current Status of Drug-resistant Aspergillus.
Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Japan; Mutation; Pulmonary Aspergillosis; Voriconazole | 2016 |
Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
Topics: Anidulafungin; Antifungal Agents; Asia; Azoles; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Candidiasis; Candidiasis, Invasive; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Incidence; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Phenotype; Prevalence; Voriconazole | 2016 |
Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations.
Topics: Antifungal Agents; Biological Availability; Drug Monitoring; Fungi; Humans; Invasive Fungal Infections; Itraconazole; Nitriles; Pyridines; Triazoles; Voriconazole | 2017 |
Scedosporium apiospermum infection of the urinary system with a review of treatment options and cases in the literature.
Topics: Adult; Antifungal Agents; Bone Marrow Transplantation; Female; Humans; Immunocompromised Host; Itraconazole; Male; Mycoses; Pyrimidines; Scedosporium; Triazoles; Urinary Tract Infections; Voriconazole | 2018 |
Chronic mucocutaneous candidiasis due to gain-of-function mutation in STAT1.
Topics: Adult; Aged; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; Female; Gain of Function Mutation; Humans; Itraconazole; Male; Middle Aged; STAT1 Transcription Factor; Voriconazole | 2019 |
Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.
Topics: Amphotericin B; Antifungal Agents; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leishmaniasis; Molecular Targeted Therapy; Phosphorylcholine; Sterol 14-Demethylase; Triazoles; Voriconazole | 2019 |
Blastomycosis.
Topics: Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Humans; Immunocompromised Host; Itraconazole; Triazoles; Voriconazole | 2020 |
An overview of the available treatments for chronic cavitary pulmonary aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Disease Management; Echinocandins; Humans; Itraconazole; Nitriles; Practice Guidelines as Topic; Pulmonary Aspergillosis; Pyridines; Triazoles; Voriconazole | 2020 |
Pseudozyma spp. human infections: A systematic review.
Topics: Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Humans; Itraconazole; Mycoses; Voriconazole; Yeasts | 2021 |
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST).
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Practice Guidelines as Topic; Triazoles; Voriconazole | 2020 |
[Azoles of then and now: a review].
Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Voriconazole | 2020 |
Tolerability of oral itraconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A systematic review and meta-analysis.
Topics: Administration, Oral; Antifungal Agents; Cardiotoxicity; Humans; Itraconazole; Pulmonary Aspergillosis; Treatment Outcome; Voriconazole | 2020 |
Inhaled Antifungal Agents for the Treatment and Prophylaxis of Pulmonary Mycoses.
Topics: Amphotericin B; Antifungal Agents; Humans; Itraconazole; Mycoses; Voriconazole | 2021 |
Clinical Pharmacokinetics of Triazoles in Pediatric Patients.
Topics: Adult; Antifungal Agents; Child; Fluconazole; Humans; Itraconazole; Mycoses; Triazoles; Voriconazole | 2021 |
Anti-fungal agents in the treatment of chronic pulmonary aspergillosis: Systematic review and a network meta-analysis.
Topics: Antifungal Agents; Echinocandins; Humans; Itraconazole; Network Meta-Analysis; Observational Studies as Topic; Pulmonary Aspergillosis; Randomized Controlled Trials as Topic; Voriconazole | 2021 |
Spinal epidural abscess caused by Aspergillus spp masquerading as spinal tuberculosis in a person with HIV.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Epidural Abscess; Female; HIV Infections; HIV-1; Humans; Itraconazole; Tuberculosis; Voriconazole | 2021 |
Antifungal Therapy with Azoles Induced the Syndrome of Acquired Apparent Mineralocorticoid Excess: a Literature and Database Analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Azoles; Child; Humans; Itraconazole; Middle Aged; Mineralocorticoid Excess Syndrome, Apparent; Voriconazole; Young Adult | 2022 |
Review of the alternative therapies for onychomycosis and superficial fungal infections: posaconazole, fosravuconazole, voriconazole, oteseconazole.
Topics: Antifungal Agents; Complementary Therapies; Dermatologic Agents; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome; Voriconazole | 2022 |
Antifungal Drugs TDM: Trends and Update.
Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Humans; Itraconazole; Voriconazole | 2022 |
Evidence-Based Guidelines for the Management of Allergic Bronchopulmonary Aspergillosis (ABPA) in Children and Adolescents with Asthma.
Topics: Adolescent; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Asthma; Child; Humans; Itraconazole; Voriconazole | 2023 |
Performances of disk diffusion method for determining triazole susceptibility of Aspergillus species: Systematic review.
Topics: Agar; Antifungal Agents; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Reproducibility of Results; Triazoles; Voriconazole | 2023 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy.
Topics: 14-alpha Demethylase Inhibitors; Antiprotozoal Agents; Azoles; Humans; Leishmania; Molecular Structure; Sterol 14-Demethylase | 2017 |
Tetrazole hybrids and their antifungal activities.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Mycoses; Pyridines; Pyrimidines; Quinolines; Structure-Activity Relationship; Tetrazoles | 2019 |
13 trial(s) available for itraconazole and voriconazole
| Article | Year |
|---|---|
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Deoxycholic Acid; Drug Combinations; Humans; Itraconazole; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Administration Schedule; Female; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Salvage Therapy; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole | 2006 |
An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Administration Schedule; Female; Humans; Itraconazole; Male; Middle Aged; Paracoccidioidomycosis; Pilot Projects; Pyrimidines; Triazoles; Voriconazole | 2007 |
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies.
Topics: Amphotericin B; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Voriconazole increases while itraconazole decreases plasma meloxicam concentrations.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Blood Coagulation; Cross-Over Studies; Cyclooxygenase 1; Cytochrome P-450 Enzyme System; Drug Interactions; Genotype; Half-Life; Humans; Itraconazole; Male; Meloxicam; Protein Binding; Pyrimidines; Thiazines; Thiazoles; Thromboxane B2; Triazoles; Voriconazole; Young Adult | 2009 |
Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Bilirubin; Drug Monitoring; Female; Humans; Infusions, Intravenous; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult | 2011 |
Voriconazole for fungal corneal ulcers.
Topics: Acremonium; Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Ascomycota; Aspergillus flavus; Aspergillus niger; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Humans; Itraconazole; Middle Aged; Mycoses; Natamycin; Prospective Studies; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA).
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Asthma; Female; Forced Expiratory Volume; Humans; Itraconazole; Male; Middle Aged; Nebulizers and Vaporizers; Quality of Life; Voriconazole | 2015 |
Plasma Concentrations of Itraconazole, Voriconazole, and Terbinafine When Delivered by an Impregnated, Subcutaneous Implant in Japanese Quail ( Coturnix japonica ).
Topics: Animals; Antifungal Agents; Coturnix; Dose-Response Relationship, Drug; Drug Implants; Itraconazole; Male; Naphthalenes; Pilot Projects; Subcutaneous Absorption; Terbinafine; Voriconazole | 2017 |
Multicenter-Based Population Pharmacokinetic Analysis of Ciclosporin in Hematopoietic Stem Cell Transplantation Patients.
Topics: Adolescent; Adult; Aged; Body Weight; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Itraconazole; Male; Middle Aged; Models, Biological; Reproducibility of Results; Transplantation Conditioning; Voriconazole | 2019 |
Intracellular concentrations of posaconazole in different compartments of peripheral blood.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Erythrocytes; Female; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Neutrophils; Triazoles | 2010 |
585 other study(ies) available for itraconazole and voriconazole
| Article | Year |
|---|---|
Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen.
Topics: Cholesterol; Crystallography, X-Ray; Cytochrome P-450 Enzyme System; Host-Pathogen Interactions; Humans; Hydroxylation; Mycobacterium tuberculosis; Oxidation-Reduction; Protein Structure, Tertiary | 2010 |
Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Dose-Response Relationship, Drug; Endocarditis; Guinea Pigs; Itraconazole; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1997 |
Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Itraconazole; Lung; Male; Pyrimidines; Rats; Rats, Sprague-Dawley; Triazoles; Voriconazole | 1997 |
In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens.
Topics: Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1997 |
In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
In vitro comparative efficacy of voriconazole and itraconazole against fluconazole-susceptible and -resistant Cryptococcus neoformans isolates.
Topics: Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Microbial; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
In vitro activity of voriconazole against Candida species.
Topics: Antifungal Agents; Candida; Drug Evaluation, Preclinical; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Triazoles; Voriconazole | 1998 |
In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; Genotype; HIV Infections; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth; North America; Pharynx; Phenotype; Pyrimidines; Triazoles; Voriconazole | 1998 |
Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
In vitro activity of voriconazole against selected fungi.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Basidiomycota; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Environmental Microbiology; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 1998 |
Organism-dependent fungicidal activities of azoles.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Dose-Response Relationship, Drug; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa.
Topics: Africa; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; United States; Voriconazole | 1999 |
Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Itraconazole; Kinetics; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 1999 |
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1999 |
In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Drug Resistance, Microbial; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1999 |
In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1998 |
Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1998 |
Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Humans; Hydrogen-Ion Concentration; Itraconazole; Male; Meningitis, Fungal; Microbial Sensitivity Tests; Osmolar Concentration; Phenotype; Pyrimidines; Staining and Labeling; Temperature; Triazoles; Voriconazole | 1999 |
Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole | 1999 |
Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1999 |
Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species.
Topics: Antifungal Agents; Candida; Colorimetry; Coloring Agents; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Oxazines; Pyrimidines; Triazoles; Voriconazole; Xanthenes | 1999 |
In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.
Topics: Amphotericin B; Antifungal Agents; Blastomyces; Coccidioides; Histoplasma; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2000 |
[Therapy of deep seated mycoses--Timing of administration and selection of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2000 |
A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole | 2000 |
Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Biopsy, Needle; Child, Preschool; Diagnostic Errors; DNA, Fungal; Galactose; Granulomatous Disease, Chronic; Humans; Itraconazole; Lung Abscess; Lung Diseases, Fungal; Male; Mannans; Pyrimidines; Triazoles; Voriconazole | 2000 |
Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Reference Standards; Time Factors; Triazoles; Trichosporon; Turkey; Voriconazole | 2000 |
Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Child, Preschool; Combined Modality Therapy; Drug Resistance, Microbial; Flucytosine; Granulocyte Colony-Stimulating Factor; Granulocytes; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Leukocyte Transfusion; Lung Diseases, Fungal; Male; Neutrophils; Osteomyelitis; Pyrimidines; Respiratory Burst; Ribs; Triazoles; Voriconazole | 2000 |
Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining.
Topics: Antifungal Agents; Aspergillus; Coloring Agents; Dye Dilution Technique; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2001 |
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2001 |
Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Drug Synergism; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2001 |
[Invasive aspergillosis on a surgical intensive care unit].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Therapy, Combination; Fatal Outcome; Female; Flucytosine; Humans; Intensive Care Units; Itraconazole; Male; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2000 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole | 2000 |
Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Microbial; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2001 |
Application of capillary zone electrophoresis with off-line solid-phase extraction to in vitro metabolism studies of antifungals.
Topics: Acetic Acid; Acetonitriles; Antifungal Agents; Clotrimazole; Drug Stability; Electrophoresis, Capillary; Fluconazole; Humans; Itraconazole; Ketoconazole; Methanol; Microsomes, Liver; Molecular Structure; Molecular Weight; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Solvents; Triazoles; Verapamil; Voriconazole | 2001 |
Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Sporothrix; Sporotrichosis; Triazoles; Voriconazole | 2001 |
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole | 2001 |
In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2001 |
Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2001 |
Azole cross-resistance in Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Microbial; Drug Resistance, Multiple; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2002 |
[Antimycotic treatment of pulmonary aspergilloma in patients without neutropenia].
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Female; Humans; Itraconazole; Male; Middle Aged; Neutropenia; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2002 |
In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles.
Topics: Antifungal Agents; Azoles; Candida; Dose-Response Relationship, Drug; Fluconazole; HIV Infections; Humans; Itraconazole; Laboratories; Microbial Sensitivity Tests; Mouth; Naphthalenes; Pyrimidines; Quality Control; Terbinafine; Triazoles; Voriconazole | 2002 |
Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum.
Topics: Adult; Antifungal Agents; Humans; Hyphae; Itraconazole; Neutrophils; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2002 |
Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Netherlands; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2002 |
Effect of medium composition on static and cidal activity of amphotericin B, itraconazole, voriconazole, posaconazole and terbinafine against Aspergillus fumigatus: a multicenter study.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Culture Media; France; Humans; Itraconazole; Laboratories; Microbial Sensitivity Tests; Naphthalenes; Observer Variation; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2002 |
Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Deoxycholic Acid; Drug Combinations; Drug Resistance, Fungal; Etoposide; Fatal Outcome; Humans; Immunocompromised Host; Itraconazole; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelomonocytic, Acute; Liposomes; Lung Diseases, Fungal; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole | 2002 |
Characterization of a lanosterol 14 alpha-demethylase from Pneumocystis carinii.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Base Sequence; Blotting, Northern; Candida; Chromosome Mapping; Cloning, Molecular; Cytochrome P-450 Enzyme System; DNA, Complementary; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Fluconazole; Gene Deletion; Immunoblotting; Itraconazole; Lung; Molecular Sequence Data; Mutagenesis, Site-Directed; Oxidoreductases; Pneumocystis; Polymerase Chain Reaction; Protein Biosynthesis; Pyrimidines; Rats; Recombinant Proteins; RNA, Messenger; RNA, Ribosomal; Saccharomyces cerevisiae; Sequence Homology, Amino Acid; Sterol 14-Demethylase; Triazoles; Voriconazole | 2003 |
In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.
Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2003 |
In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs.
Topics: Antifungal Agents; Aspergillus; Humans; Itraconazole; Microbial Sensitivity Tests; Microbiological Techniques; Pyrimidines; Triazoles; Voriconazole | 2003 |
Effect of increasing inoculum sizes of Aspergillus hyphae on MICs and MFCs of antifungal agents by broth microdilution method.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Humans; In Vitro Techniques; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2003 |
An unusual dematiaceous fungal infection of the skin caused by Fonsecaea pedrosoi: a case report and review of the literature.
Topics: Adult; Antifungal Agents; Ascomycota; Chromoblastomycosis; Humans; Itraconazole; Male; Pyrimidines; Skin; Triazoles; Voriconazole | 2003 |
Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2003 |
In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Flucytosine; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Triazoles; Voriconazole | 2003 |
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.
Topics: Amphotericin B; Anti-Bacterial Agents; Aspergillus; Caspofungin; Echinocandins; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Penicillium; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2003 |
In vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Spain; Triazoles; Voriconazole | 2003 |
[In vitro activity of voriconazole and three other antifungal agents against dermatophytes].
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Microsporum; Naphthalenes; Pyrimidines; Species Specificity; Terbinafine; Triazoles; Trichophyton; Voriconazole | 2003 |
Attenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole.
Topics: Antifungal Agents; Aspergillus fumigatus; Colorimetry; Fluconazole; Hyphae; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Tetrazolium Salts; Triazoles; Voriconazole | 2003 |
Flow cytometry antifungal susceptibility testing of Aspergillus fumigatus and comparison of mode of action of voriconazole vis-à-vis amphotericin B and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Flow Cytometry; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2003 |
In vitro activity of ravuconazole against Zygomycetes, Scedosporium and Fusarium isolates.
Topics: Amphotericin B; Antifungal Agents; Fungi; Fusarium; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Thiazoles; Triazoles; Voriconazole | 2003 |
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Resistance, Fungal; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Quinazolines; Sensitivity and Specificity; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2004 |
In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Fungi; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Spain; Terbinafine; Triazoles; Voriconazole | 2004 |
In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2004 |
Altered susceptibility of Candida glabrata bloodstream isolates to triazoles at clinically relevant pH values: comparison of the NCCLS M27-A2, Sensititre YeastOne, and Etest methods.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Culture Media; Fluconazole; Hydrogen-Ion Concentration; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2004 |
Determination of antifungal drug susceptibilities of Aspergillus species by a fluorescence-based microplate assay.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Fluoresceins; Fluorescence; Fluorescent Dyes; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2005 |
In vitro testing of Aspergillus fumigatus clinical isolates for susceptibility to voriconazole, amphotericin B and itraconazole: comparison of sensititre versus NCCLS M38-A using two different inocula.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Itraconazole; Microbial Sensitivity Tests; Predictive Value of Tests; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole | 2004 |
Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Female; Humans; Itraconazole; Male; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Transplantation; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Cholesterol import by Aspergillus fumigatus and its influence on antifungal potency of sterol biosynthesis inhibitors.
Topics: Antifungal Agents; Aspergillus fumigatus; Azoles; Cell Membrane; Cholesterol; Culture Media, Conditioned; Ergosterol; Humans; Itraconazole; Magnetic Resonance Spectroscopy; Oxygen Consumption; Pyrimidines; Spores, Fungal; Sterols; Triazoles; Voriconazole | 2005 |
[In vitro activity of amphotericin B, itraconazole and voriconazole against 20 species of Aspergillus using the Sensititre microdilution method].
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2005 |
In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Colorimetry; Fluorescence; Fusarium; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Species Specificity; Triazoles; Voriconazole | 2005 |
Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2005 |
In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida glabrata; Candida tropicalis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Pichia; Pyrimidines; Saccharomyces cerevisiae; Species Specificity; Triazoles; Voriconazole | 2005 |
[Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole].
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Chemoprevention; Humans; Itraconazole; Lung Transplantation; Pyrimidines; Triazoles; Voriconazole | 2005 |
Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Cornea; Corneal Transplantation; Fusarium; Humans; Itraconazole; Keratitis; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2005 |
Isocratic high-performance liquid chromatographic method with ultraviolet detection for simultaneous determination of levels of voriconazole and itraconazole and its hydroxy metabolite in human serum.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Itraconazole; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Ultraviolet Rays; Voriconazole | 2005 |
In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus; Drug Synergism; Echinocandins; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.
Topics: Antifungal Agents; Candida; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2005 |
Lung infection due to opportunistic fungus, Phialemonium obovatum, in a bone marrow transplant recipient: an emerging infection with fungemia and Crohn disease-like involvement of the gastrointestinal tract.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Bone Marrow Transplantation; Drug Resistance, Fungal; Fungemia; Gastrointestinal Diseases; Graft vs Host Disease; Granuloma; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2005 |
In vitro investigation of antifungal activities of phenotypic variation Candida albicans strains against fluconazole, itraconazole and voriconazole.
Topics: Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Phenotype; Pyrimidines; Triazoles; Voriconazole | 2005 |
[In vitro susceptibility of fungal and yeast clinical isolates to itraconazole and voriconazole].
Topics: Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Scedosporium; Sporothrix; Triazoles; Voriconazole; Yeasts | 2005 |
[In vitro antifungal activity of voriconazole against dermatophytes and superficial isolates of Scopulariopsis brevicaulis].
Topics: Antifungal Agents; Arthrodermataceae; Ascomycota; Dermatomycoses; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2005 |
Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry.
Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Drug Synergism; Flow Cytometry; Fluconazole; Fungal Proteins; Ibuprofen; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Staining and Labeling; Triazoles; Voriconazole | 2005 |
Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Reproducibility of Results; Spectrophotometry; Triazoles; Voriconazole | 2005 |
Comparison of two probes for testing susceptibilities of pathogenic yeasts to voriconazole, itraconazole, and caspofungin by flow cytometry.
Topics: Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Echinocandins; Flow Cytometry; Fluorescent Dyes; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Propidium; Pyrimidines; Triazoles; Voriconazole | 2005 |
Voriconazole susceptibility of yeasts isolated from the mouths of patients with advanced cancer.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth Diseases; Mycoses; Neoplasms; Palliative Care; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2005 |
DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; DNA Fingerprinting; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Soil Microbiology; Spain; Triazoles; Voriconazole | 2005 |
Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
Topics: Academic Medical Centers; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Israel; Itraconazole; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2005 |
Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Paecilomyces; Pyrimidines; Quality Control; Triazoles; Voriconazole | 2005 |
[Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Mycoses; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
In vitro susceptibility of oral Candida to seven antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mouth Diseases; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2005 |
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emerging; Dermatomycoses; Disease Susceptibility; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Sinusitis; Transplantation Conditioning; Triazoles; Viscera; Voriconazole | 2005 |
Comparison between Aspergillus fumigatus conidia and hyphae susceptibilities to amphotericin B, itraconazole, and voriconazole by use of the mold rapid susceptibility assay.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Hyphae; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2005 |
Human albumin promotes germination, hyphal growth and antifungal resistance by Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Drug Resistance, Fungal; Growth Substances; Hyphae; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Serum Albumin; Triazoles; Voriconazole | 2005 |
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts | 2006 |
Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole | 2006 |
Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.
Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis; Child; Drug Resistance, Fungal; Fluconazole; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2006 |
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Synergism; Echinocandins; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Peptides, Cyclic; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2006 |
[Clinical cases in medical mycology. Case no. 21].
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Endophthalmitis; Exophiala; Female; Fungemia; Humans; Itraconazole; Middle Aged; Mycoses; Opportunistic Infections; Osteolysis; Pregnancy; Pregnancy Complications, Infectious; Pyrimidines; Recurrence; Th2 Cells; Triazoles; Voriconazole | 2006 |
Application of fluorescent probes to study structural changes in Aspergillus fumigatus exposed to amphotericin B, itraconazole, and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Benzenesulfonates; Fluorescent Dyes; Itraconazole; Microbial Sensitivity Tests; Microscopy, Fluorescence; Propidium; Pyrimidines; Triazoles; Voriconazole | 2006 |
Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole.
Topics: Air Sacs; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Bird Diseases; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Falconiformes; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole | 2006 |
A modified Christensen's urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Culture Media; Dermatomycoses; HIV Infections; Humans; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Polysorbates; Pyrimidines; Triazoles; Urea; Voriconazole | 2006 |
Use of voriconazole in a patient with aspergilloma caused by an itraconazole-resistant strain of Aspergillus fumigatus.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Humans; Hydroxycorticosteroids; Itraconazole; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Pyrimidines; Sarcoidosis; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
Multi-azole resistance in Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Itraconazole; Lipopeptides; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2006 |
Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Brain; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Fluorescence Resonance Energy Transfer; Immunocompromised Host; Immunosuppression Therapy; Itraconazole; Kidney; Lipopeptides; Liver; Lung; Male; Mice; Neutropenia; Nitriles; Peptides, Cyclic; Polymerase Chain Reaction; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2006 |
Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole | 2007 |
Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.
Topics: Air Microbiology; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Cross Infection; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole; Water Microbiology | 2007 |
Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, cas
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; Triazoles; Voriconazole | 2007 |
Antifungal activities of azole agents against the Malassezia species.
Topics: Antifungal Agents; Azoles; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Tinea Versicolor; Triazoles; Voriconazole | 2007 |
[Prolonged therapeutic response to voriconazole in a case of allergic bronchopulmonary aspergillosis].
Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Female; Humans; Itraconazole; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2007 |
Antifungal susceptibility testing of Trichophyton rubrum by E-test.
Topics: Antifungal Agents; Cells, Cultured; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Tinea; Triazoles; Trichophyton; Voriconazole | 2007 |
Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Hospitals; Humans; Intensive Care Units; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2007 |
The effects of caspofungin and voriconazole in experimental Candida endophthalmitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Cornea; Disease Models, Animal; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Itraconazole; Lipopeptides; Peptides, Cyclic; Pyrimidines; Rabbits; Triazoles; Voriconazole | 2007 |
[Bilateral proximal cellulitis and onychomycosis in both big toes due to Fusarium solani].
Topics: Antifungal Agents; Cellulitis; Ciclopirox; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Multiple, Fungal; Foot Dermatoses; Fusarium; Humans; Imidazoles; Immunocompetence; Itraconazole; Male; Middle Aged; Mozambique; Onychomycosis; Pyridones; Pyrimidines; Recurrence; Toes; Travel; Triazoles; Urea; Voriconazole | 2006 |
Nasofacial phycomycosis: persistence pays.
Topics: Adult; Antifungal Agents; Conidiobolus; Drug Resistance, Fungal; Facial Dermatoses; Female; Humans; Itraconazole; Pyrimidines; Timor-Leste; Triazoles; Voriconazole; Zygomycosis | 2007 |
Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Culture Media; Disk Diffusion Antimicrobial Tests; Echinocandins; Fungi; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2007 |
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Sporothrix; Sporotrichosis; Triazoles; Voriconazole | 2007 |
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Antifungal susceptibility of Cryptococcus neoformans isolates in HIV-infected patients to fluconazole, itraconazole and voriconazole in Spain: 1994-1996 and 1997-2005.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Cryptococcus neoformans; Drug Resistance, Viral; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Time Factors; Triazoles; Voriconazole | 2007 |
[Correlations among itraconazole, voriconazole and posaconazole MICs in Aspergillus fumigatus].
Topics: Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2007 |
Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP).
Topics: Antifungal Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line; Cell Survival; Chlorophyll; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Neoplasm; Flow Cytometry; Fluconazole; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Itraconazole; Ketoconazole; Neoplasm Proteins; Pyrimidines; Topotecan; Transfection; Triazoles; Voriconazole | 2007 |
[Perspectives on allergic bronchopulmonary aspergillosis].
Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Humans; Itraconazole; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Corneal Ulcer; Echinocandins; Eye Infections, Fungal; Fusarium; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Natamycin; Peptides, Cyclic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2007 |
Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis.
Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Corneal Ulcer; Disease Models, Animal; Eye Infections, Fungal; Fusarium; Itraconazole; Mycoses; Pyrimidines; Rabbits; Treatment Outcome; Triazoles; Voriconazole | 2008 |
In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Ear Diseases; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2007 |
Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea.
Topics: Antifungal Agents; Azoles; Bacteremia; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2007 |
In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2008 |
In vitro activities of voriconazole, itraconazole, and terbinafine alone or in combination against Pythium insidiosum isolates from Brazil.
Topics: Animals; Antifungal Agents; Brazil; Dog Diseases; Dogs; Drug Synergism; Horse Diseases; Horses; Infections; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Pythium; Sheep; Sheep Diseases; Terbinafine; Triazoles; Voriconazole | 2008 |
Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Child; Child, Preschool; Fluconazole; Flucytosine; Hospitals, Public; Humans; Infant; Infant, Newborn; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole | 2007 |
In vitro activity (MIC and MFC) of voriconazole, amphotericin B, and itraconazole against 192 filamentous fungi: the GISIA-2 study.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Pyrimidines; Rhodotorula; Triazoles; Trichosporon; Voriconazole | 2008 |
Solitary cutaneous nodule in an immunocompromised patient.
Topics: Alternaria; Ankle; Dermatomycoses; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Itraconazole; Kidney Transplantation; Middle Aged; Pyrimidines; Retreatment; Tacrolimus; Triazoles; Voriconazole | 2007 |
Comparison of E-Test, disk diffusion and a modified CLSI broth microdilution (M 38-A) method for in vitro testing of itraconazole, fluconazole and voriconazole against dermatophytes.
Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Aspergillus; Disk Diffusion Antimicrobial Tests; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Primary prophylaxis with voriconazole in patients receiving induction chemotherapy on the MRC adult acute lymphoblastic leukaemia trial (UK-ALL XII) to avoid itraconazole-enhanced vinca neurotoxicity.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Humans; Itraconazole; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2008 |
Comparison of disk diffusion, E-test and broth microdilution test in determination of susceptibility of Aspergillus species to amphotericin B, itraconazole and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Disk Diffusion Antimicrobial Tests; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Disseminated infection by Bipolaris spicifera in an immunocompetent subject.
Topics: Adult; Amphotericin B; Ascomycota; DNA, Fungal; DNA, Ribosomal; Humans; Immunocompetence; Itraconazole; Lymph Nodes; Male; Mycoses; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2008 |
Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2008 |
Successful treatment of histoplasmosis brain abscess with voriconazole.
Topics: Adult; Antifungal Agents; Arm; Bone Marrow Diseases; Brain Abscess; Cerebellar Ataxia; Cerebellum; Frontal Lobe; Histoplasmosis; Humans; Itraconazole; Liver Abscess; Magnetic Resonance Imaging; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fluconazole; Humans; Infant; Infant, Newborn; Itraconazole; Lipopeptides; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Thiazoles; Triazoles; Voriconazole; Young Adult | 2008 |
Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Humans; Infant; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Pyrimidines; Triazoles; Venezuela; Voriconazole; Young Adult | 2009 |
Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Azoles; Cryptococcus; Culture Media; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2008 |
Comparison of the anti-inflammatory activities of imidazole antimycotics in relation to molecular structure.
Topics: Anti-Inflammatory Agents; Antifungal Agents; Cells, Cultured; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Leukotriene B4; Molecular Structure; Neutrophils; Platelet Activating Factor; Pyrimidines; Triazoles; Voriconazole | 2008 |
In vitro susceptibility of Pythium insidiosum and a Lagenidium sp to itraconazole, posaconazole, voriconazole, terbinafine, caspofungin, and mefenoxam.
Topics: Alanine; Anti-Infective Agents; Caspofungin; Echinocandins; In Vitro Techniques; Itraconazole; Lagenidium; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Pythium; Terbinafine; Triazoles; Voriconazole | 2008 |
Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Multiple, Fungal; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2008 |
International interlaboratory proficiency testing program for measurement of azole antifungal plasma concentrations.
Topics: Antifungal Agents; Azoles; Biological Assay; Fluconazole; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2009 |
Adverse drug events complicate antifungal therapy for pulmonary aspergilloma.
Topics: Aged; Antifungal Agents; Aspergillosis; Drug Interactions; Follow-Up Studies; Hallucinations; Heart Failure; Humans; Itraconazole; Liver Function Tests; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 2008 |
Evaluation of the Neo-Sensitabs diffusion method for determining the antifungal susceptibilities of Cryptococcus gattii isolates, using three different agar media.
Topics: Agar; Amphotericin B; Antifungal Agents; Cryptococcus; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2008 |
Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Exophiala; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Disseminated Rhizopus microsporus infection in a patient on oral corticosteroid treatment: a case report.
Topics: Adrenal Cortex Hormones; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Ciprofloxacin; Fatal Outcome; Humans; Itraconazole; Male; Mucormycosis; Prednisolone; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2009 |
[Saccharomyces cerevisiae fungemia associated with multifocal pneumonia in a patient with alcohol-related hepatic cirrhosis].
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Liver Cirrhosis, Alcoholic; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Radiography; Saccharomyces cerevisiae; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Synergism; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2008 |
Avian Aspergillus fumigatus strains resistant to both itraconazole and voriconazole.
Topics: Amphotericin B; Animals; Animals, Domestic; Animals, Wild; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bird Diseases; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Cystic Fibrosis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Microbial Sensitivity Tests; Mycoses; Prescriptions; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2009 |
Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Disease Models, Animal; Drosophila; Fungi; Humans; Itraconazole; Mice; Mucor; Pyrimidines; Rhizopus; Triazoles; Virulence; Voriconazole; Zygomycosis | 2009 |
[In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2009 |
Antifungal activity of itraconazole and voriconazole against clinical isolates obtained from animals with mycoses.
Topics: Animals; Antifungal Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
In vitro activities of fluconazole, itraconazole and voriconazole against otomycotic fungal pathogens.
Topics: Antifungal Agents; Aspergillus; Candida albicans; Candidiasis; Colony Count, Microbial; Ear Diseases; Fluconazole; Humans; Itraconazole; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals.
Topics: Anisomycin; Antifungal Agents; Biological Transport; Candida albicans; Curcumin; Cycloheximide; Drug Synergism; Enzyme Inhibitors; Fluconazole; Itraconazole; Ketoconazole; Methotrexate; Miconazole; Multidrug Resistance-Associated Proteins; Pyrimidines; Rhodamines; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2009 |
In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
Topics: Amphotericin B; Antifungal Agents; Antitubercular Agents; Caspofungin; Coccidioides; Coccidioidomycosis; Drug Synergism; Echinocandins; Ethambutol; Fluconazole; Humans; Isoniazid; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole | 2009 |
In vitro interactions between antifungals and methotrexate against Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Interactions; Itraconazole; Methotrexate; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2009 |
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole | 2009 |
Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection.
Topics: Calibration; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Fluconazole; Humans; Itraconazole; Ketoconazole; Pyrimidines; Quality Control; Reproducibility of Results; Spectrophotometry, Ultraviolet; Time Factors; Triazoles; Ultraviolet Rays; Voriconazole | 2009 |
[Investigation of in vitro activities of fluconazole, itraconazole and voriconazole against clinical isolates of Blastoschizomyces capitatus (Geotrichum capitatum) by two different methods].
Topics: Antifungal Agents; Dipodascus; Fluconazole; Geotrichosis; Humans; Itraconazole; Microbial Sensitivity Tests; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2009 |
Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Disease Progression; Drug Resistance, Fungal; Evolution, Molecular; Fungal Proteins; Humans; Itraconazole; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2009 |
Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness.
Topics: Aged; Antifungal Agents; Cohort Studies; Female; Humans; Itraconazole; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Atypical Aspergillus flavus isolates associated with chronic azole therapy.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Azoles; Female; Humans; Itraconazole; Middle Aged; Pyrimidines; Sinusitis; Triazoles; Voriconazole | 2009 |
Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis.
Topics: Adult; Amino Acid Substitution; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Azoles; Bronchitis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Middle Aged; Mutation, Missense; Plasma; Pyrimidines; Triazoles; Voriconazole | 2010 |
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD.
Topics: Adult; Antifungal Agents; Chemoprevention; Female; Fluconazole; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2010 |
Discovery of highly potent novel antifungal azoles by structure-based rational design.
Topics: Antifungal Agents; Azoles; Binding Sites; Computer Simulation; Cytochrome P-450 Enzyme System; Drug Design; Fluconazole; Fungal Proteins; Hydrogen Bonding; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole | 2009 |
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Fungemia; Itraconazole; Laboratories, Hospital; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole; Yeasts | 2010 |
In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Topics: Analysis of Variance; Antifungal Agents; Arthrodermataceae; Candida; Colombia; Dose-Response Relationship, Drug; Fluconazole; Fungi; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2010 |
Vertebral osteomyelitis due to Aspergillus fumigatus in a patient with chronic granulomatous disease successfully treated with antifungal agents and interferon-gamma.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cervical Vertebrae; Drainage; Echinocandins; Granulomatous Disease, Chronic; Humans; Interferon-gamma; Itraconazole; Lipopeptides; Male; Osteomyelitis; Pyrimidines; Saudi Arabia; Thoracic Vertebrae; Treatment Outcome; Triazoles; Voriconazole | 2010 |
The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Hyphae; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Spores, Fungal; Tetrazolium Salts; Triazoles; Voriconazole | 2010 |
Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Fungal Proteins; Humans; Itraconazole; Male; Middle Aged; Mutation, Missense; Pulmonary Aspergillosis; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2010 |
In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2010 |
Synergistic activities of three triazoles with caspofungin against Candida glabrata isolates determined by time-kill, Etest, and disk diffusion methods.
Topics: Antifungal Agents; Candida glabrata; Caspofungin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Endpoint Determination; Fluconazole; Itraconazole; Lipopeptides; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2010 |
Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma.
Topics: Antifungal Agents; Calibration; Chromatography, High Pressure Liquid; Humans; Itraconazole; Mass Spectrometry; Pyrimidines; Reference Standards; Triazoles; Voriconazole | 2010 |
In vitro susceptibility of filamentous fungi to itraconazole, voriconazole and posaconazole by Clinical and Laboratory Standards Institute reference method and E-test.
Topics: Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles.
Topics: Antifungal Agents; Area Under Curve; Cytochrome P-450 CYP3A; Drug Interactions; Fluconazole; Humans; Itraconazole; Microsomes, Liver; Pyrimidines; Triazoles; Voriconazole | 2010 |
Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Europe; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; United States; Voriconazole | 2010 |
Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51).
Topics: Antifungal Agents; Azoles; Candida albicans; Econazole; Fluconazole; Itraconazole; Ketoconazole; Miconazole; Protein Binding; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2010 |
Expression, purification, and characterization of Aspergillus fumigatus sterol 14-alpha demethylase (CYP51) isoenzymes A and B.
Topics: Amino Acid Sequence; Aspergillus fumigatus; Azoles; Clotrimazole; Drug Resistance, Multiple, Fungal; Fluconazole; Fungal Proteins; Isoenzymes; Itraconazole; Lanosterol; Molecular Sequence Data; Protein Binding; Pyrimidines; Sequence Homology, Amino Acid; Sterol 14-Demethylase; Substrate Specificity; Triazoles; Voriconazole | 2010 |
Generation of mutants in Candida albicans with reduced susceptibility to caspofungin: influence on other antifungal products.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole | 2010 |
Scedosporium apiospermum infection presenting as a pneumothorax and cavitary lung lesions in a patient with acquired immune deficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Female; Humans; Itraconazole; Lung; Mycetoma; Pneumothorax; Pyrimidines; Scedosporium; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2010 |
Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2010 |
Identification and characterization of four azole-resistant erg3 mutants of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Drug Resistance, Fungal; Ergosterol; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; Pyrimidines; Triazoles; Voriconazole | 2010 |
Complementation of a Saccharomyces cerevisiae ERG11/CYP51 (sterol 14α-demethylase) doxycycline-regulated mutant and screening of the azole sensitivity of Aspergillus fumigatus isoenzymes CYP51A and CYP51B.
Topics: Anti-Bacterial Agents; Aspergillus fumigatus; Azoles; Clotrimazole; Cytochrome P-450 Enzyme System; Doxycycline; Ergosterol; Fluconazole; Fungal Proteins; Genetic Complementation Test; Itraconazole; Pyrimidines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Triazoles; Voriconazole | 2010 |
Ulcerated plaque under a ruby ring in an immunosuppressed patient.
Topics: Adenine Nucleotides; Aged; Antineoplastic Agents; Arabinonucleosides; Candida; Candidiasis, Cutaneous; Clofarabine; Cytarabine; Dermatologic Agents; Dermatomycoses; Fusarium; Humans; Immunocompromised Host; Itraconazole; Jewelry; Leukemia, Myeloid, Acute; Male; Pyrimidines; Skin Ulcer; Treatment Outcome; Triazoles; Voriconazole | 2010 |
In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella.
Topics: Amphotericin B; Animals; Antifungal Agents; Caspofungin; Cunninghamella; Diabetes Mellitus, Experimental; Echinocandins; Itraconazole; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2010 |
Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain.
Topics: Antifungal Agents; Aspergillus fumigatus; Austria; Azoles; Denmark; Drug Resistance, Fungal; Environmental Microbiology; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole | 2010 |
Comparison of a glucose consumption based method with the CLSI M38-A method for testing antifungal susceptibility of Trichophyton rubrum and Trichophyton mentagrophytes.
Topics: Antifungal Agents; Econazole; Glucose; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Trichophyton; Voriconazole | 2010 |
Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspo
Topics: Anidulafungin; Antifungal Agents; Blood Chemical Analysis; Caspofungin; Chromatography, Liquid; Echinocandins; Humans; Itraconazole; Lipopeptides; Pyrimidines; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2010 |
In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Echinocandins; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Successful treatment of systemic Geotrichum capitatum infection by liposomal amphotericin-B, itraconazole, and voriconazole in a Japanese man.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Geotrichosis; Humans; Itraconazole; Japan; Male; Middle Aged; Pyrimidines; Remission Induction; Triazoles; Voriconazole | 2010 |
Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cohort Studies; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; France; Fungal Proteins; Hematologic Neoplasms; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Pyrimidines; Triazoles; Tubulin; Voriconazole | 2011 |
In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Catheter-Related Infections; Catheterization, Central Venous; Drug Administration Routes; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Comparison of the broth microdilution methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for testing itraconazole, posaconazole, and voriconazole against Aspergillus isolates.
Topics: Antifungal Agents; Aspergillus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Mutation; Pyrimidines; Triazoles; Voriconazole | 2011 |
Bipolaris hawaiiensis as etiologic agent of allergic bronchopulmonary mycosis: first case in a paediatric patient.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Aspergillus fumigatus; beta-Glucans; Bronchi; Bronchoalveolar Lavage Fluid; Bronchoscopy; Child; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Female; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Mycological Typing Techniques; Phylogeny; Prednisone; Pyrimidines; Sequence Analysis, DNA; Sputum; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Successful treatment of intra-abdominal Exophiala dermatitidis infection in a dog.
Topics: Abdomen; Abdominal Abscess; Animals; Antifungal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Exophiala; Female; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Oral Candida isolates among HIV-infected subjects in Nigeria.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Nigeria; Pyrimidines; Triazoles; Voriconazole | 2011 |
A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Child; Child, Preschool; Denmark; Drug Resistance, Fungal; Female; Hospitals; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; Pyrimidines; Respiratory System; Respiratory Tract Infections; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
Topics: Animals; Antifungal Agents; Ascomycota; Chromoblastomycosis; Itraconazole; Male; Mice; Mice, Nude; Mitosporic Fungi; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2011 |
Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Eye Infections, Fungal; Fungi; Fusarium; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Invasive aspergillosis of orbit in immunocompetent patients: treatment and outcome.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Infant; Itraconazole; Magnetic Resonance Imaging; Male; Middle Aged; Orbital Diseases; Paranasal Sinus Diseases; Pyrimidines; Retrospective Studies; Tomography, X-Ray Computed; Triazoles; Voriconazole; Young Adult | 2011 |
Peripheral neuropathy in patients on long-term triazole antifungal therapy.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Cohort Studies; Female; Humans; Itraconazole; Long-Term Care; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2011 |
Synergistic effect of antituberculosis drugs and azoles in vitro against Histoplasma capsulatum var. capsulatum.
Topics: Antitubercular Agents; Drug Combinations; Drug Interactions; Ethambutol; Fluconazole; Histoplasma; Isoniazid; Itraconazole; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole | 2011 |
In vitro evaluation of the type of interaction obtained by the combination of terbinafine and itraconazole, voriconazole, or amphotericin B against dematiaceous molds.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fungi; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2011 |
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole | 2011 |
In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds.
Topics: Aminopyridines; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Cell Line; Echinocandins; Fluconazole; Fungi; Fusarium; Humans; Isoxazoles; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Paecilomyces; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Yeasts | 2011 |
Curvularia lunata endophthalmitis.
Topics: Antifungal Agents; Ascomycota; Cataract Extraction; Endophthalmitis; Eye Infections, Fungal; Humans; Itraconazole; Male; Middle Aged; Phacoemulsification; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2011 |
In vitro synergisms obtained by amphotericin B and voriconazole associated with non-antifungal agents against Fusarium spp.
Topics: Amphotericin B; Antifungal Agents; Drug Synergism; Fungi; Fusarium; Ibuprofen; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.
Topics: Aminopyridines; Anidulafungin; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Echinocandins; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Genetic re-identification and antifungal susceptibility testing of Aspergillus section Nigri strains of the BCCM/IHEM collection.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Biological Specimen Banks; DNA, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Phylogeny; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole | 2012 |
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Communicable Disease Control; Cross Infection; Echinocandins; Female; Fluconazole; Hospitals; Humans; Italy; Itraconazole; Lipopeptides; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
Topics: Animals; Antifungal Agents; Dermatomycoses; Dog Diseases; Dogs; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Miconazole; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populations.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Codon; Culture Media; Cytochrome P-450 Enzyme System; DNA Mutational Analysis; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Mycological Typing Techniques; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2012 |
Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Female; Fungal Proteins; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Mutation; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2012 |
Subcutaneous dematiaceous fungal infection.
Topics: Acute Kidney Injury; Aged; Amphotericin B; Antifungal Agents; Chromoblastomycosis; Combined Modality Therapy; Costa Rica; Diagnosis, Differential; Humans; Immunocompromised Host; Immunosuppressive Agents; Itraconazole; Kidney Transplantation; Leg; Male; Phaeohyphomycosis; Pneumonia; Pyrimidines; Soil Microbiology; Triazoles; Voriconazole | 2011 |
Periostitis secondary to prolonged voriconazole therapy in a lung transplant recipient.
Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Drug Substitution; Female; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Lung Transplantation; Periostitis; Postoperative Complications; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Medication Adherence; Middle Aged; Mycoses; Myelodysplastic Syndromes; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.
Topics: Acylation; Aminopyridines; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Fusarium; Glycosylphosphatidylinositols; Humans; Inositol; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2012 |
Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole.
Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Female; Fluconazole; Fungal Proteins; Genotype; Humans; Itraconazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation, Missense; Phenylalanine; Pyrimidines; Sterol 14-Demethylase; Survival Rate; Triazoles; Tyrosine; Voriconazole | 2012 |
Chronic granulomatous disease in an adult recognized by an invasive aspergillosis.
Topics: Antifungal Agents; Aspergillus; Diagnosis, Differential; Germany; Granulomatous Disease, Chronic; Humans; Infusions, Parenteral; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Phagocytes; Pyrimidines; Respiratory Insufficiency; Tachypnea; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
How does antifungal pharmacology differ for mucormycosis versus aspergillosis?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Cell Membrane; Cell Wall; Drug Resistance, Multiple, Fungal; Ergosterol; Gene Duplication; Genome, Fungal; Genomic Instability; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Species Specificity; Triazoles; Virulence Factors; Voriconazole | 2012 |
A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy.
Topics: Aminolevulinic Acid; Antifungal Agents; Ascomycota; China; Chromoblastomycosis; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Photochemotherapy; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Longitudinal Studies; Mathematical Computing; Microbial Sensitivity Tests; Models, Statistical; Mutation; Netherlands; Promoter Regions, Genetic; Pyrimidines; Sequence Analysis, DNA; Tandem Repeat Sequences; Triazoles; Voriconazole | 2012 |
Systemic mycosis in a California sea lion (Zalophus californianus) with detection of cystofilobasidiales DNA.
Topics: Animals; Antifungal Agents; Basidiomycota; DNA, Fungal; Fatal Outcome; Itraconazole; Male; Mycoses; Pyrimidines; Sea Lions; Triazoles; Voriconazole | 2012 |
[Study on in vitro susceptibility of Candida spp. isolated from blood culture].
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Risk Factors; Triazoles; Voriconazole | 2012 |
[Ambulatory therapy of aspergillosis in hematological and oncological patients].
Topics: Ambulatory Care; Antifungal Agents; Caspofungin; Echinocandins; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Neutropenia; Pyrimidines; Salvage Therapy; Triazoles; Voriconazole | 2012 |
In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole.
Topics: Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2013 |
High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Drug Resistance, Fungal; France; Humans; In Vitro Techniques; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyrimidines; Retrospective Studies; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole; Young Adult | 2012 |
Pseudomembranous necrotizing tracheobronchial aspergillosis: an analysis of 16 cases.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Bronchoscopy; Caspofungin; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2012 |
Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Resistance, Multiple, Fungal; Etoposide; Fatal Outcome; Female; Fusariosis; Fusarium; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Mitoxantrone; Neutropenia; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Premedication; Pyrimidines; Recurrence; Salvage Therapy; Transplantation, Homologous; Triazoles; Voriconazole | 2013 |
Histoplasmosis in HIV-positive patients in Ceará, Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Caspofungin; CD4 Lymphocyte Count; Echinocandins; Female; Fluconazole; Histoplasma; Histoplasmosis; Humans; Itraconazole; L-Lactate Dehydrogenase; Lipopeptides; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Azole preexposure affects the Aspergillus fumigatus population in patients.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Multigene Family; Polymorphism, Single Nucleotide; Pyrimidines; Triazoles; Voriconazole | 2012 |
Frequency of fungal isolation and antifungal susceptibility pattern of the fungal isolates from nasal polyps of chronic rhinosinusitis patients at a tertiary care centre in north India.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Female; Fungi; Humans; Immunoglobulin E; Incidence; India; Itraconazole; Male; Middle Aged; Mucins; Mycoses; Nasal Polyps; Pyrimidines; Retrospective Studies; Rhinitis, Allergic, Perennial; Sinusitis; Tertiary Healthcare; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus.
Topics: Amphotericin B; Candida; Colorimetry; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Triazoles; Voriconazole | 2012 |
Sarcoid-like reaction in Cryptococcus neoformans infection.
Topics: Administration, Oral; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Differential; Female; Humans; Itraconazole; Middle Aged; Pyrimidines; Radiography, Thoracic; Sarcoidosis; Triazoles; Voriconazole | 2012 |
Aspergillus tanneri sp. nov., a new pathogen that causes invasive disease refractory to antifungal therapy.
Topics: Adolescent; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Cluster Analysis; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Granulomatous Disease, Chronic; Humans; Itraconazole; Lung; Male; Mice; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Phylogeny; Pyrimidines; Sequence Analysis, DNA; Tomography, X-Ray Computed; Treatment Failure; Triazoles; Voriconazole; Young Adult | 2012 |
Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole.
Topics: Adult; Antifungal Agents; Bone Diseases; Female; Fluorides; Hematologic Neoplasms; Humans; Itraconazole; Middle Aged; Muscle, Skeletal; Periostitis; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2012 |
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven
Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Candidemia; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pichia; Pyrimidines; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Nitriles; Phialophora; Pyridines; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
Topics: Antifungal Agents; Australia; Cryptococcosis; Cryptococcus gattii; Drug Resistance, Fungal; Europe; Fluconazole; Humans; India; Itraconazole; Microbial Sensitivity Tests; North America; Pyrimidines; South Africa; South America; Triazoles; Voriconazole | 2012 |
Analysis of cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood concentration was markedly elevated after administration of azole antifungal agents.
Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Interactions; Female; Genotype; Humans; Immunosuppressive Agents; Itraconazole; Lupus Nephritis; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2013 |
[Early onset of paralytic ileus caused by simultaneous administration of bortezomib and azole antifungals in multiple myeloma patients].
Topics: Aged; Antifungal Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Interactions; Drug Therapy, Combination; Humans; Intestinal Pseudo-Obstruction; Itraconazole; Middle Aged; Multiple Myeloma; Mycoses; Pyrazines; Pyrimidines; Triazoles; Voriconazole | 2012 |
Validation of a fast and reliable liquid chromatography-tandem mass spectrometry (LC-MS/MS) with atmospheric pressure chemical ionization method for simultaneous quantitation of voriconazole, itraconazole and its active metabolite hydroxyitraconazole in h
Topics: Antifungal Agents; Antineoplastic Agents; Chromatography, Liquid; Drug Monitoring; Humans; Itraconazole; Liquid-Liquid Extraction; Pyrimidines; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2013 |
Subtherapeutic itraconazole and voriconazole levels in children with cystic fibrosis.
Topics: Adolescent; Antifungal Agents; Child; Cystic Fibrosis; Humans; Itraconazole; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2013 |
A simple high-performance liquid chromatography method for simultaneous determination of three triazole antifungals in human plasma.
Topics: Antifungal Agents; Calibration; Chromatography, High Pressure Liquid; Humans; Itraconazole; Limit of Detection; Naproxen; Observer Variation; Pyrimidines; Reference Standards; Reproducibility of Results; Triazoles; Voriconazole | 2013 |
Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antifungal Agents; Ascomycota; China; Chromoblastomycosis; DNA, Fungal; Female; Hospitals, Teaching; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Naphthalenes; Pyrimidines; Sequence Analysis, DNA; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens.
Topics: Antifungal Agents; Candida albicans; Clotrimazole; Escherichia coli; Fluconazole; Fungal Proteins; Humans; Itraconazole; Ketoconazole; Kinetics; Lanosterol; NADP; Protein Binding; Pyrimidines; Recombinant Proteins; Species Specificity; Sterol 14-Demethylase; Triazoles; Voriconazole | 2013 |
[Infectious diseases: progress in diagnosis and treatment. Topics: IV. Towards containing infectious diseases: 3. Development of new antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Differential pulse polarographic investigation of the antifungal drugs itraconazole, ketoconazole, fluconazole and voriconazole using a dropping mercury electrode.
Topics: Antifungal Agents; Electrochemistry; Electrodes; Fluconazole; Hydrogen-Ion Concentration; Indicators and Reagents; Itraconazole; Ketoconazole; Mercury; Polarography; Pyrimidines; Reference Standards; Reproducibility of Results; Triazoles; Voriconazole | 2012 |
Major variations in Aspergillus fumigatus arising within aspergillomas in chronic pulmonary aspergillosis.
Topics: Adult; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Female; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Middle Aged; Molecular Typing; Mycological Typing Techniques; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2013 |
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Flucytosine; Humans; Incidence; India; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycoses.
Topics: Amphotericin B; Antifungal Agents; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Pyrimidines; Schizophyllum; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Genotype; Humans; India; Itraconazole; Microbial Sensitivity Tests; Nitriles; Phenotype; Phylogeny; Polymerase Chain Reaction; Pyridines; Pyrimidines; Sequence Analysis, DNA; Tertiary Care Centers; Triazoles; Voriconazole; Young Adult | 2013 |
In vitro antifungal susceptibility and molecular identity of 99 clinical isolates of the opportunistic fungal genus Curvularia.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Drug Resistance, Multiple, Fungal; Echinocandins; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Pyrimidines; Triazoles; Voriconazole | 2013 |
cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
Topics: Alleles; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Germany; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Prevalence; Pyrimidines; Triazoles; Voriconazole | 2013 |
Association between drug tolerability and medical resource use in prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplant.
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Child; Female; Health Services; Hematopoietic Stem Cell Transplantation; Hospitalization; Humans; Itraconazole; Male; Middle Aged; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2013 |
Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.
Topics: Antifungal Agents; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2013 |
Evaluation of the conjunctival fungal flora and its susceptibility to antifungal agents in healthy horses in Switzerland.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Conjunctiva; Eurotium; Female; Fluconazole; Fungi; Horses; Itraconazole; Male; Miconazole; Microbial Sensitivity Tests; Switzerland; Voriconazole | 2014 |
Acute chiasmal abscess resulting from perineural extension of invasive sino-orbital aspergillosis in an immunocompetent patient.
Topics: Abscess; Antifungal Agents; Aspergillosis; Cranial Sinuses; Debridement; Humans; Immunocompetence; Immunohistochemistry; Itraconazole; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Optic Chiasm; Optic Nerve; Orbital Diseases; Pyrimidines; Triazoles; Visual Fields; Voriconazole | 2014 |
An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Echinocandins; Female; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Phosphoproteins; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Superinfection; Transplantation, Homologous; Triazoles; Viral Matrix Proteins; Voriconazole; Young Adult | 2014 |
In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2013 |
Differential effects of ketoconazole, itraconazole and voriconazole on the pharmacokinetics of imatinib and its main metabolite GCP74588 in rat.
Topics: Animals; Antifungal Agents; Benzamides; Drug Interactions; Imatinib Mesylate; Itraconazole; Ketoconazole; Male; Piperazines; Pyrimidines; Random Allocation; Rats; Rats, Sprague-Dawley; Voriconazole | 2014 |
In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2013 |
Invasive Aspergillus niger complex infections in a Belgian tertiary care hospital.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus niger; Belgium; Female; Humans; Incidence; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Mycological Typing Techniques; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole | 2014 |
Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study.
Topics: Adult; Antifungal Agents; Cross Infection; End Stage Liver Disease; Female; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Pyrimidines; Risk Factors; Survival Rate; Triazoles; Voriconazole | 2013 |
A reference laboratory experience of clinically achievable voriconazole, posaconazole, and itraconazole concentrations within the bloodstream and cerebral spinal fluid.
Topics: Antifungal Agents; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole | 2014 |
Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fungemia; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole | 2014 |
Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Brain Abscess; Debridement; Female; Humans; Immunosuppression Therapy; Itraconazole; Lung Abscess; Male; Middle Aged; Opportunistic Infections; Organ Transplantation; Phaeohyphomycosis; Retrospective Studies; Time Factors; Voriconazole; Young Adult | 2014 |
Antifungal susceptibility of Candida isolates at one institution.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Health Facilities; Humans; Itraconazole; Japan; Lipopeptides; Micafungin; Time Factors; Voriconazole | 2014 |
Does fungicide application in vineyards induce resistance to medical azoles in Aspergillus species?
Topics: Adaptation, Physiological; Agriculture; Antifungal Agents; Aspergillus; Azoles; Environmental Monitoring; Fungicides, Industrial; Humans; Itraconazole; Microbial Sensitivity Tests; Portugal; Pyrimidines; Triazoles; Voriconazole; Wine | 2014 |
Tacrolimus dosage requirements in lung transplant recipients receiving antifungal prophylaxis with voriconazole followed by itraconazole: a preliminary prospective study.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Prognosis; Prospective Studies; Tacrolimus; Voriconazole | 2014 |
Rare diagnosis in a neonate who presents with fever.
Topics: Anti-Infective Agents; Antifungal Agents; Biopsy; Diagnosis, Differential; Fever; Granulomatous Disease, Chronic; Humans; Infant, Newborn; Itraconazole; Lung; Male; Pulmonary Aspergillosis; Radiography, Interventional; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination; Voriconazole | 2015 |
Cryptic and rare Aspergillus species in Brazil: prevalence in clinical samples and in vitro susceptibility to triazoles.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Brazil; Calmodulin; Cluster Analysis; DNA, Fungal; DNA, Ribosomal Spacer; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Prevalence; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole | 2014 |
Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole.
Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Molecular Sequence Data; Mutation, Missense; Sequence Analysis, DNA; Triazoles; Voriconazole | 2014 |
[Two cases of pulmonary aspergilosis, which deteriorated with generic itraconazole].
Topics: Antifungal Agents; Drugs, Generic; Humans; Itraconazole; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Invasive pulmonary aspergillosis: a rare complication after microwave ablation.
Topics: Ablation Techniques; Adenocarcinoma; Aged; Antifungal Agents; Carcinoma, Squamous Cell; Female; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung Neoplasms; Male; Microwaves; Middle Aged; Voriconazole | 2014 |
Caenorhabditis elegans: a simple nematode infection model for Penicillium marneffei.
Topics: Amphotericin B; Animals; Antifungal Agents; Caenorhabditis elegans; Disease Models, Animal; Fluconazole; Host-Pathogen Interactions; Hyphae; Itraconazole; Mycoses; Naphthalenes; Penicillium; Pigments, Biological; Survival Analysis; Terbinafine; Voriconazole | 2014 |
Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro.
Topics: Aminolevulinic Acid; Antifungal Agents; Ascomycota; Chromoblastomycosis; Drug Therapy, Combination; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Photochemotherapy; Skin; Terbinafine; Treatment Outcome; Voriconazole | 2015 |
Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans.
Topics: 14-alpha Demethylase Inhibitors; Amino Acid Substitution; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Catalytic Domain; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Sterol 14-Demethylase; Voriconazole | 2015 |
Genotypic, phenotypic, and proteomic characterization of Candida glabrata during sequential fluconazole exposure.
Topics: Antifungal Agents; Candida glabrata; Chromosomes, Fungal; Copper Sulfate; Culture Media; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Genotype; Hemolysin Proteins; Humans; Itraconazole; Ketoconazole; Metallothionein; Phenotype; Proteome; Virulence; Voriconazole | 2011 |
Comparison of the effects of azole antifungal agents on the anticoagulant activity of warfarin.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antifungal Agents; Drug Interactions; Drug Resistance; Female; Fluconazole; Humans; International Normalized Ratio; Itraconazole; Male; Metabolism, Inborn Errors; Middle Aged; Retrospective Studies; Voriconazole; Warfarin | 2014 |
Surveillance of antifungal susceptibilities in clinical isolates of Candida species at 36 hospitals in China from 2009 to 2013.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Child; Child, Preschool; China; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hospitals; Humans; Infant; Itraconazole; Middle Aged; Voriconazole; Young Adult | 2015 |
Impact of inflammation and concomitant glucocorticoid administration on plasma concentration of triazole antifungals in immunocompromised patients.
Topics: Aged; Antifungal Agents; Female; Glucocorticoids; Humans; Immunocompromised Host; Inflammation; Itraconazole; Male; Middle Aged; Voriconazole | 2015 |
Phenotypic and molecular identification of Fonsecaea pedrosoi strains isolated from chromoblastomycosis patients in Mexico and Venezuela.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Ascomycota; Chromoblastomycosis; DNA, Ribosomal Spacer; Female; Humans; Itraconazole; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Mitosporic Fungi; Molecular Sequence Data; Phenotype; Sequence Analysis, DNA; Skin; Venezuela; Voriconazole | 2015 |
Secondary metabolite profiles and antifungal drug susceptibility of Aspergillus fumigatus and closely related species, Aspergillus lentulus, Aspergillus udagawae, and Aspergillus viridinutans.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Gliotoxin; Humans; Itraconazole; Microbial Sensitivity Tests; Virulence Factors; Voriconazole | 2015 |
In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Epidermophyton; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Nitriles; Pyridines; Terbinafine; Tinea; Triazoles; Trichophyton; Voriconazole | 2015 |
[Genotypes and in vitro antifungal susceptibility of Cryptococcus isolates in Sichuan Province].
Topics: Amphotericin B; Antifungal Agents; China; Cryptococcus; Fluconazole; Flucytosine; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Polymorphism, Restriction Fragment Length; Voriconazole | 2015 |
Multi-triazole-resistant Aspergillus fumigatus infections in Australia.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Australia; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Retrospective Studies; Triazoles; Voriconazole | 2015 |
Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Carcinoma; Caspofungin; Chemoradiotherapy; Chemotherapy, Adjuvant; Drug Resistance, Fungal; Echinocandins; Exophiala; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Lipopeptides; Male; Middle Aged; Mouth Diseases; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Opportunistic Infections; Phaeohyphomycosis; Radiotherapy, Intensity-Modulated; Voriconazole | 2015 |
Genetic Analysis Using an Isogenic Mating Pair of Aspergillus fumigatus Identifies Azole Resistance Genes and Lack of MAT Locus's Role in Virulence.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Crosses, Genetic; Drug Resistance, Multiple, Fungal; Fungal Proteins; Genes, Mating Type, Fungal; Genetic Loci; Hydroxymethylglutaryl CoA Reductases; Itraconazole; Larva; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mixed Function Oxygenases; Moths; Mutation; Sterol 14-Demethylase; Survival Analysis; Triazoles; Virulence; Voriconazole | 2015 |
First description of azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation in France.
Topics: Anti-Bacterial Agents; Antibodies, Fungal; Aspergillosis; Aspergillus fumigatus; Azoles; Cystic Fibrosis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Europe; France; Fungal Proteins; Humans; Immunoglobulin E; Itraconazole; Male; Mutation; Retrospective Studies; Voriconazole; Young Adult | 2015 |
Azole Antifungal Agents To Treat the Human Pathogens Acanthamoeba castellanii and Acanthamoeba polyphaga through Inhibition of Sterol 14α-Demethylase (CYP51).
Topics: 14-alpha Demethylase Inhibitors; Acanthamoeba castellanii; Amebiasis; Amebicides; Antifungal Agents; Azoles; Cell Proliferation; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Sterol 14-Demethylase; Triazoles; Voriconazole | 2015 |
Current therapeutic protocols for chronic granulomatous fungal sinusitis.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Chronic Disease; Combined Modality Therapy; Female; Granuloma; Humans; Itraconazole; Male; Middle Aged; Mycoses; Sinusitis; Treatment Outcome; Voriconazole | 2015 |
First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA Mutational Analysis; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Promoter Regions, Genetic; Triazoles; Turkey; Voriconazole; Young Adult | 2015 |
Clinical Analysis of Adverse Drug Reactions between Vincristine and Triazoles in Children with Acute Lymphoblastic Leukemia.
Topics: Antifungal Agents; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Female; Fluconazole; Humans; Itraconazole; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Time Factors; Vincristine; Voriconazole | 2015 |
Pulmonary Aspergillus Nodule--Still Challenging?
Topics: Antifungal Agents; Aspergillus fumigatus; Biopsy; Chemical and Drug Induced Liver Injury; Chronic Disease; Diagnosis, Differential; Drug Resistance, Fungal; Drug Substitution; Female; Hemoptysis; Humans; Itraconazole; Lung Neoplasms; Middle Aged; Pulmonary Aspergillosis; Solitary Pulmonary Nodule; Tomography, X-Ray Computed; Voriconazole | 2015 |
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole | 2015 |
In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.
Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Genotype; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
An in vitro and in vivo study on the synergistic effect and mechanism of itraconazole or voriconazole alone and in combination with tetrandrine against Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzylisoquinolines; Cyclophosphamide; Drug Therapy, Combination; Immunocompromised Host; Immunosuppressive Agents; Itraconazole; Mice; Microbial Sensitivity Tests; Voriconazole | 2015 |
In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
Azole resistance in canine and feline isolates of Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cat Diseases; Cats; Cytochrome P-450 Enzyme System; Dog Diseases; Dogs; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole | 2015 |
Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.
Topics: Agar; Animals; Antifungal Agents; Culture Media; Disease Models, Animal; Drosophila melanogaster; Female; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Rhizopus; Survival Analysis; Triazoles; Virulence; Voriconazole | 2015 |
Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Clinical Protocols; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Itraconazole; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Pharmaceutical Solutions; Survival Rate; Transplantation, Homologous; Voriconazole; Young Adult | 2015 |
Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Topics: Alleles; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Candida glabrata; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Humans; Itraconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Nitriles; Protein Isoforms; Pyridines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Triazoles; Voriconazole | 2016 |
Seventeen years of subcutaneous infection by Aspergillus flavus; eumycetoma confirmed by immunohistochemistry.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Chronic Disease; Delayed Diagnosis; Diagnostic Errors; Foot Dermatoses; Humans; Immunohistochemistry; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycetoma; Radiography; Scedosporium; Subcutaneous Tissue; Sudan; Voriconazole | 2015 |
Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Humans; Iran; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Mycological Typing Techniques; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Retrospective Studies; Sequence Analysis, DNA; Triazoles; Voriconazole | 2016 |
In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.
Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Azoles; Coordination Complexes; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Peptides, Cyclic; Triazoles; Voriconazole | 2016 |
Azole Resistance in Aspergillus fumigatus Clinical Isolates from an Italian Culture Collection.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bacterial Typing Techniques; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Epidemiological Monitoring; Fungal Proteins; Gene Expression; Genotype; Humans; Italy; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Mutation; Promoter Regions, Genetic; Triazoles; Voriconazole | 2016 |
A combination approach to treating fungal infections.
Topics: Antifungal Agents; Candida albicans; Cell Line, Tumor; Cell Survival; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Epithelial Cells; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Species Specificity; Tobramycin; Triazoles; Voriconazole | 2015 |
Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Eye; Eye Infections, Fungal; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
Deep-seated mycosis. Aspergillus lentulus.
Topics: Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Humans; Itraconazole; Microscopy, Electron, Scanning Transmission; Pulmonary Aspergillosis; Sputum; Voriconazole | 2015 |
Inhibition of heat-shock protein 90 enhances the susceptibility to antifungals and reduces the virulence of Cryptococcus neoformans/Cryptococcus gattii species complex.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Caenorhabditis elegans; Cell Membrane; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Ergosterol; Fluconazole; HSP90 Heat-Shock Proteins; Humans; Itraconazole; Melanins; Microbial Sensitivity Tests; Plankton; Voriconazole | 2016 |
Cutaneous protothecosis responds rapidly to voriconazole.
Topics: Aged; Antifungal Agents; Female; Humans; Infections; Itraconazole; Prototheca; Voriconazole | 2016 |
In vitro combinations of natamycin with voriconazole, itraconazole and micafungin against clinical Fusarium strains causing keratitis.
Topics: Antifungal Agents; Dermatomycoses; Drug Combinations; Drug Interactions; Drug Synergism; Echinocandins; Fusariosis; Fusarium; Itraconazole; Keratitis; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Voriconazole | 2016 |
The isolation of Candida rugosa and Candida mesorugosa from clinical samples in Ghana.
Topics: Antifungal Agents; Candida; Candidiasis; Cluster Analysis; DNA, Fungal; DNA, Ribosomal Spacer; Fluconazole; Ghana; Humans; Itraconazole; Microbial Sensitivity Tests; Microbiological Techniques; Phylogeny; Sequence Analysis, DNA; Temperature; Voriconazole | 2016 |
The slow relaxation dynamics in active pharmaceutical ingredients studied by DSC and TSDC: Voriconazole, miconazole and itraconazole.
Topics: Antifungal Agents; Calorimetry, Differential Scanning; Itraconazole; Miconazole; Transition Temperature; Voriconazole | 2016 |
In vitro antifungal susceptibility of clinical species belonging to Aspergillus genus and Rhizopus oryzae.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Base Sequence; Caspofungin; DNA, Fungal; Echinocandins; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Rhizopus; Tubulin; Voriconazole | 2016 |
Cross-resistance to fluconazole induced by exposure to the agricultural azole tetraconazole: an environmental resistance school?
Topics: Animals; Anti-Allergic Agents; Antifungal Agents; ATP-Binding Cassette Transporters; Candida; Chlorobenzenes; Drug Resistance, Microbial; Ergosterol; Fluconazole; Fungicides, Industrial; Gene Expression Regulation, Fungal; Humans; Itraconazole; Malathion; Microbial Sensitivity Tests; Promethazine; Rhodamines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2016 |
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
Chronic pulmonary aspergillosis: help is on the way.
Topics: Antifungal Agents; Chronic Disease; Hemoptysis; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Practice Guidelines as Topic; Pulmonary Aspergillosis; Voriconazole | 2016 |
In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus, an opportunistic fungal pathogen.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Environmental Microbiology; Humans; Iran; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Opportunistic Infections; Triazoles; Voriconazole | 2016 |
In Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus Species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Benzoxazoles; Caspofungin; Drug Combinations; Drug Synergism; Echinocandins; Fungal Proteins; Gene Expression; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; TOR Serine-Threonine Kinases; Triazoles; Voriconazole | 2016 |
Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
Topics: Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Echinocandins; Fluconazole; HEK293 Cells; Humans; Itraconazole; Lipopeptides; Micafungin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Triazoles; Voriconazole | 2016 |
Drug-Drug Interaction Associated with Mold-Active Triazoles among Hospitalized Patients.
Topics: Antifungal Agents; Drug Interactions; Hospitalization; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA Mutational Analysis; Drug Resistance, Multiple, Fungal; Fungal Proteins; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Fungal; Humans; Iran; Itraconazole; Mutation; Prevalence; Voriconazole | 2016 |
Azole susceptibility in clinical and environmental isolates of Aspergillus fumigatus from eastern Hokkaido, Japan.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Fungal Proteins; Humans; Itraconazole; Japan; Microbial Sensitivity Tests; Mutation; Voriconazole | 2016 |
[Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Topics: Antifungal Agents; Candida; Candidiasis, Invasive; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Intensive Care Units; Itraconazole; Microbial Sensitivity Tests; Species Specificity; Triazoles; Turkey; Voriconazole | 2016 |
Evaluation of antifungal combination against Cryptococcus spp.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Drug Combinations; Drug Synergism; Fluconazole; Flucytosine; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Typing; Naphthalenes; Polymorphism, Restriction Fragment Length; Terbinafine; Voriconazole | 2016 |
Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India.
Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Genotype; Humans; India; Itraconazole; Male; Microbial Sensitivity Tests; Mycological Typing Techniques; Phenotype; Sequence Analysis, DNA; Triazoles; Trichosporon; Trichosporonosis; Voriconazole | 2016 |
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme.
Topics: Antifungal Agents; Clotrimazole; Cryptococcus; Enzyme Activation; Ergosterol; Fluconazole; Humans; Itraconazole; Ketoconazole; Lanosterol; Pyridines; Sterol 14-Demethylase; Tetrazoles; Voriconazole | 2016 |
Fungal infection of cystic fibrosis patients - single center experience.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Candida albicans; Candida tropicalis; Cystic Fibrosis; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Scedosporium; Triazoles; Voriconazole; Yeasts | 2016 |
Azole Antifungal Sensitivity of Sterol 14α-Demethylase (CYP51) and CYP5218 from Malassezia globosa.
Topics: Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Cytochrome P450 Family 51; Drug Evaluation, Preclinical; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Kinetics; Lipids; Malassezia; Spectrophotometry; Sterol 14-Demethylase; Sterols; Voriconazole | 2016 |
Identification of Ebsulfur Analogues with Broad-Spectrum Antifungal Activity.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Candida; Fluconazole; HEK293 Cells; Hemolysis; Heterocyclic Compounds, 2-Ring; Humans; Itraconazole; Mice; Microbial Sensitivity Tests; Reactive Oxygen Species; Structure-Activity Relationship; Thiazoles; Triazoles; Voriconazole | 2016 |
Cross-reactivity between voriconazole, fluconazole and itraconazole.
Topics: Adult; Antifungal Agents; Cross Reactions; Drug Hypersensitivity; Fluconazole; Humans; Itraconazole; Male; Voriconazole | 2016 |
Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant.
Topics: Adult; Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Itraconazole; Spain; Triazoles; Voriconazole | 2017 |
Aspergillus fumigatus carrying TR34/L98H resistance allele causing complicated suppurative otitis media in Tanzania: Call for improved diagnosis of fungi in sub-Saharan Africa.
Topics: Adolescent; Adult; Alleles; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Female; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Otitis Media, Suppurative; Tanzania; Triazoles; Voriconazole; Young Adult | 2016 |
Antifungal susceptibility testing of Malassezia yeast: comparison of two different methodologies.
Topics: Agar; Amphotericin B; Antifungal Agents; Culture Media; Fluconazole; Itraconazole; Malassezia; Miconazole; Microbial Sensitivity Tests; Voriconazole | 2017 |
Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata.
Topics: Amino Acid Substitution; Antifungal Agents; ATP-Binding Cassette Transporters; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Gene Expression Profiling; Humans; Iran; Itraconazole; Microbial Sensitivity Tests; Mutation, Missense; Real-Time Polymerase Chain Reaction; Sequence Analysis, DNA; Voriconazole | 2017 |
Genotyping of Aspergillus fumigatus Reveals Compartmentalization of Genotypes in Disseminated Disease after Invasive Pulmonary Aspergillosis.
Topics: Adrenal Cortex Hormones; Adult; Antifungal Agents; Aspergillus fumigatus; Female; Genotype; Graft vs Host Disease; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Male; Microbial Sensitivity Tests; Microsatellite Repeats; Molecular Typing; Mycological Typing Techniques; Triazoles; Voriconazole | 2017 |
Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation.
Topics: Administration, Oral; Adult; Aged; Allografts; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Itraconazole; Male; Middle Aged; Retrospective Studies; Tacrolimus; Voriconazole | 2017 |
A rapid UPLC-MS/MS assay for the simultaneous measurement of fluconazole, voriconazole, posaconazole, itraconazole, and hydroxyitraconazole concentrations in serum.
Topics: Antifungal Agents; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Fluconazole; Humans; Itraconazole; Limit of Detection; Reproducibility of Results; Tandem Mass Spectrometry; Time Factors; Triazoles; Voriconazole | 2017 |
The First Isolation of Aspergillus allahabadii from a Cormorant with Pulmonary Aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Bird Diseases; Birds; Child; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Pulmonary Aspergillosis; Voriconazole | 2016 |
Tintelnotia, a new genus in Phaeosphaeriaceae harbouring agents of cornea and nail infections in humans.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Cornea; Echinocandins; Eye Infections, Fungal; Female; Humans; Itraconazole; Keratitis; Lipopeptides; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Phylogeny; Terbinafine; Triazoles; Voriconazole | 2017 |
Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungal Proteins; Gene Expression; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; RNA, Messenger; Sequence Analysis, DNA; Voriconazole | 2017 |
Erg4A and Erg4B Are Required for Conidiation and Azole Resistance via Regulation of Ergosterol Biosynthesis in Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Ergosterol; Gene Deletion; Gene Expression Regulation, Fungal; Humans; Itraconazole; Mice; Microbial Sensitivity Tests; Oxidoreductases; Saccharomyces cerevisiae Proteins; Spores, Fungal; Voriconazole | 2017 |
Synergistic Effects of Tetrandrine with Posaconazole Against Aspergillus fumigatus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzylisoquinolines; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Female; Humans; Itraconazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2017 |
Comparing Azole Plasma Trough Levels in Lung Transplant Recipients: Percentage of Therapeutic Levels and Intrapatient Variability.
Topics: Antifungal Agents; Azoles; Drug Monitoring; Female; Humans; Itraconazole; Lung Transplantation; Male; Middle Aged; Plasma; Retrospective Studies; Tablets; Transplant Recipients; Triazoles; Voriconazole | 2017 |
Triazole Resistance in
Topics: Antifungal Agents; Aspergillus fumigatus; China; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Promoter Regions, Genetic; Tandem Repeat Sequences; Triazoles; Voriconazole | 2017 |
A newly identified amino acid substitution T123I in the 14α-demethylase (Erg11p) of Candida albicans confers azole resistance.
Topics: Amino Acid Substitution; Antifungal Agents; Binding Sites; Candida albicans; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Isoleucine; Itraconazole; Microbial Sensitivity Tests; Models, Molecular; Open Reading Frames; Phosphorylation; Protein Binding; Protein Conformation, alpha-Helical; Protein Interaction Domains and Motifs; Saccharomyces cerevisiae; Threonine; Voriconazole | 2017 |
Susceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Sterol 14-Demethylase; Triazoles; Voriconazole | 2017 |
The Tetrazole VT-1161 Is a Potent Inhibitor of Trichophyton rubrum through Its Inhibition of T. rubrum CYP51.
Topics: Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyridines; Sterol 14-Demethylase; Substrate Specificity; Tetrazoles; Trichophyton; Voriconazole | 2017 |
In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
Topics: Acetamides; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genotype; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Nitriles; Piperazines; Point Mutation; Pyridines; Pyrimidines; Pyrroles; Triazoles; Voriconazole | 2017 |
Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis.
Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Fusariosis; Fusarium; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Nails; Naphthalenes; Onychomycosis; Terbinafine; Voriconazole | 2017 |
Evidence of unique genetic diversity in Aspergillus fumigatus isolates from Cameroon.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cameroon; Genetic Variation; Genotype; Geography; Humans; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Phylogeny; Soil Microbiology; Triazoles; Voriconazole | 2017 |
Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Analysis of Fluconazole, Isavuconazole, Itraconazole, Hydroxy-Itraconazole, Posaconazole, and Voriconazole in Human Plasma and Serum.
Topics: Acetonitriles; Adult; Antifungal Agents; Calibration; Chromatography, Liquid; Drug Monitoring; Female; Fluconazole; Humans; Indicators and Reagents; Isotope Labeling; Itraconazole; Nitriles; Plasma; Pyridines; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2017 |
Proteomic profiling of the antifungal drug response of Aspergillus fumigatus to voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Electrophoresis, Gel, Two-Dimensional; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Proteomics; RNA, Fungal; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Terbinafine; Up-Regulation; Voriconazole | 2017 |
Effects of Photodynamic Therapy on the Growth and Antifungal Susceptibility of Scedosporium and Lomentospora spp.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Humans; Immunocompromised Host; Itraconazole; Methylene Blue; Microbial Sensitivity Tests; Photochemotherapy; Photosensitizing Agents; Scedosporium; Triazoles; Voriconazole | 2017 |
The identification of Meyerozyma guilliermondii from blood cultures and surveillance samples in a university hospital in Northeast Turkey: A ten-year survey.
Topics: Antifungal Agents; Blood Culture; Candida; Candidiasis; Drug Resistance, Fungal; Epidemiological Monitoring; Fluconazole; Hospitalization; Hospitals, University; Humans; Intensive Care Units; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pichia; Surveys and Questionnaires; Time Factors; Turkey; Voriconazole | 2017 |
Triazole Resistance Is Still Not Emerging in Aspergillus fumigatus Isolates Causing Invasive Aspergillosis in Brazilian Patients.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brazil; Drug Resistance, Fungal; Humans; Invasive Fungal Infections; Itraconazole; Microbial Sensitivity Tests; Retrospective Studies; Voriconazole | 2017 |
[Histoplasma capsulatum bone and joint infection].
Topics: Aged; Antibodies, Monoclonal, Humanized; Antifungal Agents; Arthritis, Infectious; Arthritis, Rheumatoid; Arthroplasty, Replacement, Knee; Aspergillosis; Cervical Vertebrae; Coinfection; Female; Histoplasma; Histoplasmosis; Humans; Immunocompromised Host; Itraconazole; Knee Joint; Osteitis; Spinal Cord Compression; Voriconazole | 2017 |
PHARMACOKINETICS, EFFICACY, AND SAFETY OF VORICONAZOLE AND ITRACONAZOLE IN HEALTHY COTTONMOUTHS (AGKISTRODON PISCIVORUS) AND MASSASAUGA RATTLESNAKES (SISTRURUS CATENATUS) WITH SNAKE FUNGAL DISEASE.
Topics: Agkistrodon; Animals; Antifungal Agents; Ascomycota; Cloaca; Crotalus; Drug Delivery Systems; Itraconazole; Mycoses; Pilot Projects; Voriconazole | 2017 |
Synergistic Effects of Tacrolimus and Azoles against Exophiala dermatitidis.
Topics: Antifungal Agents; Biofilms; Calcineurin Inhibitors; Candida parapsilosis; Drug Synergism; Exophiala; Humans; Itraconazole; Microbial Sensitivity Tests; Phaeohyphomycosis; Tacrolimus; Triazoles; Voriconazole | 2017 |
Diversity of clinical isolates of Aspergillus terreus in antifungal susceptibilities, genotypes and virulence in Galleria mellonella model: Comparison between respiratory and ear isolates.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Ear; Genotype; Hospitals, University; Humans; Itraconazole; Lepidoptera; Microsatellite Repeats; Respiratory System; Triazoles; Voriconazole | 2017 |
Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2018 |
Do antibacterial and antifungal combinations have better activity against clinically relevant fusarium species? in vitro synergism.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Drug Synergism; Drug Therapy, Combination; Echinocandins; Fusarium; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Voriconazole | 2018 |
Relation of the polymorphism of cyp51A sequence and the susceptibility of Aspergillus fumigatus isolates to triazoles determined by commercial gradient test (Etest) and by reference methods.
Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Microbial Sensitivity Tests; Polymorphism, Genetic; Triazoles; Voriconazole | 2017 |
[In vitro susceptibility of Cuban Aspergillus spp. strains of clinical and environmental origin].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Cuba; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Environmental Microbiology; Hospitals; Humans; Itraconazole; Microbial Sensitivity Tests; Voriconazole | 2017 |
Necessity to identify the causative agent for appropriate treatment in fungal corneal ulcer: an in vitro study.
Topics: Antifungal Agents; Aspergillus; Corneal Ulcer; Eye Infections, Fungal; Fluconazole; Fungi; Fusarium; Humans; India; Itraconazole; Microbial Sensitivity Tests; Natamycin; Voriconazole | 2018 |
Comparative evaluation of different gradient diffusion tests for detection of azole resistance in Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Reproducibility of Results; Triazoles; Voriconazole | 2018 |
In vitro activity of azole derivatives and griseofulvin against planktonic and biofilm growth of clinical isolates of dermatophytes.
Topics: Animals; Antifungal Agents; Arthrodermataceae; Azoles; Biofilms; Cat Diseases; Cats; Dermatomycoses; Dog Diseases; Dogs; Griseofulvin; Humans; Itraconazole; Microbial Sensitivity Tests; Voriconazole | 2018 |
The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis, Invasive; Caspofungin; Drug Resistance, Fungal; Female; Fluconazole; Hospitals; Humans; Infant, Newborn; Infant, Premature; Iran; Itraconazole; Male; Microbial Sensitivity Tests; Voriconazole | 2018 |
Mutation in the Squalene Epoxidase Gene of Trichophyton interdigitale and Trichophyton rubrum Associated with Allylamine Resistance.
Topics: Allylamine; Antifungal Agents; Arthrodermataceae; Ciclopirox; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Morpholines; Squalene Monooxygenase; Terbinafine; Trichophyton; Voriconazole | 2018 |
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2018 |
A proposal for antifungal epidemiological cut-off values against Histoplasma capsulatum var. capsulatum based on the susceptibility of isolates from HIV-infected patients with disseminated histoplasmosis in Northeast Brazil.
Topics: Amphotericin B; Antifungal Agents; Brazil; Caspofungin; Echinocandins; Fluconazole; Histoplasma; Histoplasmosis; HIV; HIV Infections; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Retrospective Studies; Voriconazole | 2018 |
Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole.
Topics: Acetaminophen; Analgesics; Antifungal Agents; Aspirin; Candida; Candida albicans; Candida glabrata; Candidiasis; Dipyrone; Drug Resistance, Fungal; Fluconazole; Humans; Ibuprofen; Itraconazole; Meloxicam; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2018 |
Clinical efficacy of sequential therapy with voriconazole on COPD patients in acute phase with pulmonary aspergillosis and effects on cytokines and pulmonary functions.
Topics: Adult; Aged; Antifungal Agents; Cytokines; Female; Humans; Itraconazole; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Treatment Outcome; Voriconazole | 2018 |
Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Body Weight; Chronic Disease; Female; Humans; Immunoglobulin G; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Quality of Life; Retrospective Studies; Treatment Outcome; Voriconazole; Young Adult | 2018 |
Posaconazole vs. voriconazole in the prevention of invasive fungal diseases in patients with haematological malignancies: A retrospective study.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; China; Cost-Benefit Analysis; Female; Fluconazole; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Itraconazole; Male; Middle Aged; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2018 |
Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials.
Topics: Antifungal Agents; Clinical Trials as Topic; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2018 |
Simultaneous quantification of systemic azoles and their major metabolites in human serum by HPLC/PDA: role of azole metabolic rate.
Topics: Antifungal Agents; Azoles; Chromatography, High Pressure Liquid; Humans; Itraconazole; Serum; Triazoles; Voriconazole | 2018 |
Prospective survey of azole drug resistance among environmental and clinical isolates of Aspergillus fumigatus in a French University hospital during major demolition works.
Topics: Air Microbiology; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cross Infection; Drug Resistance, Fungal; Facility Design and Construction; France; Hospitals, University; Humans; Itraconazole; Voriconazole | 2018 |
A Case of Conjunctival Ulcer and Uveitis Caused by Acrophialophora Sp. in an Immunocompromised Patient: a Case Report and Riterature Review.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Ascomycota; Child; Child, Preschool; Cluster Analysis; Conjunctival Diseases; DNA, Fungal; DNA, Ribosomal Spacer; Eye Infections, Fungal; Female; Humans; Immunocompromised Host; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; RNA, Ribosomal; Sequence Analysis, DNA; Treatment Outcome; Ulcer; Uveitis; Voriconazole | 2018 |
Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Ascomycota; Brazil; Caspofungin; Chromoblastomycosis; DNA, Fungal; DNA, Intergenic; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Voriconazole | 2018 |
Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Candida glabrata; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Itraconazole; Lanosterol; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Sterol 14-Demethylase; Triazoles; Voriconazole | 2018 |
Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris.
Topics: Animals; Antifungal Agents; Caenorhabditis elegans; Candida; Candidiasis; Disease Models, Animal; Drug Synergism; Itraconazole; Sulfamethoxazole; Survival Analysis; Treatment Outcome; Voriconazole | 2018 |
Acanthamoeba keratitis in Mexico: Report of a clinical case and importance of sensitivity assays for a better outcome.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Chlorhexidine; Contact Lenses; Dogs; Female; Humans; Inhibitory Concentration 50; Itraconazole; Madin Darby Canine Kidney Cells; Mexico; Mice; Mice, Inbred BALB C; Mydriatics; Netilmicin; Parasitic Sensitivity Tests; Phenylephrine; Tropicamide; Voriconazole | 2019 |
Antifungal susceptibility of yeasts isolated from anthropogenic watershed.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fresh Water; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Reference Values; Sequence Analysis, DNA; Voriconazole; Yeasts | 2019 |
Predicting the Effects of Different Triazole Antifungal Agents on the Pharmacokinetics of Tamoxifen.
Topics: Antifungal Agents; Bone Density Conservation Agents; Drug Interactions; Female; Fluconazole; Forecasting; Humans; Itraconazole; Middle Aged; Models, Biological; Tamoxifen; Triazoles; Voriconazole | 2019 |
Effects of ketoconazole, voriconazole, and itraconazole on the pharmacokinetics of apatinib in rats.
Topics: Animals; Antifungal Agents; Antineoplastic Agents; Drug Evaluation, Preclinical; Drug Interactions; Drug Monitoring; Itraconazole; Ketoconazole; Male; Mycoses; Pyridines; Rats; Rats, Sprague-Dawley; Stomach Neoplasms; Voriconazole | 2019 |
Evaluation of the sensitivity to chlorhexidine, voriconazole and itraconazole of T4 genotype Acanthamoeba isolated from Mexico.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Amebiasis; Anti-Infective Agents; Chlorhexidine; Contact Lenses; Corneal Ulcer; DNA, Protozoan; Genotype; Humans; Inhibitory Concentration 50; Itraconazole; Mexico; Soil; Voriconazole | 2019 |
Successful control of exacerbation of Allergic Bronchopulmonary Aspergillosis due to Aspergillus terreus in a cystic fibrosis patient with short-term adjunctive therapy with voriconazole: A case report.
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Child; Cystic Fibrosis; Drug Administration Schedule; Humans; Itraconazole; Male; Sputum; Thorax; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole | 2019 |
The Evolution of Azole Resistance in
Topics: Amino Acid Sequence; Antifungal Agents; Azoles; Candida albicans; Fluconazole; Fungal Proteins; Itraconazole; Mutation; Protein Binding; Sterol 14-Demethylase; Triazoles; Voriconazole | 2019 |
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult | 2019 |
Why do lung transplant patients discontinue triazole prophylaxis?
Topics: Adult; Aged; Antifungal Agents; Drug Interactions; Female; Humans; Invasive Fungal Infections; Itraconazole; Lung Transplantation; Male; Medication Adherence; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Voriconazole | 2019 |
Epidemiology and susceptibility profile to classic antifungals and over-the-counter products of Malassezia clinical isolates from a Portuguese University Hospital: a prospective study.
Topics: Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Itraconazole; Malassezia; Microbial Sensitivity Tests; Nonprescription Drugs; Portugal; Prospective Studies; Skin; Voriconazole | 2019 |
Selection of Oral Antifungals for Initial Maintenance Therapy in Chronic Pulmonary Aspergillosis: A Longitudinal Analysis.
Topics: Aged; Antifungal Agents; Follow-Up Studies; Humans; Itraconazole; Maintenance; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole | 2020 |
The pathogen spectrum and resistance in patients with peritoneal dialysis-associated peritonitis: A single-center, observational clinical study
.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cefazolin; Ceftriaxone; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Vancomycin; Voriconazole; Young Adult | 2019 |
Comparison of the inhibitory effect of ketoconazole, voriconazole, fluconazole, and itraconazole on the pharmacokinetics of bosentan and its corresponding active metabolite hydroxy bosentan in rats.
Topics: Animals; Antifungal Agents; Antihypertensive Agents; Bosentan; Drug Interactions; Fluconazole; Itraconazole; Ketoconazole; Male; Rats; Rats, Sprague-Dawley; Triazoles; Voriconazole | 2020 |
Evaluation of Candida colonization and use of the Candida Colonization Index in a paediatric Intensive Care Unit: a prospective observational study.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Child; Child, Preschool; Disease Susceptibility; Feasibility Studies; Female; Fluconazole; Humans; Infant; Intensive Care Units, Pediatric; Itraconazole; Male; Microbial Sensitivity Tests; Organ Specificity; Prospective Studies; Sensitivity and Specificity; Voriconazole | 2019 |
Impact of Triazole Therapeutic Drug Monitoring Availability and Timing.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Monitoring; Female; Humans; Invasive Fungal Infections; Itraconazole; Male; Middle Aged; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2019 |
Epidemiological aspects and characterization of the resistance profile of
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brazil; Child; Child, Preschool; Female; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Voriconazole; Young Adult | 2019 |
Topics: Administration, Ophthalmic; Administration, Oral; Aged; Antifungal Agents; Aspergillosis; Aspergillus flavus; Eye Infections, Fungal; Female; Humans; Itraconazole; Phacoemulsification; Scleritis; Visual Acuity; Vitrectomy; Voriconazole | 2020 |
Characteristics and Prognosis of Talaromyces marneffei Infection in Non-HIV-Infected Children in Southern China.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Child; Child, Preschool; China; Female; HIV-1; Humans; Infant; Itraconazole; Male; Mycoses; Retrospective Studies; Talaromyces; Voriconazole | 2019 |
In vitro synergy of azole antifungals and methotrexate against Candida albicans.
Topics: Candida albicans; Cell Membrane; Cell Wall; Dose-Response Relationship, Drug; Drug Synergism; Fluconazole; Gastrula; In Vitro Techniques; Itraconazole; Methotrexate; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Voriconazole | 2019 |
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole | 2019 |
Antifungals in a case of basidiobolomycosis: role and limitations.
Topics: Abdominal Pain; Administration, Intravenous; Antifungal Agents; Child; Crohn Disease; Disease Progression; Humans; Itraconazole; Male; Treatment Outcome; Voriconazole; Zygomycosis | 2019 |
Topics: Antifungal Agents; Base Sequence; Epidermophyton; Humans; Iran; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Terbinafine; Tinea; Trichophyton; Voriconazole | 2019 |
First isolation of voriconazole-resistant Candida albicans, C. tropicalis, and Aspergillus niger from the blowholes of bottlenose dolphins (Tursiops truncatus).
Topics: Animals; Antifungal Agents; Aspergillus niger; Bottle-Nosed Dolphin; Candida albicans; Candida tropicalis; Drug Resistance, Fungal; Itraconazole; Japan; Microbial Sensitivity Tests; Mycoses; Voriconazole | 2019 |
Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro.
Topics: Aminolevulinic Acid; Antifungal Agents; Ascomycota; China; Chromoblastomycosis; DNA, Fungal; Female; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Photochemotherapy; Skin; Terbinafine; Voriconazole | 2019 |
In vitro antifungal activity of luliconazole against nondermatophytic moulds.
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2020 |
Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole | 2020 |
Synergistic Effects of Efflux Pump Modulators on the Azole Antifungal Susceptibility of Microsporum canis.
Topics: Anti-Dyskinesia Agents; Antifungal Agents; Azoles; Dermatomycoses; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Haloperidol; Histamine H1 Antagonists; Humans; Itraconazole; Microbial Sensitivity Tests; Microsporum; Promethazine; Voriconazole | 2020 |
Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Cross-Sectional Studies; Drug Resistance, Fungal; Female; Fluconazole; Follow-Up Studies; Humans; Incidence; Infant, Newborn; Itraconazole; Lebanon; Microbial Sensitivity Tests; Pregnancy; Prevalence; Vaginal Discharge; Voriconazole | 2020 |
Azole resistance in Candida from animals calls for the One Health approach to tackle the emergence of antimicrobial resistance.
Topics: Animals; Antifungal Agents; Candida albicans; Candida parapsilosis; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Male; Voriconazole | 2020 |
MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; United Kingdom; Voriconazole | 2020 |
Synergistic effects of vorinostat (SAHA) and azoles against Aspergillus species and their biofilms.
Topics: Aspergillus; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; Azoles; Biofilms; Drug Synergism; Gene Expression Regulation; HSP90 Heat-Shock Proteins; Itraconazole; Microbial Sensitivity Tests; Plankton; Triazoles; Voriconazole; Vorinostat | 2020 |
Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Terbinafine; Tinea; Tinea Pedis; Triazoles; Trichophyton; Voriconazole | 2020 |
Topics: Antifungal Agents; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Exophiala; Fungi; Fusarium; Itraconazole; Microbial Sensitivity Tests; Minocycline; Voriconazole | 2020 |
Impact of high baseline Aspergillus-specific IgG levels on weight and quality-of-life outcomes of patients with chronic pulmonary aspergillosis.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Fungal; Antifungal Agents; Aspergillus; Chronic Disease; Female; Humans; Immunoglobulin G; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Quality of Life; Retrospective Studies; United Kingdom; Voriconazole; Weight Loss | 2020 |
Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
Topics: Aged; Antifungal Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Incidence; Itraconazole; Lung Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Skin Neoplasms; Triazoles; United States; Voriconazole | 2020 |
Inhibitory effects of voriconazole, itraconazole and fluconazole on the pharmacokinetic profiles of ivosidenib in rats by UHPLC-MS/MS.
Topics: Animals; Antifungal Agents; Antineoplastic Agents; Chromatography, High Pressure Liquid; Drug Interactions; Fluconazole; Glycine; Itraconazole; Male; Pyridines; Rats; Rats, Sprague-Dawley; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Voriconazole | 2020 |
Successful treatment of resistant onychomycosis with voriconazole in a liver transplant patient.
Topics: Antifungal Agents; Humans; Itraconazole; Liver Transplantation; Onychomycosis; Terbinafine; Voriconazole | 2020 |
Subcutaneous phaeohyphomycosis caused by Hongkongmyces snookiorum in a kidney transplant patient: a case report.
Topics: Antifungal Agents; Ascomycota; Female; Humans; Itraconazole; Kidney Transplantation; Middle Aged; Phaeohyphomycosis; Renal Insufficiency, Chronic; Voriconazole | 2020 |
Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: II. Therapies for allergic bronchopulmonary aspergillosis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Amphotericin B; Anti-Infective Agents; Antibodies, Monoclonal; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Child; Cystic Fibrosis; Female; Humans; Itraconazole; Omalizumab; Voriconazole | 2020 |
Antifungal susceptibility profile and molecular identification of Cyp51C mutations in clinical and environmental isolates of Aspergillus flavus from Argentina.
Topics: Amphotericin B; Antifungal Agents; Argentina; Aspergillosis; Aspergillus flavus; Cytochrome P450 Family 51; Drug Resistance, Fungal; Environmental Microbiology; Environmental Monitoring; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole | 2021 |
Purpureocillium roseum sp. nov. A new ocular pathogen for humans and mice resistant to antifungals.
Topics: Aged; Amphotericin B; Animals; Antifungal Agents; Cornea; DNA, Fungal; Drug Resistance, Fungal; Female; Humans; Hypocreales; Itraconazole; Keratitis; Mexico; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycological Typing Techniques; Mycoses; Phylogeny; Voriconazole | 2021 |
Voriconazole Versus Itraconazole for the Initial and Step-down Treatment of Histoplasmosis: A Retrospective Cohort.
Topics: Adult; Antifungal Agents; Histoplasma; Histoplasmosis; Humans; Itraconazole; Retrospective Studies; Voriconazole | 2021 |
Differential Impacts of Azole Antifungal Drugs on the Pharmacokinetic Profiles of Dasatinib in Rats by LC-MS-MS.
Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dasatinib; Drug Interactions; Drug Monitoring; Humans; Itraconazole; Ketoconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Models, Animal; Protein Kinase Inhibitors; Rats; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2020 |
Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Caspofungin; DNA, Fungal; DNA, Ribosomal Spacer; Fluconazole; Humans; Imidazoles; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Rhodotorula; Species Specificity; Triazoles; Voriconazole | 2020 |
Do high MICs predict the outcome in invasive fusariosis?
Topics: Antifungal Agents; Fusariosis; Humans; Itraconazole; Microbial Sensitivity Tests; Retrospective Studies; Voriconazole | 2021 |
Rapid and Simple Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) Method for Simultaneous Quantifications of Triazole Antifungals in Human Serum.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Itraconazole; Reproducibility of Results; Triazoles; Voriconazole | 2021 |
Species distribution and antifungal susceptibility of
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Child; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Lebanon; Male; Microbial Sensitivity Tests; Middle Aged; Voriconazole; Young Adult | 2021 |
THE ISOLATION AND ANTIMICROBIAL SENSITIVITY OF
Topics: Air Sacs; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bird Diseases; Drug Resistance, Multiple, Fungal; Itraconazole; Lung; Species Specificity; Spheniscidae; Terbinafine; United Kingdom; Voriconazole | 2020 |
Effects of CYP3A inhibitors ketoconazole, voriconazole, and itraconazole on the pharmacokinetics of sunitinib and its main metabolite in rats.
Topics: Administration, Oral; Animals; Cytochrome P-450 CYP3A Inhibitors; Itraconazole; Ketoconazole; Male; Rats, Sprague-Dawley; Sunitinib; Voriconazole | 2021 |
Isavuconazole nonwildtype Aspergillus fumigatus isolates from a global surveillance study display alterations in multiple genes involved in the ergosterol biosynthesis pathway not previously associated with resistance to other azoles.
Topics: Antifungal Agents; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Ergosterol; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole; Whole Genome Sequencing | 2021 |
Candida tropicalis distribution and drug resistance is correlated with ERG11 and UPC2 expression.
Topics: Antifungal Agents; Azoles; Candida tropicalis; China; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Humans; Itraconazole; Voriconazole | 2021 |
Species identification and antifungal susceptibility testing of Aspergillus strains isolated from patients with otomycosis in northern China.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Humans; Itraconazole; Microbial Sensitivity Tests; Otomycosis; Voriconazole | 2022 |
Clinical utility of antifungal susceptibility testing in patients with fungal rhinosinusitis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Mycoses; Sinusitis; Triazoles; Voriconazole | 2021 |
Genotypic diversity of Iranian Cryptococcus neoformans using multilocus sequence typing (MLST) and susceptibility to antifungals.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Flucytosine; Genetic Loci; Genetic Variation; Genotype; Imidazoles; Iran; Itraconazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mycological Typing Techniques; Voriconazole | 2021 |
Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal
Topics: Adult; Amphotericin B; Antifungal Agents; Biofilms; Biomass; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Middle Aged; Polymorphism, Restriction Fragment Length; Vagina; Virulence; Voriconazole; Young Adult | 2021 |
Pseudohyperaldosteroism during itraconazole treatment: a hitherto neglected clinically significant side effect.
Topics: Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Itraconazole; Voriconazole | 2021 |
Comparison of Disc Diffusion, Etest, and a Modified CLSI Broth Microdilution Method for
Topics: Antifungal Agents; Disk Diffusion Antimicrobial Tests; Itraconazole; Madurella; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2021 |
The effect of biosynthesized selenium nanoparticles on the expression of CYP51A and HSP90 antifungal resistance genes in Aspergillus fumigatus and Aspergillus flavus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Itraconazole; Microbial Sensitivity Tests; Nanoparticles; Selenium; Triazoles; Voriconazole | 2022 |
Azole resistance in Aspergillus fumigatus isolates from respiratory specimens in Lyon University Hospitals, France: prevalence and mechanisms involved.
Topics: Antifungal Agents; Aspergillus fumigatus; Cross-Sectional Studies; Cytochrome P-450 Enzyme System; France; Fungal Proteins; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Pyridines; Respiratory Tract Infections; Retrospective Studies; Triazoles; Tubulin; Voriconazole | 2021 |
Is Itraconazole Superior to Voriconazole for Treatment of Histoplasmosis?
Topics: Antifungal Agents; Histoplasma; Histoplasmosis; Humans; Itraconazole; Voriconazole | 2021 |
Successful treatment of Talaromyces marneffei infection in a kidney transplant recipient with voriconazole followed by itraconazole for the first time.
Topics: Antifungal Agents; Humans; Itraconazole; Kidney Transplantation; Mycoses; Voriconazole | 2022 |
The accuracy and clinical impact of the morphological identification of Aspergillus species in the age of cryptic species: A single-centre study.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Itraconazole; Microbial Sensitivity Tests; Voriconazole | 2022 |
The Pharmacokinetic Effect of Itraconazole and Voriconazole on Ripretinib in Beagle Dogs by UPLC-MS/MS Technique.
Topics: Administration, Oral; Animals; Chromatography, High Pressure Liquid; Dogs; Female; Itraconazole; Male; Naphthyridines; Tandem Mass Spectrometry; Urea; Voriconazole | 2021 |
Use of Modeling and Simulation to Predict the Influence of Triazole Antifungal Agents on the Pharmacokinetics of Crizotinib.
Topics: Antifungal Agents; Carcinoma, Non-Small-Cell Lung; Crizotinib; Fluconazole; Humans; Itraconazole; Lung Neoplasms; Triazoles; Voriconazole | 2022 |
Topics: Antifungal Agents; Aspergillus; Azoles; Candida; Candida albicans; Drug Resistance, Fungal; Exophiala; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Morpholines; Sirolimus; TOR Serine-Threonine Kinases; Triazoles; Voriconazole | 2022 |
Itraconazole and Voriconazole: The Complexity of Dose Adjustments.
Topics: Antifungal Agents; Humans; Itraconazole; Triazoles; Voriconazole | 2022 |
Empiric antifungal therapy in patients with cutaneous and subcutaneous phaeohyphomycosis.
Topics: Antifungal Agents; Azoles; Exophiala; Humans; Itraconazole; Phaeohyphomycosis; Terbinafine; Voriconazole | 2022 |
Spectrum of voriconazole-associated periostitis in clinical characteristics, diagnosis and management.
Topics: Alkaline Phosphatase; Antifungal Agents; Bone Diseases; Female; Fluorides; Humans; Itraconazole; Male; Middle Aged; Pain; Periostitis; Retrospective Studies; Voriconazole | 2022 |
Prevalence and susceptibility profiles of oral yeast species isolated from a healthy adult Thai cohort.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida tropicalis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Prevalence; Thailand; Voriconazole | 2022 |
Antifungal Prophylaxis and Treatment Among Lung Transplant Recipients in Early Postoperative Stage: A Single-Center Study.
Topics: Antifungal Agents; Caspofungin; Female; Humans; Itraconazole; Lung; Lung Transplantation; Male; Retrospective Studies; Transplant Recipients; Voriconazole | 2022 |
Nannizzia incurvata in Hue city - Viet Nam: Molecular identification and antifungal susceptibility testing.
Topics: Antifungal Agents; Arthrodermataceae; DNA, Ribosomal; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Lipase; Microbial Sensitivity Tests; Peptide Hydrolases; Phospholipases; Phylogeny; Terbinafine; Tinea; Vietnam; Voriconazole | 2022 |
Isolation of antifungal-resistant Candida from the blowholes of captive dolphins.
Topics: Animals; Antifungal Agents; Candida; Candida albicans; Dolphins; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Voriconazole | 2022 |
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus oryzae; Clotrimazole; Econazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Terbinafine; Tolnaftate; Voriconazole | 2022 |
Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Candidiasis, Invasive; Critical Illness; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Risk Factors; Voriconazole | 2022 |
Malassezia species: the need to establish epidemiological cutoff values.
Topics: Amphotericin B; Animals; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Voriconazole | 2022 |
Multidrug resistant tinea corporis/cruris: Response to voriconazole.
Topics: Antifungal Agents; Humans; Itraconazole; Terbinafine; Tinea; Tinea cruris; Voriconazole | 2022 |
Molecular epidemiology and clinical-laboratory aspects of chromoblastomycosis in Mato Grosso, Brazil.
Topics: Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Brazil; Chromoblastomycosis; Diabetes Mellitus, Type 2; Humans; Itraconazole; Middle Aged; Molecular Epidemiology; Terbinafine; Voriconazole | 2022 |
Voriconazole is superior to combined itraconazole/isotretinoin therapy and itraconazole monotherapy in recalcitrant dermatophytosis.
Topics: Antifungal Agents; Humans; Isotretinoin; Itraconazole; Tinea; Voriconazole | 2022 |
COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; COVID-19; Female; Fluconazole; Humans; Iran; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Pulmonary Aspergillosis; SARS-CoV-2; Voriconazole | 2023 |
A fatal case of pneumonia caused by Thermothelomycesthermophila.
Topics: Antifungal Agents; Child; Female; Humans; Itraconazole; Microbial Sensitivity Tests; Pneumonia; Voriconazole | 2023 |
Biased Genotype Distributions of Candida albicans Strains Associated with 649 Clinical Vulvovaginal Candidiasis in China.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Voriconazole | 2022 |
PULMONARY AND COELOMIC MYCOSES DUE TO
Topics: Alligators and Crocodiles; Animals; Beauveria; Fluconazole; Itraconazole; Metarhizium; Mycoses; Pest Control, Biological; Terbinafine; Turtles; Voriconazole | 2022 |
Interaction of Amiodarone with Azoles Against Aspergillus Planktonic Cells and Biofilms in vitro.
Topics: Amiodarone; Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Biofilms; Itraconazole; Microbial Sensitivity Tests; Plankton; Voriconazole | 2022 |
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato.
Topics: Antifungal Agents; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Voriconazole | 2023 |
In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
Topics: Antifungal Agents; Azoles; Candida; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Caspofungin; Female; Fluconazole; Humans; Itraconazole; Voriconazole | 2023 |
Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India.
Topics: Adult; Amphotericin B; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Fluconazole; Humans; Itraconazole; Middle Aged; Natamycin; Prospective Studies; Tertiary Care Centers; Voriconazole; Young Adult | 2022 |
A survey to describe common practices on antifungal monitoring among Spanish clinicians.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Mycoses; Voriconazole | 2023 |
Antifungal activity of miltefosine against both azole-susceptible and -resistant Aspergillus strains.
Topics: Antifungal Agents; Aspergillus; Azoles; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2023 |
Matrix-assisted laser desorption/ionisation-time of flight mass spectrometry azole susceptibility assessment in Candida and Aspergillus species.
Topics: Antifungal Agents; Aspergillus; Azoles; Candida; Fluconazole; Itraconazole; Lasers; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Voriconazole | 2023 |
Talaromyces marneffei infection and complicate manifestation of respiratory system in HIV-negative children.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Child; Humans; Itraconazole; Respiratory System; Respiratory Tract Infections; Retrospective Studies; Voriconazole | 2023 |
In vitro antifungal and antibiofilm activities of auranofin against itraconazole-resistant Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Auranofin; Itraconazole; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2023 |
Phenotypic and genotypic characterization of virulence markers and antifungal susceptibility of oral Candida species from diabetic and non-diabetic hemodialysis patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Peptide Hydrolases; Phospholipases; Virulence; Voriconazole | 2023 |
Aspergillus welwitschiae; an otomycosis predominant agent, new epidemiological and antifungal susceptibility data from Iran.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus niger; Calmodulin; Female; Humans; Iran; Itraconazole; Male; Microbial Sensitivity Tests; Nystatin; Otomycosis; Voriconazole | 2023 |
Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Program (2018-2021) and application of single-site epidemiological c
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Caspofungin; Drug Resistance, Fungal; Fungi; Itraconazole; Microbial Sensitivity Tests; Voriconazole | 2023 |
Observed isavuconazole exposure: 5-year experience of azole TDM from a Spanish reference laboratory.
Topics: Animals; Antifungal Agents; Azoles; Itraconazole; Voriconazole | 2023 |
Antifungal susceptibility patterns for Aspergillus, Scedosporium, and Exophiala isolates recovered from cystic fibrosis patients against amphotericin B, and three triazoles and their impact after long-term therapies.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Azoles; Cystic Fibrosis; Exophiala; Itraconazole; Scedosporium; Triazoles; Voriconazole | 2023 |
HPLC-MS/MS Method Validation for Antifungal Agents in Human Serum in Clinical Application.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Itraconazole; Tandem Mass Spectrometry; Triazoles; United States; Voriconazole | 2023 |
In vitro sensitivity of Malassezia furfur isolates from HIV-positive and negative patients to antifungal agents
Topics: Amphotericin B; Animals; Antifungal Agents; Dermatitis, Seborrheic; Fluconazole; HIV Infections; Humans; Itraconazole; Malassezia; Saccharomyces cerevisiae; Voriconazole | 2023 |
Triazole Antifungal Quantification for Therapeutic Drug Monitoring in Serum by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): Posaconazole, Voriconazole, Itraconazole, and Hydroxyitraconazole.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drug Monitoring; Itraconazole; Methanol; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2024 |
New azole antifungals. 2. Synthesis and antifungal activity of heterocyclecarboxamide derivatives of 3-amino-2-aryl-1-azolyl-2-butanol.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbial; Fungi; Male; Mice; Molecular Conformation; Pyrimidinones; Rats; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Thiophenes; Triazoles | 1998 |
New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbial; Fungi; Male; Mice; Molecular Conformation; Quinazolines; Rabbits; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Triazoles | 1998 |
Novel antifungals based on 4-substituted imidazole: solid-phase synthesis of substituted aryl sulfonamides towards optimization of in vitro activity.
Topics: Antifungal Agents; Candida albicans; Fungi; Imidazoles; Microbial Sensitivity Tests; Structure-Activity Relationship; Sulfonamides; Yeasts | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Synthesis and antifungal activity of (Z)-5-arylidenerhodanines.
Topics: Antifungal Agents; Computer Simulation; Drug Design; Microbial Sensitivity Tests; Microwaves; Mitosporic Fungi; Molecular Structure; Rhodanine; Sensitivity and Specificity; Stereoisomerism; Structure-Activity Relationship; Yeasts | 2007 |
Prevalence and susceptibility testing of new species of pseudallescheria and scedosporium in a collection of clinical mold isolates.
Topics: Antifungal Agents; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Pseudallescheria; Scedosporium | 2007 |
Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; DNA Primers; Genes, Fungal; Genetic Complementation Test; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Phenotype; Polyenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Fungal; RNA, Messenger; Sterols | 2007 |
In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Quality Control; Zygomycosis | 2007 |
Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia.
Topics: Amphotericin B; Antifungal Agents; Cross Infection; Fluconazole; Fungemia; Humans; Itraconazole; Microbial Sensitivity Tests; Pichia | 2007 |
In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
Topics: Antifungal Agents; Area Under Curve; Candida; Fungemia; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2007 |
A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Mutation; Oxidative Phosphorylation; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2007 |
Synthesis of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase (CYP51).
Topics: Antifungal Agents; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Triazoles | 2007 |
A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genotype; Humans; Microbial Sensitivity Tests; Tandem Repeat Sequences | 2007 |
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Oral; Drug Resistance, Fungal; Environmental Microbiology; Fungicides, Industrial; Germany; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; Oropharynx; Vitis | 2007 |
Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy.
Topics: Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Colletotrichum; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fungi; Fungicides, Industrial; Humans; In Vitro Techniques; Lipopeptides; Microbial Sensitivity Tests; Microscopy, Fluorescence; Nystatin; Plant Diseases; Skin; Triazoles | 2007 |
Voriconazole inhibits melanization in Cryptococcus neoformans.
Topics: Animals; Antifungal Agents; Cell Line; Cryptococcus neoformans; Fluconazole; Gene Expression Regulation, Fungal; Laccase; Macrophages; Melanins; Mice; Microbial Sensitivity Tests; Phagocytosis; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2007 |
Antifungal and cytotoxic activities of some N-substituted aniline derivatives bearing a hetaryl fragment.
Topics: Aniline Compounds; Antifungal Agents; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Imines; Microbial Sensitivity Tests; Molecular Structure; National Cancer Institute (U.S.); United States | 2008 |
In vitro antifungal susceptibilities of five species of sporothrix.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis | 2008 |
In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods.
Topics: Azoles; Candida albicans; Colony Count, Microbial; Colorimetry; Culture Media; Drug Interactions; Drug Resistance, Fungal; Drug Synergism; Humans; Immunosuppressive Agents; Microbial Sensitivity Tests; Models, Biological; Spectrophotometry; Tacrolimus | 2008 |
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Aspergillosis; Aspergillus; Candida; Candidiasis; Catheterization, Central Venous; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fungemia; Fungi; Humans; Microbial Sensitivity Tests | 2008 |
Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Culture Media; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Reproducibility of Results; Yeasts | 2008 |
Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification.
Topics: Antifungal Agents; Aspergillus fumigatus; Fungal Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Nuclear Proteins; Phylogeny; Polymerase Chain Reaction; Sequence Analysis, DNA; Tubulin | 2008 |
In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.
Topics: Antifungal Agents; Azoles; Cryptococcosis; Cryptococcus neoformans; Cuba; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2008 |
Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Clinical Trials as Topic; Female; Health Surveys; Humans; Infant; Male; Middle Aged; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity | 2008 |
In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Fusarium; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Triazoles; Tubulin | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy.
Topics: Antifungal Agents; Base Sequence; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Fusarium; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Species Specificity | 2008 |
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.
Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents.
Topics: Antifungal Agents; Candida albicans; Fluconazole; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole; Yeasts | 2008 |
Susceptibility testing and molecular classification of Paecilomyces spp.
Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; Echinocandins; Itraconazole; Microbial Sensitivity Tests; Paecilomyces; Phylogeny | 2008 |
1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies.
Topics: Antifungal Agents; Arthrodermataceae; Candida albicans; Cell Line, Tumor; Cell Survival; Computer Simulation; Humans; Imidazoles; Models, Molecular; Molecular Structure; Stereoisomerism; Structure-Activity Relationship | 2008 |
CYP56 (Dit2p) in Candida albicans: characterization and investigation of its role in growth and antifungal drug susceptibility.
Topics: Base Sequence; Candida albicans; Cell Wall; Cytochrome P-450 Enzyme System; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Gene Deletion; Gene Expression; Genes, Fungal; Mutation; Phenotype; Recombinant Proteins; Tyrosine | 2008 |
Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Europe; Fungi; Guidelines as Topic; Humans; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Triazoles; Yeasts | 2008 |
Differential azole antifungal efficacies contrasted using a Saccharomyces cerevisiae strain humanized for sterol 14 alpha-demethylase at the homologous locus.
Topics: Antifungal Agents; Azoles; Base Sequence; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Genes, Fungal; Humans; Molecular Sequence Data; Recombinant Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Species Specificity; Sterol 14-Demethylase | 2008 |
Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biofilms; Bronchi; Cells, Cultured; Cystic Fibrosis; Drug Resistance, Fungal; Epithelial Cells; Humans; Microbial Sensitivity Tests; Microscopy, Confocal; Microscopy, Electron, Scanning; Respiratory Tract Infections | 2008 |
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged | 2008 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae | 2009 |
In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; DNA, Fungal; Humans; Microbial Sensitivity Tests; Soil Microbiology | 2009 |
Identification, characterization, and azole-binding properties of Mycobacterium smegmatis CYP164A2, a homolog of ML2088, the sole cytochrome P450 gene of Mycobacterium leprae.
Topics: Amino Acid Motifs; Amino Acid Sequence; Azoles; Base Sequence; Cloning, Molecular; Conserved Sequence; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Genes, Bacterial; Hydrogen-Ion Concentration; Molecular Sequence Data; Molecular Structure; Molecular Weight; Mycobacterium leprae; Mycobacterium smegmatis; Osmolar Concentration; Recombinant Proteins; Sequence Homology, Amino Acid; Sodium Chloride | 2009 |
Design, synthesis, and biological evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Enzyme Inhibitors; Protein Binding; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2009 |
Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Humans; Immunohistochemistry; Injections, Intraperitoneal; Lipopeptides; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2009 |
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.
Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies | 2009 |
Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers.
Topics: Amphotericin B; Antifungal Agents; DNA, Ribosomal Spacer; Microbial Sensitivity Tests; Mucorales; Triazoles | 2009 |
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain | 2009 |
Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols.
Topics: Antifungal Agents; Catalytic Domain; Chemistry, Pharmaceutical; Computer Simulation; Crystallography, X-Ray; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Models, Chemical; Propanols; Protein Binding; Triazoles | 2009 |
New azoles with potent antifungal activity: design, synthesis and molecular docking.
Topics: Antifungal Agents; Azoles; Candida albicans; Catalytic Domain; Cytochrome P-450 Enzyme System; Drug Design; Fungal Proteins; Fungi; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Protein Binding; Structure-Activity Relationship | 2009 |
Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri.
Topics: Antifungal Agents; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny | 2009 |
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.
Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia | 2009 |
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Kidney; Male; Mice; Mucormycosis; Rhizopus; Triazoles | 2009 |
In vitro activity of thimerosal against ocular pathogenic fungi.
Topics: Alternaria; Amphotericin B; Antifungal Agents; Aspergillus; Eye Infections, Fungal; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Natamycin; Thimerosal | 2010 |
Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene.
Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disease Models, Animal; Drug Administration Schedule; Female; Fungal Proteins; Mice; Microbial Sensitivity Tests; Mutation; Triazoles | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection.
Topics: Animals; Antifungal Agents; Base Sequence; Candida albicans; Candidiasis; Disease Models, Animal; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Female; Fluconazole; Fungal Proteins; Genes, Fungal; Genetic Engineering; Humans; In Vitro Techniques; Membrane Transport Proteins; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation | 2010 |
Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata.
Topics: Animals; Antifungal Agents; Base Sequence; Calcineurin; Candida glabrata; Candidiasis; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Female; Fungal Proteins; Genes, Fungal; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation; Opportunistic Infections; Transcription Factors; Virulence | 2010 |
Structure-based rational design, synthesis and antifungal activity of oxime-containing azole derivatives.
Topics: Antifungal Agents; Azoles; Binding Sites; Catalytic Domain; Computer Simulation; Cytochrome P-450 Enzyme System; Drug Design; Microbial Sensitivity Tests; Oximes; Sterol 14-Demethylase; Structure-Activity Relationship | 2010 |
Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling.
Topics: Amino Acid Substitution; Antifungal Agents; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genes, Fungal; Humans; In Vitro Techniques; Models, Molecular; Mutation, Missense; Protein Conformation; Structural Homology, Protein; Tandem Repeat Sequences | 2010 |
Antifungal susceptibility profile of human-pathogenic species of Lichtheimia.
Topics: Amphotericin B; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mucorales; Pyrimidines; Triazoles; Voriconazole | 2010 |
In vitro antifungal activities of bis(alkylpyridinium)alkane compounds against pathogenic yeasts and molds.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyridinium Compounds; Yeasts | 2010 |
A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Drug Resistance, Fungal; Fungal Proteins; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction | 2010 |
Synthesis and antifungal evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Fungi; Humans; Models, Molecular; Mycoses; Sterol 14-Demethylase; Triazoles | 2010 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
New azoles with antifungal activity: Design, synthesis, and molecular docking.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Azoles; Fungi; Humans; Microbial Sensitivity Tests; Models, Molecular; Mycoses; Protein Binding; Sterol 14-Demethylase; Structure-Activity Relationship | 2011 |
Design, synthesis and antifungal evaluation of 1-(2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)-1H-1,2,4-triazol-5(4H)-one.
Topics: Antifungal Agents; Candida albicans; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2011 |
Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives.
Topics: Antifungal Agents; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Piperazines; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles; Voriconazole | 2011 |
Design, synthesis and molecular docking studies of novel triazole as antifungal agent.
Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Piperazines; Propanols; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles; Voriconazole | 2011 |
Synthesis, in vitro evaluation and molecular docking studies of new triazole derivatives as antifungal agents.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Binding Sites; Catalytic Domain; Computer Simulation; Hydrogen Bonding; Microbial Sensitivity Tests; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2011 |
New triazole derivatives as antifungal agents: synthesis via click reaction, in vitro evaluation and molecular docking studies.
Topics: Antifungal Agents; Catalysis; Catalytic Domain; Click Chemistry; Computer Simulation; Copper; Fungi; Humans; Microbial Sensitivity Tests; Triazoles | 2012 |
Synthesis and biological evaluation of vinyl ether-containing azole derivatives as inhibitors of Trichophyton rubrum.
Topics: Antifungal Agents; Azoles; Molecular Structure; Structure-Activity Relationship; Trichophyton; Vinyl Compounds | 2012 |
Synthesis and anti-Candida activity of novel 2-hydrazino-1,3-thiazole derivatives.
Topics: Animals; Antifungal Agents; Candida; Candida albicans; Cell Survival; Drug Resistance, Fungal; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Structure-Activity Relationship; Thiazoles | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis and evaluation of novel azoles as potent antifungal agents.
Topics: Antifungal Agents; Azoles; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2014 |
Design, synthesis, and structure-activity relationship studies of novel fused heterocycles-linked triazoles with good activity and water solubility.
Topics: Animals; Antifungal Agents; Area Under Curve; Candida; Drug Design; Drug Evaluation, Preclinical; Half-Life; Heterocyclic Compounds; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Molecular Docking Simulation; Rats; Solubility; Structure-Activity Relationship; Triazoles; Water | 2014 |
Polyhydroxy cyclohexanols from a Dendrodochium sp. fungus associated with the sea cucumber Holothuria nobilis Selenka.
Topics: Animals; Antifungal Agents; Cryptococcus neoformans; Cyclohexanols; Holothuria; Humans; Microbial Sensitivity Tests; Molecular Structure; Oceans and Seas; Trichophyton | 2014 |
Discovery of a novel broad-spectrum antifungal agent derived from albaconazole.
Topics: | 2013 |
Design and optimization of highly-selective fungal CYP51 inhibitors.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Candida albicans; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Conformation; Sterol 14-Demethylase; Structure-Activity Relationship | 2014 |
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
Topics: Antifungal Agents; Benzimidazoles; Carbon-13 Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Proton Magnetic Resonance Spectroscopy; Reactive Oxygen Species; Yeasts | 2016 |
Novel alkylated azoles as potent antifungals.
Topics: Alkylation; Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Cell Line; Ergosterol; Fungi; Hemolysis; Humans; Mice; Microbial Sensitivity Tests; Mycoses | 2017 |
Design, synthesis and evaluation of benzoheterocycle analogues as potent antifungal agents targeting CYP51.
Topics: Antifungal Agents; Aspergillus fumigatus; Binding Sites; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Drug Design; Drug Resistance, Fungal; Drug Stability; Fluconazole; Fungal Proteins; Gas Chromatography-Mass Spectrometry; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Isoforms; Sterol 14-Demethylase; Sterols; Structure-Activity Relationship; Triazoles | 2018 |
Design, synthesis, and structure-activity relationship studies of l-amino alcohol derivatives as broad-spectrum antifungal agents.
Topics: A549 Cells; Amino Alcohols; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Candida tropicalis; Catalytic Domain; Cryptococcus neoformans; Drug Design; Drug Stability; Ergosterol; Humans; Microbial Sensitivity Tests; Protein Binding; Stereoisomerism; Sterol 14-Demethylase; Structure-Activity Relationship | 2019 |
Antifungal activity, mode of action variability, and subcellular distribution of coumarin-based antifungal azoles.
Topics: Antifungal Agents; Azoles; Candida; Cell Survival; Coumarins; Dose-Response Relationship, Drug; HEK293 Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Optical Imaging; Structure-Activity Relationship | 2019 |
New azole antifungals with a fused triazinone scaffold.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Mice; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazines | 2020 |
Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis.
Topics: 14-alpha Demethylase Inhibitors; Animals; Azoles; Candida albicans; Candidiasis; Cytochrome P450 Family 51; Drug Discovery; Drug Resistance, Fungal; Female; Histone Deacetylase Inhibitors; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred ICR; Sterol 14-Demethylase; Treatment Outcome | 2020 |
Lanosterol 14α-demethylase (CYP51)/histone deacetylase (HDAC) dual inhibitors for treatment of Candida tropicalis and Cryptococcus neoformans infections.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Candida tropicalis; Candidiasis, Cutaneous; Cryptococcosis; Cryptococcus neoformans; Cytochrome P450 Family 51; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Histone Deacetylase Inhibitors; Histone Deacetylases; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2021 |
Identification of Thiazoyl Guanidine Derivatives as Novel Antifungal Agents Inhibiting Ergosterol Biosynthesis for Treatment of Invasive Fungal Infections.
Topics: Antifungal Agents; Aspergillus fumigatus; Dose-Response Relationship, Drug; Ergosterol; Guanidine; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thiazoles | 2021 |
Design, synthesis and evaluation of novel 5-phenylthiophene derivatives as potent fungicidal of Candida albicans and antifungal reagents of fluconazole-resistant fungi.
Topics: Antifungal Agents; Candida albicans; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Fungal; Fluconazole; Fungicides, Industrial; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thiophenes | 2021 |
Relaxed Substrate Requirements of Sterol 14α-Demethylase from
Topics: 14-alpha Demethylase Inhibitors; Ligands; Naegleria fowleri; Sterol 14-Demethylase; Substrate Specificity | 2021 |